Sleep disorders (combined)

SLEEP

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints F5_SLEEP G6_SLEEPAPNO G6_NARCOCATA G6_SLEEPDISOTH	129509
6. Filter based on genotype QC (FinnGen only)	117492

Control definitions (FinnGen only)

Control exclude: F5_BEHAVE

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	SLEEP
CONTROL_EXCLUDE	F5_BEHAVE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	F5_SLEEP\|G6_SLEEPAPNO\|G6_NARCOCATA\|G6_SLEEPDISOTH
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleep disorders (combined) based on the number of shared cases.

Similar with more cases:

None

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	117492	66304	51188
Unadjusted period prevalence (%)	23.51	23.54	23.47
Median age at first event (years)	54.80	53.94	55.92

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
72456: Matched controls
378258

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

G56.0

ICD-10 Finland

Carpal tunnel syndrome

1.7

323.3

8137

26705

L02

ICPC

Back symptom/complaint

1.7

322.7

6765

21107

OAA81, ,

SPAT

2.5

322.7

2540

5466

R03AK08

ATC

formoterol and beclometasone; inhalant

2.4

321.9

2781

6258

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.5

321.1

13869

51661

R01BA52

ATC

pseudoephedrine, combinations; oral

1.4

320.3

17101

66440

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

1.8

320.0

6361

19537

SDA03

NOMESCO Finland

Periodontal treatment

1.4

319.8

26360

110605

T36

ICD-10 Finland

Poisoning by systemic antibiotics

2.4

317.2

2649

5866

3074A

ICD-9 Finland

Special symptoms or syndromes not elsewhere classified, Specific disorders of sleep of nonorganic origin[UNIHÄIRIÖ]

+∞

317.1

399

SPAT1260

SPAT

Consultation of another employee

1.6

316.3

10669

37634

S29

ICPC

Skin symptom/complaint other

1.5

315.9

12885

47402

N03AE01

ATC

clonazepam; systemic

2.2

314.3

3256

7937

Z05

ICPC

Work problem

2.5

312.2

2341

4917

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.8

311.3

5278

15425

R29

ICPC

Respiratory symptom/complaint other

2.0

310.5

4321

11809

J01FF01

ATC

clindamycin; systemic

1.5

309.7

16229

62758

H04.10

ICD-10 Finland

Dry eye syndrome

1.7

308.9

7210

23170

M01AH01

ATC

celecoxib; oral

1.6

308.7

10025

35031

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

307.7

8403

28145

R03AC02

ATC

salbutamol; inhalant

2.0

307.7

40634

148852

J34.2

ICD-10 Finland

Deviated nasal septum

2.6

307.7

3409

7085

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.6

307.7

13294

47627

R01AD58

ATC

fluticasone, combinations; nasal

1.8

307.7

18053

58826

R06.5

ICD-10 Finland

Mouth breathing

6.1

307.7

9253

8914

OAB91, ,

SPAT

2.0

307.7

4866

12955

N02AJ06

ATC

codeine and paracetamol; systemic

1.9

307.7

31208

109368

F32.1

ICD-10 Finland

Moderate depressive episode

3.1

307.7

5008

8868

ENC30

NOMESCO Finland

Plastic operation of pharynx

6.3

307.7

881

734

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

307.7

47299

207126

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

2.4

307.7

2756

6069

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

3.2

307.7

4343

7400

346

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.1

307.7

3825

6606

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

307.7

26275

94040

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.6

307.7

19911

73766

SXC06

NOMESCO Finland

Clinical work to produce sleep apnoea splint

25.6

307.7

391

SPAT1283

SPAT

Restricted health certificate

1.6

307.7

11484

40463

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

307.7

16162

55421

L28

ICPC

Limited function/disability (L)

1.6

307.7

11345

38520

M01AE01

ATC

ibuprofen; systemic, rectal

1.7

307.7

62988

300569

SPAT1263

SPAT

Sampling

1.5

307.7

27936

110205

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

2.9

307.7

2202

3993

Z01.2

ICD-10 Finland

Dental examination

1.5

307.7

32257

131780

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

3.6

307.7

1503

2225

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

3.5

307.7

3464

5321

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

+∞

307.7

3425

S18

ICPC

Laceration/cut

1.5

307.7

30965

123166

WX722

NOMESCO Finland

PEEP

13.8

307.7

4787

1927

K02.1

ICD-10 Finland

Caries of dentine

1.5

307.7

41189

175758

OAA65, ,

SPAT

2.1

307.7

14360

40142

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.4

307.7

2844

6233

XG466

NOMESCO Finland

Sleep oxymetry

12.7

307.7

2993

1276

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

3.1

307.7

1891

3251

N01

ICPC

Headache

1.7

307.7

7935

25066

SPAT1377

SPAT

Polysomnography

8.3

307.7

3027

1980

R5140

NOMESCO Finland

Monitoring the use of the aid

22.9

307.7

15380

4390

E0000UV, ,

ATC

1.4

307.7

27185

112866

A06AC01

ATC

ispaghula (psylla seeds); oral

1.8

307.7

17381

56097

R03BA05

ATC

fluticasone; inhalant

1.6

307.7

11456

39319

P03

ICPC

Feeling depressed

2.5

307.7

8595

19078

L08

ICPC

Shoulder symptom/complaint

1.6

307.7

14657

51207

N06AB03

ATC

fluoxetine; oral

2.4

307.7

8417

19943

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.6

307.7

18138

65065

JDF11

NOMESCO Finland

Laparoscopic gastric bypass

4.9

307.7

1092

1188

R07.4

ICD-10 Finland

Chest pain, unspecified

1.8

307.7

18938

61752

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.8

307.7

3503

6802

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.0

307.7

2440

4352

A02BC03

ATC

lansoprazole; oral

1.6

307.7

16853

61866

M01AB05

ATC

diclofenac; systemic, rectal

1.6

307.7

44172

185043

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.8

307.7

8441

25708

P02

ICPC

Acute stress reaction

2.5

307.7

4084

8746

M53.0

ICD-10 Finland

Cervicocranial syndrome

1.9

307.7

5881

17220

A10BK03

ATC

empagliflozin; oral

2.0

307.7

5955

16593

N05AH04

ATC

quetiapine; oral

3.4

307.7

16494

30153

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

307.7

8235

24461

N06AB05

ATC

paroxetine; oral

2.4

307.7

3736

8370

N03AX16

ATC

[U] pregabalin

1.9

307.7

15205

45818

OAB93, ,

SPAT

2.8

307.7

5242

10377

N04BC05

ATC

pramipexole; oral

2.5

307.7

4919

10516

P01

ICPC

Feeling anxious/nervous/tense

2.4

307.7

11132

26448

A10BJ02

ATC

liraglutide; parenteral

4.2

307.7

2022

2540

P76

ICPC

Depressive disorder

2.8

307.7

5368

10615

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.6

307.7

28663

110522

C09CA01

ATC

losartan; oral

1.5

307.7

14628

54133

R51.80

ICD-10 Finland

Headache

2.0

307.7

11368

32837

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.6

307.7

37951

154639

OAB50

NOMESCO Finland

Delivery of care equipment and instruction on their use

18.3

307.7

1055

305

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.7

307.7

17954

62131

R01AD12

ATC

fluticasone furoate; nasal

1.8

307.7

22747

76445

F50.9

ICD-10 Finland

Eating disorder, unspecified

15.8

307.7

485

161

F43.0

ICD-10 Finland

Acute stress reaction

2.9

307.7

4409

8390

R02

ICPC

Shortness of breath/dyspnoea

2.0

307.7

9554

26490

G04BD12

ATC

mirabegron; oral

1.8

307.7

7013

20792

SPAT1312

SPAT

General health counselling

1.5

307.7

20453

80607

L03

ICPC

Low back symptom/complaint

1.9

307.7

21363

69605

WX723, ,

SPAT

12.0

307.7

726

320

N06AB04

ATC

citalopram; systemic

2.2

307.7

14771

38985

C03CA01

ATC

furosemide; systemic

1.5

307.7

16688

63115

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.5

307.7

26744

106021

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.6

307.7

20238

74283

XA421

NOMESCO Finland

Nocturnal polygraphy

22.2

307.7

478

113

KMAK, ,

NOMESCO Finland

1.4

307.7

32900

141473

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.5

307.7

14634

53584

M54.5

ICD-10 Finland

Low back pain

2.0

307.7

27400

89902

R04

ICPC

Breathing problem other

3.2

307.7

2825

4726

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.1

307.7

7068

18663

AA1AD

NOMESCO Finland

CT of head and brain

1.5

307.7

17289

64808

SFA10

NOMESCO Finland

One-surface restoration

1.5

307.7

38062

159728

SPAT1240

SPAT

Therapeutic discussion

2.2

307.7

7801

19487

ENC40

NOMESCO Finland

Uvulopalatopharyngoplasty

10.5

307.7

784

395

R74

ICPC

Upper respiratory infection acute

1.6

307.7

23828

88280

N06AX26

ATC

vortioxetine; oral

3.1

307.7

6672

11854

R52.9

ICD-10 Finland

Pain, unspecified

1.8

307.7

6702

20273

J20

ICD-10 Finland

Acute bronchitis

1.8

307.7

6614

20126

M03BC01

ATC

orphenadrine (citrate); systemic

1.8

307.7

14753

47434

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.5

307.7

16650

63086

F33

ICD-10 Finland

Recurrent depressive disorder

3.9

307.7

1818

2500

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

307.7

38827

152831

F34.1

ICD-10 Finland

Dysthymia

3.1

307.7

2538

4355

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

307.7

29841

110117

N06AX22

ATC

agomelatine; oral

4.3

307.7

1845

2265

R06AE07

ATC

cetirizine; oral

1.5

307.7

29305

118186

J01FA09

ATC

clarithromycin; systemic

1.4

307.7

19100

74980

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.7

307.7

37738

145903

R06.0

ICD-10 Finland

Dyspnoea

2.1

307.7

19812

57624

C10AA07

ATC

rosuvastatin; oral

1.5

307.7

19790

76483

M17.1

ICD-10 Finland

Other primary gonarthrosis

1.6

307.7

12369

42657

F32

ICD-10 Finland

Depressive episode

3.0

307.7

4398

7851

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

7.0

307.7

2304

1768

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.8

307.7

6374

19084

J01DB01

ATC

cefalexin; oral

1.9

307.7

58892

264535

R01AD08

ATC

fluticasone; nasal

1.7

307.7

19173

66199

EB1SA

NOMESCO Finland

Dental X-ray, bite-wing X-ray on one side of the mouth

1.4

307.7

33321

144472

J01DA01

ATC

[U] cefalexin

1.4

307.7

39408

174360

SPAT1262

SPAT

Handing over of treatment supplies

1.7

307.7

10063

33297

P74

ICPC

Anxiety disorder/anxiety state

2.6

307.7

3415

7012

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

2.9

307.7

1961

3603

WX110

NOMESCO Finland

Infiltration anesthesia

1.7

307.7

50693

221337

A10BA02

ATC

metformin; oral

1.7

307.7

17409

58954

C10AA05

ATC

atorvastatin; oral

1.5

307.7

24607

98374

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.2

307.7

3584

8908

N05CD07

ATC

temazepam; oral

2.0

307.7

6700

17934

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

3.3

307.7

3523

5792

R60.0

ICD-10 Finland

Localized oedema

1.8

307.7

7688

23693

K30

ICD-10 Finland

Functional dyspepsia

1.7

307.7

7138

22258

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

307.7

31203

119385

P06

ICPC

Sleep disturbance

7.3

307.7

16345

14565

R05

ICPC

Cough

1.6

307.7

16877

59715

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

4.1

307.7

3469

4628

N06BA04

ATC

methylphenidate; oral

2.7

307.7

2536

5086

E66.2

ICD-10 Finland

Extreme obesity with alveolar hypoventilation

10.8

307.7

802

393

R00.2

ICD-10 Finland

Palpitations

1.9

307.7

5089

14474

L17

ICPC

Foot/toe symptom/complaint

1.7

307.7

21335

73902

I49.9

ICD-10 Finland

Cardiac arrhythmia, unspecified

1.7

307.7

7613

24211

SPAT1094

SPAT

Continuous Positive Airway Pressure

62.8

307.7

1032

G47.9

ICD-10 Finland

Sleep disorder, unspecified

9.3

307.7

3106

1821

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.7

307.7

14252

47873

R53

ICD-10 Finland

Malaise and fatigue

2.1

307.7

19782

56935

AA40B, ,

NOMESCO Finland

95.9

307.7

420

C09CA06

ATC

candesartan; oral

1.6

307.7

15033

53392

R03BA08

ATC

ciclesonide; inhalant

1.9

307.7

5397

15119

M79.6

ICD-10 Finland

Pain in limb

1.9

307.7

32431

112171

N03AX09

ATC

lamotrigine; oral

2.5

307.7

3180

6817

SFA30

NOMESCO Finland

Three-surface restoration

1.5

307.7

26855

108604

N02BF02

ATC

pregabalin; oral

2.2

307.7

4431

10732

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.9

307.7

11394

22601

R99

ICPC

Respiratory disease other

4.3

307.7

1313

1621

J45

ICD-10 Finland

Asthma

2.0

307.7

6963

19374

R96

ICPC

Asthma

1.9

307.7

6277

18065

WX780

NOMESCO Finland

Remote monitoring CPAP

1977.5

307.7

6232

D01

ICPC

Abdominal pain/cramps general

1.7

307.7

8403

26708

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.9

307.7

5019

9515

P29

ICPC

Psychological sympt/compl other

2.4

307.7

5908

13653

R03AK07

ATC

formoterol and budesonide; inhalant

1.7

307.7

14051

46667

WX290

NOMESCO Finland

Other blockage of nerve

1.5

307.7

32667

134936

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

307.7

31082

125768

N05BA04

ATC

oxazepam; oral

2.5

307.7

20811

53112

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

3.5

307.7

2033

3061

M54

ICD-10 Finland

Dorsalgia

1.8

307.7

8537

25547

N05BA01

ATC

diazepam; systemic, rectal

1.9

307.7

7824

22745

C07AB07

ATC

bisoprolol; oral

1.6

307.7

30013

115854

N06AX05

ATC

trazodone; oral

5.0

307.7

1890

2023

R05

ICD-10 Finland

Cough

1.7

307.7

14287

48052

N06AB06

ATC

sertraline; oral

2.5

307.7

8715

19785

R03BA02

ATC

budesonide; inhalant

1.6

307.7

11159

38334

OAB43, ,

SPAT

1.4

307.7

21040

84540

XA420

NOMESCO Finland

Extensive sleep examination

22.7

307.7

926

216

M01AC06

ATC

meloxicam; systemic, rectal

1.5

307.7

21234

82932

N06AX03

ATC

mianserin; oral

3.1

307.7

3091

5408

L01

ICPC

Neck symptom/complaint

1.8

307.7

11075

35031

A02BC01

ATC

omeprazole; systemic

1.5

307.7

16405

61474

Z01.8

ICD-10 Finland

Other specified special examinations

1.8

307.7

15608

50047

D82

ICPC

Teeth/gum disease

1.4

307.7

24852

101712

A01

ICPC

Pain general/multiple sites

1.8

307.7

6348

18746

N03AX12

ATC

[U] gabapentin; oral

1.9

307.7

10281

29692

N06AB10

ATC

escitalopram; oral

2.5

307.7

17200

41633

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.6

307.7

12092

41500

R07.3

ICD-10 Finland

Other chest pain

1.8

307.7

6375

19137

H03AA01

ATC

levothyroxine sodium; systemic

1.5

307.7

13604

49994

C07AA05

ATC

propranolol; systemic

1.9

307.7

13867

42302

Z76.0

ICD-10 Finland

Issue of repeat prescription

1.8

307.7

19822

64269

A02BC02

ATC

pantoprazole; systemic

1.8

307.7

47655

192797

M01AH05

ATC

etoricoxib; oral

1.8

307.7

43036

172154

WZC00

NOMESCO Finland

Treatment plan or consultation

1.4

307.7

23845

98211

A02BC05

ATC

esomeprazole; systemic

1.7

307.7

26998

98133

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.8

307.7

8202

24442

D07AC01

ATC

betamethasone; topical

1.4

307.7

22711

91958

SFA20

NOMESCO Finland

Two-surface restoration

1.5

307.7

40076

169492

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.3

307.7

7166

17109

N06CA01

ATC

amitriptyline and psycholeptics; systemic

2.3

307.7

6379

15524

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

307.7

17364

59591

J01CA04

ATC

amoxicillin; systemic

1.6

307.7

57483

266315

C08CA13

ATC

lercanidipine; oral

1.7

307.7

8095

26486

E11

ICD-10 Finland

Type 2 diabetes mellitus

1.8

307.7

9224

28201

R42

ICD-10 Finland

Dizziness and giddiness

1.7

307.7

15008

50915

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

307.7

51451

222465

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.0

307.7

8982

17125

103

Kela drug reimbursment

Diabetes, insulin-treated

1.6

307.7

15639

55916

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

3.6

307.7

2579

3813

F90.0

ICD-10 Finland

Disturbance of activity and attention

2.6

307.7

2874

5901

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

2.4

307.7

3268

7323

J02AC01

ATC

fluconazole; systemic

1.5

307.7

24674

97865

T82

ICPC

Obesity

4.2

307.7

3592

4659

N06AA12

ATC

doxepin; systemic

2.6

307.7

2926

6056

N06AX12

ATC

bupropion; oral

3.2

307.7

6136

10753

N05CF01

ATC

zopiclone; oral

2.6

307.7

25024

63745

SAA03

NOMESCO Finland

Extended examination of mouth

1.4

307.7

25799

105660

H02AB06

ATC

prednisolone; systemic

1.6

307.7

31570

123425

Z71.8

ICD-10 Finland

Other specified counselling

1.6

307.7

23649

89337

R21

ICPC

Throat symptom/complaint

1.5

307.7

14854

54821

M01AE03

ATC

ketoprofen; systemic, rectal

1.4

307.7

21511

85735

SPAT1249

SPAT

Treatment-related counselling outside office

1.5

307.7

25462

101446

UJF32

NOMESCO Finland

Coloscopy

1.5

307.7

15529

57467

F43.8

ICD-10 Finland

Other reactions to severe stress

2.9

307.7

1915

3476

C08CA01

ATC

amlodipine; oral

1.5

307.7

22758

86804

SPAT1310

SPAT

Counselling related to known health issue

1.5

307.7

20607

77200

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.7

307.7

8379

26973

F41.1

ICD-10 Finland

Generalized anxiety disorder

2.9

307.7

4340

8125

SPAT1051

SPAT

Guidance regarding sleep disorders

8.0

307.7

1401

930

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.8

307.7

6442

19019

P01AB01

ATC

metronidazole; oral, rectal

1.5

307.7

25300

100446

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

1.8

307.7

7324

22224

3472A

ICD-9 Finland

Cataplexy and narcolepsy[OBSTRUKTIIVINEN UNIAPNEA]

+∞

307.7

1440

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.6

307.7

13924

48731

R03DC03

ATC

montelukast; oral

1.8

307.7

10837

33758

M79.7

ICD-10 Finland

Fibromyalgia

2.9

307.7

2283

4162

J01FA10

ATC

azithromycin; systemic

1.5

307.7

38984

165420

Z3231

NOMESCO Finland

Registered nurse

1.5

307.7

16401

62694

WX780, ,

SPAT

14.1

307.7

577

215

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.7

307.7

11948

38482

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

307.7

26198

105386

M70.6

ICD-10 Finland

Trochanteric bursitis

1.9

307.7

8086

23881

Z73.0

ICD-10 Finland

Burn-out

3.4

307.7

3153

4927

OAB50, ,

SPAT

2.0

307.7

5004

13500

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

307.7

16426

56533

L13

ICPC

Hip symptom/complaint

1.6

307.7

11718

40185

J01AA02

ATC

doxycycline; systemic

1.7

307.7

52347

229131

E66.8

ICD-10 Finland

Other obesity

4.4

307.7

4820

6095

E66.01

ICD-10 Finland

Obesity due to excess calories

3.9

307.7

8815

13080

E66

ICD-10 Finland

Obesity

3.4

307.7

4389

6995

R06AX27

ATC

desloratadine; oral

1.5

307.7

19192

71673

J31.0

ICD-10 Finland

Chronic rhinitis

2.0

307.7

5624

14916

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

3.0

307.7

9411

18050

WX723

NOMESCO Finland

CPAP therapy

589.7

307.7

6009

M54.4

ICD-10 Finland

Lumbago with sciatica

1.9

307.7

12347

37768

G44.2

ICD-10 Finland

Tension-type headache

2.0

307.7

9580

27017

N02BE01

ATC

paracetamol; systemic, rectal

2.3

307.7

63993

290644

N05CF02

ATC

zolpidem; oral

3.0

307.7

14372

28798

R4110, ,

SPAT

1.8

307.7

8301

25583

N06AA06

ATC

trimipramine; systemic

3.6

307.7

1448

2110

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

1.7

307.7

8201

25828

215

Kela drug reimbursment

Diabetes, non-insulin-treated

1.7

307.7

14978

50171

E66.00

ICD-10 Finland

Metabolic syndrome

3.7

307.7

4291

6392

M25.5

ICD-10 Finland

Pain in joint

1.8

307.7

23004

79118

A10BJ06

ATC

semaglutide; parenteral

3.2

307.7

3608

6050

R03BB04

ATC

tiotropium bromide; inhalant

1.9

307.7

5617

16380

285

Kela drug reimbursment

Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)

3.1

307.7

4093

7060

N06AX11

ATC

mirtazapine; oral

4.1

307.7

33557

66392

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.8

307.7

12910

41074

A04

ICPC

Weakness/tiredness general

1.9

307.7

11557

34720

F51

ICD-10 Finland

Nonorganic sleep disorders

4.7

307.7

4112

4807

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.7

307.7

6614

13633

T90

ICPC

Diabetes non-insulin dependent

1.8

307.7

14953

48518

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.8

307.7

7675

23162

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

9.3

307.7

15290

10616

M03BX02

ATC

tizanidine; oral

1.8

307.7

43568

171101

L15

ICPC

Knee symptom/complaint

1.7

307.7

16810

57608

D11

ICPC

Diarrhoea

1.8

307.7

8403

25169

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

2.8

307.7

2337

4414

N05AX12

ATC

aripiprazole; systemic

2.5

307.7

2700

5834

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

307.7

35380

148063

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.7

307.7

12816

42560

DHB50

NOMESCO Finland

Turbinoplasty

3.2

307.7

1668

2776

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.4

307.7

19184

76006

R01AD09

ATC

mometasone; nasal

1.9

307.7

33049

117507

K03.82

ICD-10 Finland

Split tooth for reasons other than trauma

1.5

307.7

18232

69518

M01AE02

ATC

naproxen; oral, rectal

1.6

307.7

38358

158292

M03BC51

ATC

orphenadrine, combinations; systemic

1.6

307.7

17007

59575

A98

ICPC

Health maint/preventive medicine

2.8

307.7

69931

343709

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.6

307.7

10453

35962

N06AA09

ATC

amitriptyline; systemic

2.2

307.7

5614

14220

N02AX02

ATC

tramadol; systemic, rectal

1.8

307.7

29158

104404

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

307.7

6232

18089

M79.1

ICD-10 Finland

Myalgia

1.8

307.7

10141

30727

G47.3

ICD-10 Finland

Sleep apnoea

66.9

307.7

39882

6794

N05BA12

ATC

alprazolam; oral

2.1

307.7

6113

15782

N05AH03

ATC

olanzapine; systemic

2.1

307.7

3931

10189

N06AX21

ATC

duloxetine; oral

2.7

307.7

9346

19361

J01FA06

ATC

roxithromycin; oral

1.4

307.7

24012

96841

F51.0

ICD-10 Finland

Nonorganic insomnia

+∞

307.7

35656

J45.9

ICD-10 Finland

Asthma, unspecified

2.0

307.7

13248

38706

J01CE02

ATC

phenoxymethylpenicillin; oral

1.4

307.7

45514

206553

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.7

307.7

8537

28312

E66.9

ICD-10 Finland

Obesity, unspecified

3.8

307.7

2788

3909

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.5

307.7

13472

49672

N02BF01

ATC

gabapentin; oral

2.1

307.7

6903

18161

N06AX16

ATC

venlafaxine; oral

2.8

307.7

11552

24283

R03BA01

ATC

beclometasone; inhalant

1.6

307.3

8123

26982

WZA90

NOMESCO Finland

Other medical or dental certificate

1.5

306.9

14845

56503

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.8

306.0

5892

17912

L16

ICPC

Ankle symptom/complaint

1.7

305.8

7627

24948

ZXC60

NOMESCO Finland

Application of heat

4.4

305.1

984

1175

SPAT1307

SPAT

Psychosocial counselling and guidance

2.0

304.3

4173

11342

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

1.8

302.7

5851

17805

G43.9

ICD-10 Finland

Migraine, unspecified

2.0

300.7

3975

10659

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.6

300.2

8356

28109

-1, ,

NOMESCO Finland

1.4

298.8

21282

86867

J34.3

ICD-10 Finland

Hypertrophy of nasal turbinates

3.4

298.3

1358

2123

F43.1

ICD-10 Finland

Post-traumatic stress disorder

2.8

298.0

1838

3476

GD1AA, ,

SPAT

1.6

296.9

10204

36095

SPAT1301

SPAT

No procedures

1.4

295.3

19188

77054

160

Kela drug reimbursment

exenatide

4.0

294.9

1086

1450

Z01.7

ICD-10 Finland

Laboratory examination

1.5

294.5

10435

37161

R35

ICD-10 Finland

Polyuria

2.0

294.1

4016

10894

L12

ICPC

Hand/finger symptom/complaint

1.5

293.1

10937

39394

N17

ICPC

Vertigo/dizziness

1.6

291.6

7764

25812

IHZ05, ,

SPAT

2.2

291.3

3168

7875

A11

ICPC

Chest pain NOS

1.8

291.0

5111

15093

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

3.1

291.0

1511

2577

A10BK01

ATC

dapagliflozin; oral

1.9

290.8

4452

12569

M02AA07

ATC

piroxicam; topical

1.4

289.8

20066

81412

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.6

288.9

7663

25447

R51

ICD-10 Finland

Headache

2.0

288.8

3701

9807

DJD20

NOMESCO Finland

Plastic repair of septum of nose

2.6

288.7

2087

4300

A02BA02

ATC

ranitidine; systemic

1.5

288.7

10276

36615

ZY010

NOMESCO Finland

Hospital outpatient

2.1

286.3

3213

8087

F32.0

ICD-10 Finland

Mild depressive episode

2.7

285.2

1892

3725

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

28.0

284.7

320

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

282.3

11123

40502

SPAT1058

SPAT

PEF monitoring instruction

1.9

282.0

4598

13252

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.9

281.9

4706

13667

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.6

281.7

9147

31900

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

281.6

5378

16290

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.8

279.7

1729

3273

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

8.0

279.7

533

351

R01AD01

ATC

beclometasone; nasal

1.6

276.3

8687

30057

SPAT1153

SPAT

Removal of sutures

1.4

275.9

17963

71985

3051, ,

Kela drug reimbursment

5.3

275.0

733

729

R83

ICPC

Respiratory infection other

1.4

274.9

16895

67016

IGY02

NOMESCO Finland

Psychiatric monitoring contact

2.5

274.8

2072

4361

D07AB02

ATC

hydrocortisone butyrate; topical

1.4

274.6

18017

72287

M48.0

ICD-10 Finland

Spinal stenosis

1.7

274.0

6668

21630

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

2.6

273.3

1961

4024

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.6

272.9

7340

24436

4471

FHL

Pharyngoplasty

18.6

270.9

341

R05FA02

ATC

opium derivatives and expectorants; systemic

1.4

269.7

23431

98384

J45.1

ICD-10 Finland

Nonallergic asthma

1.9

269.7

4229

12026

A03

ICPC

Fever

1.5

269.5

11395

42065

F43

ICD-10 Finland

Reaction to severe stress, and adjustment disorders

3.0

268.7

1491

2649

GX2D5

NOMESCO Finland

Sleep oximetry

8.3

268.6

500

318

C03DA01

ATC

spironolactone; oral

1.7

268.3

6815

22350

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.5

268.1

13489

51535

290

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.6

266.8

8741

30515

F50.2

ICD-10 Finland

Bulimia nervosa

22.7

266.6

316

M54.2

ICD-10 Finland

Cervicalgia

1.8

266.1

4819

14352

N06AG02

ATC

moclobemide; oral

2.3

266.0

2362

5376

R12

ICD-10 Finland

Heartburn

1.8

265.2

5231

15987

C10AX09

ATC

ezetimibe; oral

1.5

264.0

9232

32703

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

2.5

263.6

2025

4301

OAB72

NOMESCO Finland

Weight control and weight loss guidance

5.8

262.8

644

585

E78.01

ICD-10 Finland

Pure hypercholesterolaemia

1.4

262.3

14037

54224

G47.1

ICD-10 Finland

Disorders of excessive somnolence [hypersomnias]

73.9

262.2

254

EBA00

NOMESCO Finland

Extraction of tooth

1.4

261.6

23492

99023

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

1.7

261.5

5584

17460

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

2.8

260.1

1566

2919

UDQ12

NOMESCO Finland

Flexible laryngoscopy

2.0

259.1

3261

8575

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

2.8

258.6

1603

3038

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.6

258.0

1875

3872

D19

ICPC

Teeth/gum symptom/complaint

1.4

257.7

19766

81222

P25

ICPC

Phase of life problem adult

2.1

257.6

2795

6934

SBB10

NOMESCO Finland

Dental impressions

1.9

257.3

4280

12404

R05FB02

ATC

cough suppressants and expectorants; systemic

1.4

256.9

20730

85870

A10BJ05

ATC

dulaglutide; parenteral

3.5

256.8

1121

1701

EB1VA, ,

NOMESCO Finland

1.5

256.5

11066

40972

R06AX22

ATC

ebastine; oral

1.5

255.0

10039

36466

J01MA02

ATC

ciprofloxacin; systemic

1.4

255.0

22920

96526

K59.1

ICD-10 Finland

Functional diarrhoea

2.0

254.6

3366

9012

U02

ICPC

Urinary frequency/urgency

1.5

254.5

8962

31774

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

2.1

252.6

3081

8004

A46

ICD-10 Finland

Erysipelas

1.6

252.3

8328

29092

K04.5

ICD-10 Finland

Chronic apical periodontitis

1.4

251.8

15901

63201

R5110, ,

SPAT

1.8

249.6

4869

14821

SDA04

NOMESCO Finland

Demanding periodontal treatment

1.4

248.3

18471

75427

A97

ICPC

No disease

1.4

247.8

12552

47922

SPAT1097

SPAT

Recording of ECG

1.6

247.7

7806

26970

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.5

247.5

11795

44506

A02BC04

ATC

rabeprazole; oral

1.8

247.5

4969

15252

S01GX01

ATC

cromoglicic acid; ophthalmic

1.5

247.4

12113

45945

R03AC03

ATC

terbutaline; inhalant

1.6

245.4

7954

27657

F41.0

ICD-10 Finland

Panic disorder [episodic paroxysmal anxiety]

2.7

244.8

1610

3153

R23.8

ICD-10 Finland

Other and unspecified skin changes

1.4

244.3

12890

49572

M54.6

ICD-10 Finland

Pain in thoracic spine

1.8

243.7

4513

13519

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

1.6

243.5

6535

21706

N30.0

ICD-10 Finland

Acute cystitis

1.5

241.9

10470

38741

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.5

241.5

1888

4043

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.6

241.1

7591

26210

ZXE00

NOMESCO Finland

One hour or less

1.3

241.0

22978

97419

N05AA02

ATC

levomepromazine; systemic

2.3

240.6

2146

4891

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.7

240.2

4884

15042

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

2.4

238.4

1934

4217

R03AK10

ATC

vilanterol and fluticasone furoate; inhalant

2.1

238.3

2871

7420

N05BE01

ATC

buspirone; oral

2.6

238.0

1666

3373

F41

ICD-10 Finland

Other anxiety disorders

3.1

237.6

1228

2087

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.7

236.4

5474

17485

R52.2

ICD-10 Finland

Other chronic pain

2.3

235.7

2192

5090

E78.0

ICD-10 Finland

Pure hypercholesterolaemia

1.4

235.1

12918

50002

M01AX17

ATC

nimesulide; oral

1.4

234.0

12525

48244

SGA01

NOMESCO Finland

Emergency treatment

1.5

232.9

9909

36511

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.3

232.9

22081

93418

A08

ICPC

Swelling

2.0

232.3

3238

8830

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.3

232.2

1082

1718

H01

ICPC

Ear pain/earache

1.6

231.0

7582

26414

ZXE10

NOMESCO Finland

More than one and less than three hours

1.3

229.3

20197

84461

R11

ICD-10 Finland

Nausea and vomiting

1.7

229.0

5273

16810

A10BH01

ATC

sitagliptin; oral

1.7

228.8

4910

15350

Z00.0

ICD-10 Finland

General medical examination

1.4

228.7

11733

44818

OAB72, ,

SPAT

3.3

227.7

1057

1674

M01AX05

ATC

glucosamine; oral

1.5

227.3

9676

35639

351

Kela drug reimbursment

Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation

1.5

227.1

7821

27537

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

1.7

227.0

5440

17529

C10AA01

ATC

simvastatin; oral

1.3

226.7

21905

92839

OAB48, ,

SPAT

1.5

226.7

10578

39676

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

1.7

226.3

5410

17420

SHA02

NOMESCO Finland

Stomatognathic treatment, basic

1.8

225.8

4214

12644

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.4

224.9

18499

76510

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

224.3

24295

104631

EB1MA

NOMESCO Finland

Cephalometry with X-ray

2.7

223.8

1481

2909

XF402

NOMESCO Finland

ECG with work load test

1.7

223.7

5430

17553

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

1.9

223.3

3447

9734

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.4

223.3

12656

49203

B01AB05

ATC

enoxaparin; parenteral

1.4

222.8

17878

73634

T83

ICPC

Overweight

2.7

222.0

1459

2855

SFA40

NOMESCO Finland

Restoration involving the entire crown of the tooth

1.4

221.9

12460

48353

M19.0

ICD-10 Finland

Primary arthrosis of other joints

1.7

219.6

5514

17980

G43

ICD-10 Finland

Migraine

1.9

219.0

3348

9422

A99

ICPC

Disease/condition unspecnature/site

1.6

218.3

6152

20653

S06.0

ICD-10 Finland

Concussion

1.6

217.7

6494

22103

R03AL09

ATC

formoterol, glycopyrronium bromide and beclometasone; inhalant

2.4

217.6

1806

3979

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.4

217.2

14706

58901

F50.0

ICD-10 Finland

Anorexia nervosa

34.9

217.2

233

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

2.6

217.0

1547

3161

WZC00, ,

SPAT

1.5

216.7

9271

34151

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

216.6

3830

11299

A10BX07

ATC

[U] liraglutide

4.5

216.4

688

811

JN3AD

NOMESCO Finland

Abdominal CT examination

1.5

215.0

7451

26247

D07AC13

ATC

mometasone; topical

1.4

215.0

16772

68705

ZYC01

NOMESCO Finland

Remote contact by phone

1.8

214.8

3685

10767

D06

ICPC

Abdominal pain localized other

1.6

214.6

5538

18180

H02

ICPC

Hearing complaint

1.5

212.6

8073

29003

7849C

ICD-9 Finland

Symptoms involving head and neck, Other symptoms involving head and neck[KUORSAUS]

5.6

212.4

537

505

F31.8

ICD-10 Finland

Other bipolar affective disorders

3.0

212.3

1129

1953

K80

ICPC

Cardiac arrhythmia NOS

1.7

212.1

4823

15310

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

211.6

11495

44297

F39

ICD-10 Finland

Unspecified mood [affective] disorder

2.9

211.0

1190

2134

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

210.4

3632

10631

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.8

210.3

3680

10818

207

Kela drug reimbursment

Chronic arrhythmias

1.5

210.1

8092

29155

UKC02

NOMESCO Finland

Cystoscopy

1.5

209.4

8451

30743

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

2.8

209.3

1292

2442

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

1.7

209.2

4600

14464

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.5

209.0

8185

29591

C09DA01

ATC

losartan and diuretics; oral

1.6

207.7

5521

18255

R60.9

ICD-10 Finland

Oedema, unspecified

1.9

206.9

3227

9139

P99

ICPC

Psychological disorders other

2.3

205.3

1868

4293

Z02.7

ICD-10 Finland

Issue of medical certificate

1.7

204.7

4439

13902

K03.65

ICD-10 Finland

Deposits [accretions] on teeth betel

1.4

204.2

12927

51121

IGY99

NOMESCO Finland

Other psychiatric treatment contact

2.7

203.0

1309

2535

F45.8

ICD-10 Finland

Other somatoform disorders

1.7

202.3

4051

12400

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.7

202.2

4303

13403

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.8

201.4

1275

2444

U07.1

ICD-10 Finland

Emergency use of U07.1 | COVID-19, virus identified

1.4

201.3

12404

48816

N89

ICPC

Migraine

2.1

199.5

2317

5898

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.1

198.2

2272

5754

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.7

197.1

4349

13681

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

1.9

197.0

3120

8878

M02AA10

ATC

ketoprofen; topical

1.5

196.8

8580

31672

K08.80

ICD-10 Finland

Toothache NOS

1.6

196.3

5416

18064

R06AE09

ATC

levocetirizine; oral

1.5

196.2

8236

30170

WX002

NOMESCO Finland

Sedation and analgesia

1.4

195.8

10302

39407

M04AA01

ATC

allopurinol; systemic

1.5

195.8

6519

22729

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

3.0

195.6

1085

1926

L86

ICPC

Back syndrome with radiating pain

1.8

195.3

3503

10371

D07AD01

ATC

clobetasol; topical

1.4

194.9

9406

35405

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.6

194.7

5972

20430

H02AB04

ATC

methylprednisolone; systemic

1.5

193.8

7811

28373

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

1.6

193.0

5547

18682

F41.3

ICD-10 Finland

Other mixed anxiety disorders

3.0

193.0

1061

1873

OAB42, ,

SPAT

1.5

193.0

7937

28948

M10.9

ICD-10 Finland

Gout, unspecified

1.8

192.2

3574

10697

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.4

191.9

1664

3741

U07

ICPC

Urine symptom/complaint other

1.6

191.0

4845

15815

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.5

190.9

837

1274

SPAT1211

SPAT

Application of soft bandage

1.6

190.3

4932

16187

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.5

190.1

6484

22721

205

Kela drug reimbursment

Chronic hypertension

1.4

190.0

13211

52971

K03.64

ICD-10 Finland

Dental calculus supragingival

1.3

189.3

20682

88636

N07BB01

ATC

disulfiram; oral

2.1

189.1

2276

5873

SPAT1254

SPAT

Administration of medicine

1.5

188.9

8610

32041

B01AF02

ATC

apixaban; oral

1.5

188.6

6957

24795

H29

ICPC

Ear symptom/complaint other

1.5

188.2

7026

25106

C02AC05

ATC

moxonidine; oral

2.0

187.7

2333

6093

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

1.6

187.7

6133

21280

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

1.7

187.7

4620

14961

H60.9

ICD-10 Finland

Otitis externa, unspecified

1.6

187.4

4660

15131

I87.2

ICD-10 Finland

Venous insufficiency (chronic)(peripheral)

1.6

187.3

6103

21162

L03.0

ICD-10 Finland

Cellulitis of finger and toe

1.6

186.9

4952

16341

R20.2

ICD-10 Finland

Paraesthesia of skin

1.7

186.3

4142

13051

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

1.8

186.2

3616

10962

K59.0

ICD-10 Finland

Constipation

1.8

185.5

3163

9213

K85

ICPC

Elevated blood pressure

1.4

185.5

8922

33533

H81.1

ICD-10 Finland

Benign paroxysmal vertigo

1.6

185.2

5735

19653

L14

ICPC

Leg/thigh symptom/complaint

1.6

185.1

4722

15431

L90

ICPC

Osteoarthrosis of knee

1.8

184.5

3573

10821

S80.0

ICD-10 Finland

Contusion of knee

1.7

184.4

4504

14554

R01AD59

ATC

mometasone, combinations; nasal

1.7

184.2

4002

12527

162

Kela drug reimbursment

liraglutide

4.4

183.4

594

712

R07.0

ICD-10 Finland

Pain in throat

1.7

183.3

4523

14652

F61.0

ICD-10 Finland

Mixed personality disorders

3.1

183.3

969

1670

WX320

NOMESCO Finland

Spinalanesthesy

1.4

182.8

13681

55450

WX402

NOMESCO Finland

General anaesthesia

1.4

182.6

13100

52742

D01BA02

ATC

terbinafine; oral

1.3

181.6

14283

58324

K04.08

ICD-10 Finland

Other specified pulpit

1.6

180.8

4675

15327

J01MA12

ATC

levofloxacin; systemic

1.4

180.5

9897

38084

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.8

180.4

3333

9951

G04BD08

ATC

solifenacin; oral

1.8

180.3

3328

9934

Z01.9

ICD-10 Finland

Special examination, unspecified

1.8

179.8

3327

9938

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.5

179.5

7894

29149

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.6

179.0

5107

17156

-1, ,

ICD-10 Finland

1.9

178.9

2815

7988

K21

ICD-10 Finland

Gastro-oesophageal reflux disease

1.8

178.7

3373

10135

R06.2

ICD-10 Finland

Wheezing

1.9

178.7

2529

6922

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

2.8

178.6

1113

2114

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.5

178.6

7415

27065

F43.00

ICD-10 Finland

Acute stress reaction mild

2.4

178.5

1469

3222

XQ800

NOMESCO Finland

Prick test

1.7

178.5

4115

13090

RK323, ,

NOMESCO Finland

18.2

178.3

226

F50.3

ICD-10 Finland

Atypical bulimia nervosa

18.6

178.1

224

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

5.0

178.0

504

533

RK320, ,

NOMESCO Finland

5.1

177.5

485

495

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

3.0

177.4

956

1667

F50.8

ICD-10 Finland

Other eating disorders

17.3

176.8

228

N03AG01

ATC

valproic acid; systemic, rectal

1.8

176.4

3223

9589

ACC51

NOMESCO Finland

Release of median nerve

1.7

176.3

4010

12707

C05AA08

ATC

fluocortolone; rectal, topical

1.5

176.3

7121

25842

D10

ICPC

Vomiting

1.7

176.2

3727

11576

Z2445

NOMESCO Finland

Psychologist

2.0

176.0

2200

5757

IBA01, ,

SPAT

2.5

175.8

1302

2712

L60.0

ICD-10 Finland

Ingrowing nail

1.9

175.1

2807

8013

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

175.1

6816

24546

C09DA06

ATC

candesartan and diuretics; oral

1.7

174.6

3872

12184

3055, ,

Kela drug reimbursment

5.3

174.3

463

459

X58

ICD-10 Finland

Exposure to other specified factors

1.4

174.2

8871

33662

A05

ICPC

Feeling ill

1.7

173.7

3932

12442

K04.0

ICD-10 Finland

Pulpitis

1.6

172.9

5287

18049

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.4

172.9

1391

3018

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

239.3

172.5

229

R01AD11

ATC

triamcinolone; nasal

1.6

172.5

4601

15197

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

1.9

171.6

2731

7777

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.5

171.5

6370

22708

H53.1

ICD-10 Finland

Subjective visual disturbances

1.7

171.4

3980

12681

WX408

NOMESCO Finland

General anesthesy, balanced

1.3

171.3

14441

59503

I50.9

ICD-10 Finland

Heart failure, unspecified

1.5

170.4

6913

25098

IHZ04, ,

SPAT

2.7

170.4

1105

2146

S93.4

ICD-10 Finland

Sprain and strain of ankle

1.5

169.4

6771

24506

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.4

169.0

9015

34482

R13

ICD-10 Finland

Dysphagia

1.7

168.4

3692

11579

D09

ICPC

Nausea

1.8

168.3

2946

8647

310

Kela drug reimbursment

Orlistat, sibutramine and other major and expensive medicines used to treat obesity

4.0

168.3

604

790

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

2.7

168.2

1078

2080

P20

ICPC

Memory disturbance

1.5

167.9

6979

25459

F43.01

ICD-10 Finland

Acute stress reaction moderate

2.8

167.4

1010

1884

S21

ICPC

Skin texture symptom/complaint

1.4

167.2

8822

33670

F32.8

ICD-10 Finland

Other depressive episodes

2.9

167.1

971

1772

C01DA14

ATC

isosorbide mononitrate; oral

1.5

167.0

7365

27182

XKD00

NOMESCO Finland

Uroflowmetry

1.4

166.9

7762

28942

M01AG02

ATC

tolfenamic acid; oral, rectal

1.4

166.7

7817

29192

SDE03

NOMESCO Finland

Periodontal treatment by dental hygienist, extensive

1.3

166.5

13267

54176

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.3

165.8

18236

77913

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.8

165.5

2930

8630

SPAT1216

SPAT

Assessment of functional ability

1.4

164.7

8034

30219

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

1.7

164.7

3981

12815

C09CA03

ATC

valsartan; oral

1.6

164.6

4699

15774

F33.8

ICD-10 Finland

Other recurrent depressive disorders

4.1

164.5

578

743

C07AB02

ATC

metoprolol; systemic

1.4

164.2

10011

39170

Z3226

NOMESCO Finland

Physiotherapist

1.4

164.0

9647

37515

UJF30

NOMESCO Finland

Ileoscopy through colon

1.5

164.0

5774

20338

E66.0

ICD-10 Finland

Obesity due to excess calories

4.0

164.0

595

785

J22

ICD-10 Finland

Unspecified acute lower respiratory infection

1.7

163.4

3711

11748

E29.1

ICD-10 Finland

Testicular hypofunction

3.4

163.3

747

1171

XA421, ,

SPAT

3.6

162.6

666

965

B01AF01

ATC

rivaroxaban; oral

1.5

162.3

6372

22965

K42.9

ICD-10 Finland

Umbilical hernia without obstruction or gangrene

1.9

162.0

2611

7464

A08AA62

ATC

bupropion and naltrexone; systemic

5.0

162.0

459

486

G04CA01

ATC

alfuzosin; oral

1.5

161.7

5943

21124

F40.1

ICD-10 Finland

Social phobias

2.3

161.6

1511

3513

N06AB08

ATC

fluvoxamine; oral

2.4

161.0

1324

2902

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

160.7

1873

4770

J96.1

ICD-10 Finland

Chronic respiratory failure

2.7

160.4

1077

2131

M77.1

ICD-10 Finland

Lateral epicondylitis

1.6

160.3

4413

14680

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

160.2

9999

39259

G04CA02

ATC

tamsulosin; oral

1.4

159.8

11650

46892

SCA01

NOMESCO Finland

Preventive oral health care, short

1.3

159.4

17950

76851

R5130

NOMESCO Finland

Repair work or maintenance done on the aid

2.1

159.0

1839

4670

M77.4

ICD-10 Finland

Metatarsalgia

1.7

158.8

3379

10505

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.8

158.7

2644

7638

J46

ICD-10 Finland

Status asthmaticus

2.2

158.4

1555

3692

A06AC51

ATC

ispaghula, combinations; oral

1.9

158.3

2521

7177

R06AX13

ATC

loratadine; oral

1.4

158.0

8429

32208

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.3

157.6

16170

68359

F50.1

ICD-10 Finland

Atypical anorexia nervosa

17.8

157.5

201

SPAT1243

SPAT

Psychiatric/psychological examination

2.2

157.3

1560

3720

XG410

NOMESCO Finland

Flow-volume spirometry

2.0

157.3

2016

5322

F43.2

ICD-10 Finland

Adjustment disorders

2.6

157.2

1069

2130

R07

ICPC

Sneezing/nasal congestion

1.6

156.8

3940

12807

SPAT1281

SPAT

Other administrative function

1.6

156.4

4236

14032

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.1

155.9

1811

4606

M54.8

ICD-10 Finland

Other dorsalgia

1.8

155.8

2603

7526

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.3

155.7

23687

105187

H81

ICPC

Excessive ear wax

1.4

155.5

9516

37221

L29

ICPC

Musculoskeletal sympt/complt other

1.6

155.5

4991

17212

H90.3

ICD-10 Finland

Sensorineural hearing loss, bilateral

1.4

155.5

8959

34687

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.4

155.4

7231

26939

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

3.7

154.8

625

896

F29

ICPC

Eye symptom/complaint other

1.5

154.6

6099

21992

K10.3

ICD-10 Finland

Alveolitis of jaws

1.8

154.4

2765

8170

WZC30

NOMESCO Finland

Teaching

1.4

154.3

8926

34580

C03AA03

ATC

hydrochlorothiazide; oral

1.6

154.3

4284

14277

H02.3

ICD-10 Finland

Blepharochalasis

1.7

153.9

3249

10075

R50.9

ICD-10 Finland

Fever, unspecified

1.4

153.9

8766

33868

M15

ICD-10 Finland

Polyarthrosis

1.8

152.9

2517

7242

A10BX04

ATC

[U] exenatide

4.1

152.3

527

669

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

1.5

152.3

5637

20055

J05AB01

ATC

aciclovir; systemic

1.3

150.5

12273

50186

H13

ICPC

Plugged feeling ear

1.4

150.3

10724

42973

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

2.7

150.1

964

1862

I48.0

ICD-10 Finland

Paroxysmal atrial fibrillation

1.6

149.4

4337

14607

Z3229

NOMESCO Finland

Other healthcare associate professional

1.6

149.2

4302

14465

M47.82

ICD-10 Finland

Other spondylosis, cervical region

2.0

149.2

2045

5531

J01DA09

ATC

[U] cefadroxil

1.3

147.9

14894

62713

G47.8

ICD-10 Finland

Other sleep disorders

2.5

147.8

1105

2312

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

1.6

147.7

3734

12152

U04

ICPC

Incontinence urine

1.7

147.2

2965

9070

I48

ICD-10 Finland

Atrial fibrillation and flutter

1.4

147.2

10399

41593

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

2.1

147.1

1718

4378

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.5

147.0

4985

17397

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

3.0

146.9

781

1351

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.8

146.6

2604

7672

L04

ICPC

Chest symptom/complaint

1.6

146.0

3603

11652

S76

ICPC

Skin infection other

1.7

146.0

2902

8844

P58

ICPC

Psychological, Therapeutic counselling/listening

2.4

145.9

1256

2813

XF404

NOMESCO Finland

Ambulatory ECG

1.6

145.8

4361

14789

N06BA12

ATC

lisdexamfetamine; oral

3.1

145.7

739

1241

M01AH02

ATC

rofecoxib; oral

1.5

145.7

6140

22422

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

145.6

6668

24747

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.6

145.3

3864

12735

H92.0

ICD-10 Finland

Otalgia

1.6

145.2

3763

12322

SDE02

NOMESCO Finland

Periodontal treatment by dental hygienist

1.3

145.1

13528

56344

F60.9

ICD-10 Finland

Personality disorder, unspecified

3.1

144.5

728

1217

R4190

NOMESCO Finland

Nutritional therapy

1.9

144.4

2132

5916

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

144.4

5855

21215

J01

ICD-10 Finland

Acute sinusitis

1.7

144.3

3171

9940

ZXA10

NOMESCO Finland

Bilateral

1.4

144.2

9731

38627

A48

ICPC

General and Unspecified, Clarification/discussion RFE/demand

1.6

144.2

3714

12141

XF400

NOMESCO Finland

ECG with 12 standard connections

1.4

143.9

7851

30079

M54.3

ICD-10 Finland

Sciatica

1.7

143.8

3105

9686

N30

ICD-10 Finland

Cystitis

1.5

143.6

4744

16456

DFF00

NOMESCO Finland

Pure tone audiometry

1.5

143.5

5288

18783

K03.00

ICD-10 Finland

Approximal wear

1.6

143.0

4389

14971

T07

ICPC

Weight gain

2.7

143.0

964

1912

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.5

142.4

6406

23687

F31

ICD-10 Finland

Bipolar affective disorder

3.1

142.3

732

1240

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.3

142.1

14987

63440

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

2.8

141.6

878

1663

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

1.7

141.6

2825

8616

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.7

141.3

3172

10000

L11

ICPC

Wrist symptom/complaint

1.5

141.1

5389

19282

R03AK11

ATC

formoterol and fluticasone; inhalant

2.3

140.7

1279

2936

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

2.6

140.0

1005

2060

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

139.7

4436

15246

XG474

NOMESCO Finland

Exhalation nntrogen oxide

2.2

139.6

1337

3140

J01CA08

ATC

pivmecillinam; oral

1.2

139.0

23321

104353

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.5

138.9

5757

20943

D73

ICPC

Gastroenteritis presumed infection

1.9

138.9

2063

5736

Z71.9

ICD-10 Finland

Counselling, unspecified

1.5

138.7

4582

15889

SPAT1325

SPAT

Vaccination

1.3

138.7

18719

81678

SDA01

NOMESCO Finland

Periodontal treatment, very brief

1.3

138.2

16886

72787

N76.0

ICD-10 Finland

Acute vaginitis

1.6

138.1

3715

12274

D02

ICPC

Abdominal pain epigastric

1.6

138.0

3516

11460

J02AC02

ATC

itraconazole; systemic

1.4

137.0

9224

36573

K04

ICPC

Palpitations/awareness of heart

1.7

136.8

2901

9002

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.6

136.7

3618

11905

J01EA01

ATC

trimethoprim; systemic

1.3

136.3

14139

59666

DM1AI

NOMESCO Finland

Cone beam CT of paranasal sinus

2.1

136.0

1516

3792

3478X

ICD-9 Finland

Cataplexy and narcolepsy[MUUT ORGANISET UNIHÄIRIÖT]

+∞

135.8

171

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.4

135.8

9406

37457

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.3

135.5

14127

59647

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

1.8

135.4

2321

6761

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

1.5

135.3

4998

17752

I49.3

ICD-10 Finland

Ventricular premature depolarization

1.6

135.2

3751

12486

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.3

135.0

10650

43254

K07.60

ICD-10 Finland

Snapping jaw

1.7

134.7

2880

8956

S10

ICPC

Boil/carbuncle

1.7

134.7

3248

10435

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.6

134.4

3745

12478

SPAT1212

SPAT

Extensive examination of musculoskeletal system

1.6

134.3

3983

13472

P15

ICPC

Chronic alcohol abuse

2.1

133.5

1572

4018

UDC00

NOMESCO Finland

Ear microscopy

1.6

133.5

3961

13398

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

2.0

133.4

1819

4908

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.7

133.1

3076

9771

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

132.9

4911

17442

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

1.6

132.6

3386

11040

J01FA15

ATC

telithromycin; oral

1.5

132.3

4935

17561

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

132.3

20749

92010

E78.5

ICD-10 Finland

Hyperlipidaemia, unspecified

1.5

132.1

5161

18542

N07BA03

ATC

varenicline; oral

1.8

131.6

2536

7654

SGA02

NOMESCO Finland

Opening and preparing the root canals

1.4

131.6

6972

26543

H02AB07

ATC

prednisone; oral

1.4

131.6

6938

26391

Z2221

NOMESCO Finland

Medical doctor

1.3

131.6

15229

65130

SFA00

NOMESCO Finland

Small restoration

1.4

131.3

7797

30271

R03AC13

ATC

formoterol; inhalant

1.8

131.1

2451

7331

U01

ICPC

Dysuria/painful urination

1.5

131.1

4450

15517

SHA03

NOMESCO Finland

Stomatognathic treatment, demanding

2.0

131.1

1725

4596

L82

ICD-10 Finland

Seborrhoeic keratosis

1.3

131.0

9971

40262

R30.0

ICD-10 Finland

Dysuria

1.8

131.0

2403

7147

SCA04

NOMESCO Finland

Guidance on care of mouth and oral mucosa

9.5

130.8

222

122

G47.4

ICD-10 Finland

Narcolepsy and cataplexy

105.8

130.4

182

NG1AA, ,

SPAT

1.5

130.3

4290

14857

Z00.8

ICD-10 Finland

Other general examinations

1.5

130.2

4578

16085

N03AX11

ATC

topiramate; oral

2.2

130.2

1281

3044

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

1.6

130.1

3382

11074

A28

ICPC

Limited function/disability NOS

1.4

130.0

9038

35990

H93.1

ICD-10 Finland

Tinnitus

1.6

129.5

3688

12350

S04

ICPC

Lump/swelling localized

1.4

129.5

6352

23845

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

25.1

129.4

149

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

1.8

128.9

2330

6898

SPAT1215

SPAT

Assessment of need for medical rehabilitation

1.8

128.7

2098

6013

E23.04

ICD-10 Finland

Hypogonadotropic hypogonadism

3.5

128.6

548

818

SPAT1238

SPAT

Brief therapy

2.5

128.5

999

2131

K04.1

ICD-10 Finland

Necrosis of pulp

1.4

128.3

6090

22721

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

1.6

128.3

3276

10678

K02.0

ICD-10 Finland

Caries limited to enamel

1.3

127.6

12371

51674

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

2.9

127.4

724

1304

A03CA02

ATC

clidinium and psycholeptics; oral

1.7

127.1

2648

8173

SPAT1059

SPAT

Spirometry at the office

1.8

127.1

2459

7430

SPAT1043

SPAT

Audiometry

1.5

127.0

4919

17636

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

2.9

126.8

722

1302

H66.0

ICD-10 Finland

Acute suppurative otitis media

1.5

126.4

4505

15872

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

1.5

126.3

5159

18697

L05

ICPC

Flank/axilla symptom/complaint

1.6

125.9

3447

11431

N05AN01

ATC

lithium; oral

2.2

125.9

1227

2904

SGC00

NOMESCO Finland

Medication, disinfection of root canals

1.4

125.4

5795

21507

F99

ICD-10 Finland

Mental disorder, not otherwise specified

2.3

125.3

1103

2495

XQ858

NOMESCO Finland

Oxygen partial pressure measurement

3.4

125.3

556

854

WZA00

NOMESCO Finland

Concise certificate

1.6

125.2

3567

11944

R03AL01

ATC

fenoterol and ipratropium bromide; inhalant

2.0

125.2

1601

4221

F51.1

ICD-10 Finland

Nonorganic hypersomnia

18.7

125.0

157

F33.0

ICD-10 Finland

Recurrent depressive disorder, current episode mild

3.0

124.7

664

1150

A29

ICPC

General symptom/complaint other

1.4

123.7

7399

28739

TPH04

NOMESCO Finland

Cathetrisation of vein

1.3

123.6

12150

50813

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

1.5

123.6

4359

15319

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.3

123.3

1076

2425

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

2.8

123.2

738

1371

L18

ICPC

Muscle pain

1.8

123.2

2366

7133

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.4

122.9

7504

29244

R4110

NOMESCO Finland

Physiotherapy

1.3

122.8

15286

65865

R00.0

ICD-10 Finland

Tachycardia, unspecified

1.8

122.8

2274

6781

WYA10

NOMESCO Finland

Emergency care or similar visit

1.5

122.6

4026

13928

K05.30

ICD-10 Finland

Periodontitis complex

1.4

122.6

7919

31144

J37.0

ICD-10 Finland

Chronic laryngitis

2.0

122.1

1637

4390

M76.6

ICD-10 Finland

Achilles tendinitis

1.7

121.8

2591

8043

E03

ICD-10 Finland

Other hypothyroidism

1.6

121.8

3107

10123

D12

ICPC

Constipation

1.8

121.7

1969

5630

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

1.8

121.7

2232

6637

N39.3

ICD-10 Finland

Stress incontinence

1.6

121.5

3571

12044

SXA20

NOMESCO Finland

Local application of medicine to mouth

1.6

121.3

3274

10818

B02AA02

ATC

tranexamic acid; systemic

1.4

121.1

7655

29996

K58

ICD-10 Finland

Irritable bowel syndrome

2.0

120.9

1510

3946

SAA04

NOMESCO Finland

Special examination of mouth

1.7

120.5

2844

9080

SGB10

NOMESCO Finland

Root filling of tooth with one root canal

1.4

120.5

6442

24542

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

1.5

120.4

4207

14752

N62

ICD-10 Finland

Hypertrophy of breast

1.8

120.2

2092

6121

S22

ICPC

Nail symptom/complaint

1.6

120.2

3644

12380

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.6

119.8

2930

9442

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

3.4

118.8

521

794

SGA03

NOMESCO Finland

Opening and preparing the root canals, complicated

1.5

118.7

5194

19068

M75.8

ICD-10 Finland

Other shoulder lesions

1.8

118.6

2054

6000

L02.2

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of trunk

1.7

118.0

2454

7569

A10BJ01

ATC

exenatide; parenteral

3.5

117.9

497

736

R06AX26

ATC

fexofenadine; oral

1.6

117.8

3550

12041

K07

ICPC

Swollen ankles/oedema

1.7

117.7

2346

7148

R55

ICD-10 Finland

Syncope and collapse

1.4

117.6

5766

21624

R09

ICPC

Sinus symptom/complaint

1.5

117.4

4591

16482

M10

ICD-10 Finland

Gout

1.8

117.4

2137

6339

J06

ICD-10 Finland

Acute upper respiratory infections of multiple and unspecified sites

1.7

117.3

2500

7763

D20

ICPC

Mouth/tongue/lip symptom/complaint

1.7

117.1

2576

8070

C09AA05

ATC

ramipril; oral

1.3

116.9

12330

51995

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.4

116.6

7178

27997

N40

ICD-10 Finland

Hyperplasia of prostate

1.3

116.5

10140

41671

Z2446

NOMESCO Finland

Social worker

1.6

115.3

3274

10950

K05.31

ICD-10 Finland

Periodontitis pronounced

1.4

115.2

5531

20657

N05AF03

ATC

chlorprothixene; systemic

2.1

114.9

1261

3134

S97

ICPC

Chronic ulcer skin

1.6

114.0

3117

10329

R5140, ,

SPAT

2.8

113.4

698

1317

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

1.7

113.3

2448

7629

M54.1

ICD-10 Finland

Radiculopathy

1.8

113.3

1984

5815

E000001, ,

ATC

1.3

112.8

10996

45867

SPAT1053

SPAT

Memory test

1.4

112.6

6464

24911

SPAT1229

SPAT

Assessment of need for aid

1.5

112.6

3632

12510

L09

ICPC

Arm symptom/complaint

1.7

112.4

2665

8516

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.5

112.0

4443

15992

R30.1

ICD-10 Finland

Vesical tenesmus

2.2

111.8

1144

2763

EB4VA, ,

NOMESCO Finland

1.3

111.8

9936

40928

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

1.9

111.6

1685

4708

IBA03

NOMESCO Finland

Psychotherapy evaluation

3.2

111.3

556

925

A03FA02

ATC

cisapride; oral, rectal

1.5

111.2

3532

12121

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

1.6

111.2

2983

9837

A08AB01

ATC

orlistat; oral

4.2

110.9

381

481

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.8

110.7

1949

5721

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.5

110.6

4371

15718

A10AE04

ATC

insulin glargine; parenteral

1.5

110.1

4828

17722

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

110.1

9294

38002

JDF01

NOMESCO Finland

Laparoscopic gastroplasty

5.0

110.0

310

327

N06AA10

ATC

nortriptyline; systemic

2.3

109.6

1023

2376

F41.00

ICD-10 Finland

Moderate panic disorder

2.5

109.4

836

1769

H66.9

ICD-10 Finland

Otitis media, unspecified

1.5

109.0

3790

13267

C09DA03

ATC

valsartan and diuretics; oral

1.7

108.9

2181

6652

J01DA06

ATC

[U] cefuroxime

1.4

108.7

7367

29154

NA1AD

NOMESCO Finland

Cervical spine CT examination

1.7

108.6

2469

7801

E11.7

ICD-10 Finland

Type 2 diabetes mellitus, with multiple complications

1.7

108.6

2344

7302

J01CF05

ATC

flucloxacillin; systemic

1.5

108.3

3783

13255

H60

ICD-10 Finland

Otitis externa

1.6

108.2

2904

9576

L29.9

ICD-10 Finland

Pruritus, unspecified

1.9

107.5

1489

4039

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

1.4

107.5

4937

18278

NA3AA, ,

SPAT

1.8

107.3

2013

6023

J45.8

ICD-10 Finland

Mixed asthma

1.9

107.1

1525

4176

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

107.1

2652

8570

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.5

106.9

3766

13220

D07XC01

ATC

betamethasone; topical

1.4

106.4

6072

23363

A06AD11

ATC

lactulose; oral

1.4

106.4

7091

27982

I48.9

ICD-10 Finland

Atrial fibrillation and atrial flutter, unspecified

1.5

106.3

3778

13286

SPAT1104

SPAT

Monitoring of emergency patient

1.6

105.8

3150

10649

G03DB01

ATC

dydrogesterone; oral

1.4

105.7

6092

23479

ZYC01, ,

SPAT

1.4

105.7

6252

24201

EB1CA

NOMESCO Finland

Tooth X-ray additional picture

1.4

105.6

5143

19245

C09AA02

ATC

enalapril; systemic

1.3

105.4

9229

37906

N92.1

ICD-10 Finland

Excessive and frequent menstruation with irregular cycle

1.6

105.2

2805

9234

N95.1

ICD-10 Finland

Menopausal and female climacteric states

1.4

105.0

6120

23629

IGY02, ,

SPAT

2.4

104.9

888

1973

N02AJ13

ATC

tramadol and paracetamol; systemic

2.1

104.9

1148

2850

N06AX18

ATC

reboxetine; oral

3.1

104.8

534

900

RK250, ,

NOMESCO Finland

5.6

104.7

265

250

S82

ICPC

Naevus/mole

1.3

104.4

7935

31936

TLC00

NOMESCO Finland

Insertion of intrauterine device

1.6

104.1

3014

10121

DM1AD

NOMESCO Finland

CT of paranasal sinuses and face area

1.8

103.7

1930

5761

S22.3

ICD-10 Finland

Fracture of rib

1.5

103.6

3639

12763

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

103.3

3710

13075

C09CA07

ATC

telmisartan; oral

1.5

103.1

3525

12291

EBA10

NOMESCO Finland

Operative extraction of tooth

1.3

103.0

7933

31985

I48.2

ICD-10 Finland

Chronic atrial fibrillation

1.7

102.8

2136

6583

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.3

102.8

9025

37072

J30.4

ICD-10 Finland

Allergic rhinitis, unspecified

1.7

102.4

2119

6523

ZXD05

NOMESCO Finland

Urgent procedure

1.2

102.4

16750

74170

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

102.2

2361

7491

N30.9

ICD-10 Finland

Cystitis, unspecified

1.5

102.2

3554

12439

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

1.4

102.0

5431

20642

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.5

101.8

3345

11561

N02CC07

ATC

frovatriptan; oral

1.7

101.5

2007

6098

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

1.9

101.3

1406

3816

SPAT1360

SPAT

Extensive global examination

1.5

101.3

3487

12176

H57.1

ICD-10 Finland

Ocular pain

1.7

101.2

2108

6502

SPAT1139

SPAT

Nutrition survey

1.8

101.1

1630

4654

SXC05

NOMESCO Finland

Other oral or dental procedure

1.5

100.9

3678

13000

F60.5

ICD-10 Finland

Anankastic personality disorder

2.8

100.9

595

1096

D07AB08

ATC

desonide; topical

1.4

100.6

5715

21962

G43.3

ICD-10 Finland

Complicated migraine

2.3

100.3

919

2117

U05

ICPC

Urination problems other

1.6

100.3

2605

8518

SGC10

NOMESCO Finland

Pulp capping

1.4

100.2

4735

17613

EB1AA, ,

SPAT

1.5

100.1

3343

11595

TQW40, ,

SPAT

1.4

100.1

5230

19810

T74.1

ICD-10 Finland

Physical abuse

2.2

99.5

1023

2476

C08CA02

ATC

felodipine; oral

1.5

99.3

4340

15908

TFP20

NOMESCO Finland

Cardiodefibrillation

1.5

99.0

3250

11230

M19.8

ICD-10 Finland

Other specified arthrosis

1.7

98.9

1925

5823

OAB44, ,

SPAT

1.4

98.3

5847

22639

F29

ICD-10 Finland

Unspecified nonorganic psychosis

1.8

97.8

1826

5455

K03.80

ICD-10 Finland

Irradiated enamel

1.6

97.8

2937

9946

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

1.5

97.7

3315

11538

K03.66

ICD-10 Finland

Tooth plaque

1.5

97.4

4185

15287

N02CC04

ATC

rizatriptan; oral

1.6

96.5

2820

9488

S02.51

ICD-10 Finland

Fracture of tooth, open

1.4

96.1

4763

17867

N05AX08

ATC

risperidone; systemic

1.5

96.1

4186

15331

I50

ICD-10 Finland

Heart failure

1.9

95.8

1412

3913

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.7

95.4

2242

7145

N92.0

ICD-10 Finland

Excessive and frequent menstruation with regular cycle

1.4

95.1

4467

16592

K07.4

ICD-10 Finland

Malocclusion, unspecified

2.3

95.1

867

1993

JN3BD

NOMESCO Finland

Extensive abdominal CT

1.4

95.1

4837

18228

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.3

94.9

8390

34463

N05AB03

ATC

perphenazine; systemic, rectal

1.8

94.9

1588

4588

R52.0

ICD-10 Finland

Acute pain

1.8

94.8

1721

5098

SPAT1257

SPAT

Teaching of medicine inhalation technique

1.8

94.8

1596

4619

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

94.8

2195

6967

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

2.4

94.7

787

1734

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1.7

94.6

2008

6224

U71

ICPC

Cystitis/urinary infection other

1.5

94.6

3605

12857

I49.8

ICD-10 Finland

Other specified cardiac arrhythmias

1.8

94.3

1543

4426

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.4

94.2

5200

19874

SPAT1359

SPAT

Use of symptom diary

2.0

94.2

1212

3202

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

2.4

94.1

753

1630

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.5

93.8

3960

14413

M75

ICD-10 Finland

Shoulder lesions

1.7

93.7

2235

7149

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

1.7

93.7

1963

6063

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.4

93.7

5119

19532

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

1.9

93.6

1445

4067

S01

ICPC

Pain/tenderness of skin

1.6

93.5

2430

7945

R01AD05

ATC

budesonide; nasal

1.5

93.5

3662

13132

R15

ICD-10 Finland

Faecal incontinence

1.9

93.5

1325

3623

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

1.9

93.5

1481

4204

L84

ICPC

Back syndrome without radiat pain

1.6

93.4

2424

7923

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

3.1

93.3

476

803

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

4.7

93.1

277

308

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

93.1

8365

34426

S60.2

ICD-10 Finland

Contusion of other parts of wrist and hand

1.6

92.8

2877

9811

K86

ICPC

Hypertension uncomplicated

1.3

92.8

6500

25813

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.2

92.6

17410

78043

I48.1

ICD-10 Finland

Persistent atrial fibrillation

1.7

92.4

2042

6400

LCA06

NOMESCO Finland

Biopsy of endometrium

1.4

92.3

5499

21286

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

1.4

92.1

5425

20958

C07AB12

ATC

nebivolol; oral

1.9

92.0

1367

3799

WW200, ,

SPAT

1.2

91.9

16495

73589

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

2.5

91.7

671

1390

R03AC12

ATC

salmeterol; inhalant

1.7

91.6

2041

6412

XFP20

NOMESCO Finland

Check up of cardiac pacemaker

1.5

91.5

2947

10136

WX110, ,

SPAT

1.5

91.5

2932

10074

J30.10

ICD-10 Finland

Allergic rhinitis due to pollen

1.5

91.4

3265

11487

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

1.6

91.3

2816

9592

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

1.6

91.2

2760

9360

J01DC02

ATC

cefuroxime; systemic

1.6

91.2

2697

9098

R04.2

ICD-10 Finland

Haemoptysis

1.8

91.2

1566

4561

N02CC05

ATC

almotriptan; oral

1.7

91.0

1927

5969

LX1AE

NOMESCO Finland

Gynecological ultrasound examination as part of clinical examination

1.4

90.8

5641

21980

H43.8

ICD-10 Finland

Other disorders of vitreous body

1.4

90.7

4463

16713

D07AA02

ATC

hydrocortisone; topical

1.3

90.6

7630

31117

SGA04

NOMESCO Finland

Opening and preparing the root canals, extremely complicated

1.4

90.5

5846

22920

I11.9

ICD-10 Finland

Hypertensive heart disease without (congestive) heart failure

1.7

90.4

1887

5821

M01AB55

ATC

diclofenac, combinations; oral

1.5

90.4

2928

10084

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

1.6

90.3

2203

7087

J44.0

ICD-10 Finland

Chronic obstructive pulmonary disease with acute lower respiratory infection

1.7

90.2

2066

6537

G04CA52

ATC

tamsulosin and dutasteride; systemic

1.4

90.2

4397

16438

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

1.3

90.0

9282

38882

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

26.7

89.9

102

X23

ICPC

Fear sexually transm dis female

1.5

89.3

2866

9848

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

206.8

89.3

119

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

3.4

88.6

401

625

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

1.5

88.5

2902

10021

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

1.6

88.4

2479

8256

J01MA14

ATC

moxifloxacin; systemic

1.4

88.4

4294

16041

WX006

NOMESCO Finland

Intravenous sedation or analgesia without general anesthesia

1.5

88.3

3391

12108

M47.9

ICD-10 Finland

Spondylosis, unspecified

1.8

88.3

1479

4274

N02CC03

ATC

zolmitriptan; nasal, oral

1.6

88.2

2577

8666

HMAK, ,

NOMESCO Finland

1.3

88.2

6027

23834

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

2.0

88.0

1165

3110

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

2.3

87.5

783

1785

C10AA03

ATC

pravastatin; oral

1.5

87.4

3190

11270

J44.1

ICD-10 Finland

Chronic obstructive pulmonary disease with acute exacerbation, unspecified

1.8

87.2

1420

4066

B01AC04

ATC

clopidogrel; oral

1.3

87.2

7641

31319

N06BA07

ATC

modafinil; oral

5.1

87.0

240

248

J30.0

ICD-10 Finland

Vasomotor rhinitis

1.9

86.8

1363

3857

D01AE16

ATC

amorolfine; topical

1.4

86.8

5522

21590

S02

ICPC

Pruritus

1.7

86.8

1976

6243

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.9

86.6

1206

3278

D02AE01

ATC

carbamide; topical

1.5

86.3

3110

10957

H53.9

ICD-10 Finland

Visual disturbance, unspecified

1.7

86.2

1922

6038

M47.80

ICD-10 Finland

Other spondylosis, multiple sites in spine

1.8

85.3

1373

3917

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.5

85.2

2777

9574

H01.0

ICD-10 Finland

Blepharitis

1.5

84.9

3688

13490

A10BH05

ATC

linagliptin; oral

1.6

84.9

2309

7634

T78.4

ICD-10 Finland

Allergy, unspecified

1.6

84.7

2367

7877

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

84.6

5843

23134

N07CA01

ATC

betahistine; oral

1.5

84.3

3319

11907

A02BA04

ATC

nizatidine; systemic

1.5

84.3

3301

11831

G56.2

ICD-10 Finland

Lesion of ulnar nerve

1.8

84.1

1597

4794

B35.3

ICD-10 Finland

Tinea pedis

1.6

84.0

2439

8189

R25.2

ICD-10 Finland

Cramp and spasm

1.9

83.6

1251

3484

J01AA07

ATC

tetracycline; systemic

1.3

83.5

7787

32170

XKD06

NOMESCO Finland

Physiologic investigation of micturition

1.9

83.5

1282

3602

R75

ICPC

Sinusitis acute/chronic

1.6

83.4

2451

8254

SPAT1252

SPAT

Overall medication plan or its review

1.5

83.2

3088

10946

J30.3

ICD-10 Finland

Other allergic rhinitis

1.7

83.2

1842

5775

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

83.1

10336

44247

DM1QA, ,

SPAT

1.6

83.1

2189

7180

EMB10

NOMESCO Finland

Tonsillectomy

1.5

83.0

3077

10904

ZY000

NOMESCO Finland

Hospital inpatient

2.4

82.8

664

1439

F33.01

ICD-10 Finland

Recurrent depression, mild episode of somatic syndrome

3.9

82.7

303

404

R03BC03

ATC

nedocromil; inhalant

1.5

82.7

3155

11248

K04.09

ICD-10 Finland

Pulpit UNS

1.6

82.6

2394

8035

H60.8

ICD-10 Finland

Other otitis externa

1.7

82.5

1589

4791

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

1.5

82.5

2739

9482

R31

ICD-10 Finland

Unspecified haematuria

1.4

82.2

4907

18984

N92.6

ICD-10 Finland

Irregular menstruation, unspecified

1.5

82.1

3122

11122

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.1

82.1

965

2465

E03.89

ICD-10 Finland

Other specified hypothyroidism

1.7

82.0

1938

6182

M01AB08

ATC

etodolac; oral

1.5

82.0

3265

11740

P27

ICPC

Fear of mental disorder

2.3

81.9

716

1616

E11.2

ICD-10 Finland

Type 2 diabetes mellitus, with renal complications

1.8

81.5

1462

4315

J01.9

ICD-10 Finland

Acute sinusitis, unspecified

1.6

81.5

2194

7235

G62.9

ICD-10 Finland

Polyneuropathy, unspecified

1.7

81.4

1564

4711

R06.4

ICD-10 Finland

Hyperventilation

2.2

81.4

796

1887

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.4

81.3

4031

15106

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.5

81.3

2804

9787

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

2.6

81.3

561

1128

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

1.6

81.2

1985

6388

N06AA04

ATC

clomipramine; systemic

2.3

81.1

752

1742

M19.9

ICD-10 Finland

Arthrosis, unspecified

1.6

81.1

1989

6407

GD1AD

NOMESCO Finland

Thorax CT examination

1.5

81.0

2994

10602

XF600

NOMESCO Finland

Bloodpressure measurement

1.5

80.9

3054

10862

H10.0

ICD-10 Finland

Mucopurulent conjunctivitis

1.4

80.8

3984

14914

J05AB11

ATC

valaciclovir; oral

1.3

80.8

7578

31319

P18

ICPC

Medication abuse

3.4

80.7

365

569

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

1.6

80.6

2012

6511

H10.3

ICD-10 Finland

Acute conjunctivitis, unspecified

1.4

80.4

3537

12965

G54.0

ICD-10 Finland

Brachial plexus disorders

1.9

80.3

1243

3501

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

1.6

80.2

2035

6611

130

Kela drug reimbursment

Malignant tumour

0.7

79.8

2249

17748

ZXA00

NOMESCO Finland

Right side

1.2

79.8

13058

57568

G04BD07

ATC

tolterodine; oral

1.6

79.4

2037

6636

M43.1

ICD-10 Finland

Spondylolisthesis

1.7

79.2

1842

5851

2780A

ICD-9 Finland

Obesity and other hyperalimentation, Obesity

3.8

79.2

298

406

L10

ICPC

Elbow symptom/complaint

1.5

79.1

2884

10184

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

2.7

79.1

510

989

I49.4

ICD-10 Finland

Other and unspecified premature depolarization

1.7

79.0

1736

5431

M70.7

ICD-10 Finland

Other bursitis of hip

1.9

79.0

1163

3222

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

1.6

79.0

2004

6511

Z73.3

ICD-10 Finland

Stress, not elsewhere classified

2.2

78.8

816

1982

ICB06, ,

NOMESCO Finland

3.0

78.8

416

718

M01AC01

ATC

piroxicam; systemic, rectal

1.3

78.8

6035

24253

N06AX17

ATC

milnacipran; oral

2.8

78.7

484

914

XKC03

NOMESCO Finland

Water cystometry

1.8

78.6

1333

3866

C10AC01

ATC

colestyramine; oral

1.8

78.6

1304

3756

DAX00

NOMESCO Finland

Adjustment or review of hearing aid

1.6

78.4

2301

7744

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

1.6

78.2

2309

7783

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

1.6

77.9

2254

7561

R32

ICD-10 Finland

Unspecified urinary incontinence

1.8

77.8

1266

3625

JN3AE, ,

SPAT

1.6

77.7

1993

6492

D01AE15

ATC

terbinafine; topical

1.5

77.7

3333

12157

R04.0

ICD-10 Finland

Epistaxis

1.4

77.7

3576

13218

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.3

77.7

8329

35003

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.3

77.6

5850

23452

AN1

Coronary angiography

1.4

77.5

4766

18520

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.6

77.4

2348

7963

D03

ICPC

Heartburn

1.6

77.3

1905

6144

F51.5

ICD-10 Finland

Nightmares

11.9

77.1

116

J40

ICD-10 Finland

Bronchitis, not specified as acute or chronic

1.8

77.1

1423

4236

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

1.7

77.1

1758

5556

K05.18

ICD-10 Finland

Chronic gingivitis

1.4

77.0

4047

15320

I20.09

ICD-10 Finland

Unstable angina

1.5

76.9

2429

8313

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

76.8

9032

38376

SPAT1131

SPAT

Colonoscopy

1.8

76.8

1386

4098

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.5

76.7

2415

8260

M16.1

ICD-10 Finland

Other primary coxarthrosis

1.3

76.7

5467

21735

S20.2

ICD-10 Finland

Contusion of thorax

1.5

76.6

2662

9303

R39.1

ICD-10 Finland

Other difficulties with micturition

1.7

76.6

1501

4547

R19.4

ICD-10 Finland

Change in bowel habit

1.8

76.3

1459

4389

K04.00

ICD-10 Finland

Hyperemia of pulp

1.6

76.3

2346

7981

B01AA03

ATC

warfarin; systemic

1.3

76.2

8575

36241

IGY99, ,

SPAT

1.9

76.2

1176

3310

XKD03

NOMESCO Finland

Urethral pressure profilometry

2.0

76.2

994

2640

L20

ICPC

Joint symptom/complaint NOS

1.6

76.0

1966

6419

M21.4

ICD-10 Finland

Flat foot [pes planus] (acquired)

1.8

75.9

1438

4314

R28

ICPC

Limited function/disability (R)

2.4

75.9

619

1353

K64.9

ICD-10 Finland

Haemorrhoids, unspecified

1.6

75.9

2147

7164

J01MA06

ATC

norfloxacin; oral

1.3

75.8

6086

24614

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.2

75.6

737

1745

IER02

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, group

2.7

75.6

481

926

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

1.4

75.5

3321

12171

N05CD02

ATC

nitrazepam; oral

2.3

75.2

665

1509

NA3BG, ,

SPAT

1.6

74.9

2109

7029

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

2.2

74.9

733

1739

G57.1

ICD-10 Finland

Meralgia paraesthetica

2.2

74.8

739

1760

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.6

74.8

524

1062

R03AL08

ATC

vilanterol, umeclidinium bromide and fluticasone furoate; inhalant

2.1

74.7

839

2106

S89.9

ICD-10 Finland

Unspecified injury of lower leg

1.6

74.4

1837

5927

A23

ICPC

Risk factor NOS

1.3

74.4

5369

21381

N71.0

ICD-10 Finland

Acute inflammatory disease of uterus

1.8

74.1

1253

3632

L72.1

ICD-10 Finland

Trichilemmal cyst

1.4

73.9

3445

12761

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.3

73.6

6386

26098

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

1.4

73.6

3245

11896

R06.8

ICD-10 Finland

Other and unspecified abnormalities of breathing

2.2

73.6

771

1882

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.1

73.4

796

1970

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

2.0

73.3

934

2459

C08DA01

ATC

verapamil; systemic

1.6

73.3

1783

5730

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

2.1

73.3

814

2034

IEY01

NOMESCO Finland

Psychoeducation, individual

2.8

73.3

442

826

SGB30

NOMESCO Finland

Other complicated root filling

1.3

72.9

6167

25114

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.4

72.9

3199

11717

M35.7

ICD-10 Finland

Hypermobility syndrome

2.2

72.8

698

1641

SPAT1255

SPAT

Intravenous administration of medicine

1.4

72.7

3147

11496

Z02.4

ICD-10 Finland

Examination for driving licence

1.2

72.6

13947

62383

G04BD11

ATC

fesoterodine; oral

1.8

72.6

1229

3563

D01AC03

ATC

econazole; topical

1.5

72.3

2591

9114

JN1AE, ,

SPAT

1.6

72.1

1959

6472

X15

ICPC

Vaginal symptom/complaint other

1.6

72.1

2100

7055

Z56.6

ICD-10 Finland

Other physical and mental strain related to work

2.8

72.1

424

781

CBB11

NOMESCO Finland

Resection of lax skin in upper eyelid

1.8

72.0

1180

3386

S63.5

ICD-10 Finland

Sprain and strain of wrist

1.6

72.0

1915

6294

WVA30, ,

SPAT

1.4

71.9

3262

12022

H10.9

ICD-10 Finland

Conjunctivitis, unspecified

1.4

71.9

3701

13955

QBJ30

NOMESCO Finland

Correction of abdominal apron

2.9

71.9

409

739

J35.0

ICD-10 Finland

Chronic tonsillitis

1.5

71.8

2694

9566

D01AC02

ATC

miconazole; topical

1.4

71.6

3438

12804

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

1.6

71.5

1835

5978

SDE04

NOMESCO Finland

Periodontal treatment by dental hygienist, very extensive

1.4

71.5

4630

18132

J01AA04

ATC

lymecycline; systemic

1.3

71.3

7011

29121

Z76

ICD-10 Finland

Persons encountering health services in other circumstances

1.8

71.3

1227

3576

A50

ICPC

General and Unspecified, Medication/prescr/renewal

1.6

71.3

1849

6040

H10

ICD-10 Finland

Conjunctivitis

1.4

71.2

3985

15240

R73

ICD-10 Finland

Elevated blood glucose level

1.7

71.2

1366

4114

R51.81

ICD-10 Finland

Facial pain NOS

1.8

71.1

1134

3226

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

3.1

70.9

353

587

C01CA24

ATC

epinephrine; parenteral

1.4

70.9

3116

11414

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

1.5

70.9

2477

8665

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.4

70.8

4508

17605

L02.9

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle, unspecified

1.7

70.7

1589

5002

G44.8

ICD-10 Finland

Other specified headache syndromes

2.1

70.6

769

1907

NF1AA, ,

SPAT

1.6

70.6

2154

7314

WZB00, ,

SPAT

1.3

70.6

5626

22719

DAX08

NOMESCO Finland

Fitting of hearing aid

1.5

70.5

2537

8930

C09DX01

ATC

valsartan, amlodipine and hydrochlorothiazide; oral

2.0

70.5

886

2321

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.5

70.3

2727

9750

G47

ICD-10 Finland

Sleep disorders

6.1

70.2

163

140

SPAT1298

SPAT

Other function in accordance with nutritional therapy nomenclature

2.7

70.1

459

898

K78

ICPC

Atrial fibrillation/flutter

1.4

70.1

3406

12711

R08

ICPC

Nose symptom/complaint other

1.6

70.0

1782

5793

K59.00

ICD-10 Finland

Constipation caused by slow bowel passage (SCT)

1.9

70.0

1022

2824

Z95.0

ICD-10 Finland

Presence of electronic cardiac devices

1.6

70.0

2144

7287

L08.9

ICD-10 Finland

Local infection of skin and subcutaneous tissue, unspecified

1.6

69.8

1739

5623

P16

ICPC

Acute alcohol abuse

2.1

69.8

769

1916

M01AB01

ATC

indometacin; systemic, rectal

1.4

69.7

3130

11511

R01BA51

ATC

phenylpropanolamine, combinations; oral

1.3

69.5

6451

26590

H02.4

ICD-10 Finland

Ptosis of eyelid

1.7

69.4

1330

4003

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.4

69.4

3028

11076

G04CB01

ATC

finasteride; oral

1.3

69.4

4685

18462

N05BA02

ATC

chlordiazepoxide; systemic

1.9

69.4

969

2637

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.4

69.3

3246

12032

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

69.3

15013

67862

Z12

ICPC

Relationship problem with partner

2.0

69.3

875

2297

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

1.5

69.2

2194

7515

C09DA07

ATC

telmisartan and diuretics; oral

1.6

69.1

1792

5853

W19

ICD-10 Finland

Unspecified fall

1.3

69.1

5126

20485

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

2.6

69.0

495

1016

A07AA02

ATC

nystatin; oral

1.5

69.0

2626

9352

Z97.4

ICD-10 Finland

Presence of external hearing-aid

1.5

69.0

2167

7407

H61.2

ICD-10 Finland

Impacted cerumen

1.4

68.8

3434

12875

A03FA01

ATC

metoclopramide; systemic, rectal

1.2

68.6

11555

50988

ZXA05

NOMESCO Finland

Left side

1.2

68.5

12039

53346

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

1.5

68.4

2835

10269

I50.0

ICD-10 Finland

Congestive heart failure

1.4

68.3

3212

11914

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.2

68.3

663

1568

B35.6

ICD-10 Finland

Tinea inguinalis [Tinea cruris]

1.9

68.2

973

2667

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.8

68.2

1116

3202

R95

ICPC

Chron obstructive pulmonary disease

1.8

68.1

1273

3804

N05BA06

ATC

lorazepam; systemic, sublingual

1.5

68.1

2252

7785

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.5

67.9

2888

10512

NB1AA, ,

SPAT

1.6

67.7

2020

6824

R49.01

ICD-10 Finland

Functional dysphonia

1.7

67.5

1319

3993

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

1.8

67.4

1121

3232

I49.1

ICD-10 Finland

Atrial premature depolarization

1.6

67.4

1717

5584

K08.3

ICD-10 Finland

Retained dental root

1.4

67.3

3770

14416

A01AB09

ATC

miconazole; local oral

1.4

67.3

4009

15486

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.4

67.3

2934

10731

SFC92

NOMESCO Finland

Other complicated additional procedure necessary for restorative treatment

1.4

67.2

3025

11129

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

3.4

67.2

298

459

NF1AA

NOMESCO Finland

Hip X-ray examination

1.4

67.1

4230

16488

UJF32, ,

SPAT

1.6

67.1

1600

5115

N02CC06

ATC

eletriptan; oral

1.6

67.1

1699

5516

NG2AA

NOMESCO Finland

Patella X-ray examination

1.8

67.0

1276

3834

358

Kela drug reimbursment

liraglutide

4.0

66.9

240

315

J44.9

ICD-10 Finland

Chronic obstructive pulmonary disease, unspecified

1.6

66.9

1830

6056

SPAT1225

SPAT

Implementation of podiatry rehabilitation plan

1.8

66.9

1080

3085

N32.82

ICD-10 Finland

Instability of the detrusor vesicae muscle

2.2

66.6

684

1656

R25.1

ICD-10 Finland

Tremor, unspecified

1.7

66.6

1416

4391

G93.3

ICD-10 Finland

Postviral fatigue syndrome

3.6

66.4

273

398

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

1.4

66.3

2925

10720

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

1.4

66.1

3224

12037

R61

ICD-10 Finland

Hyperhidrosis

2.5

66.0

488

1017

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

1.4

66.0

3560

13527

K29.7

ICD-10 Finland

Gastritis, unspecified

1.6

65.9

1601

5143

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

65.9

6030

24799

SPAT1241

SPAT

Extensive assessment of psychosocial situation

2.3

65.9

617

1437

RD210, ,

NOMESCO Finland

2.0

65.7

789

2033

K05

ICPC

Irregular heartbeat other

1.7

65.6

1475

4644

F32.01

ICD-10 Finland

Mild depressive episode with somatic syndrome

2.6

65.5

449

900

S01GX08

ATC

ketotifen; ophthalmic

1.5

65.5

2248

7834

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.3

65.5

6568

27333

S80.1

ICD-10 Finland

Contusion of other and unspecified parts of lower leg

1.6

65.4

1657

5381

XG480

NOMESCO Finland

Histamine provocation of respiratroy tract

2.2

65.1

668

1617

M10.0

ICD-10 Finland

Idiopathic gout

1.7

65.1

1494

4729

SCA02

NOMESCO Finland

Preventive oral health care

1.3

65.0

5751

23546

VALMI, ,

NOMESCO Finland

1.2

64.9

13700

61724

N06BA09

ATC

atomoxetine; oral

3.8

64.7

245

336

N94.6

ICD-10 Finland

Dysmenorrhoea, unspecified

1.9

64.6

999

2814

M01AH03

ATC

valdecoxib; oral

1.5

64.5

2670

9667

J01FA01

ATC

erythromycin; systemic

1.3

64.4

7264

30660

Z75.1

ICD-10 Finland

Person awaiting admission to adequate facility elsewhere

1.7

64.3

1256

3802

N48.1

ICD-10 Finland

Balanoposthitis

1.8

64.3

1220

3662

WZC30, ,

SPAT

1.4

64.3

4175

16347

IER01

NOMESCO Finland

Psychoeducation, group

2.8

64.2

379

700

E78.9

ICD-10 Finland

Disorder of lipoprotein metabolism, unspecified

1.6

64.2

1537

4920

UJD02

NOMESCO Finland

Gastroscopy

1.5

64.0

2096

7229

NA3AD

NOMESCO Finland

Lumbar spine and sacrum CT examination

1.7

63.9

1250

3785

E11.4

ICD-10 Finland

Type 2 diabetes mellitus, with neurological complications

1.9

63.9

939

2601

IHZ01, ,

SPAT

2.2

63.8

666

1624

F10.20

ICD-10 Finland

Alcohol dependence currently independent

1.9

63.7

874

2364

Z03.8

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

63.7

1791

5966

R4190, ,

SPAT

3.0

63.7

343

600

L30.4

ICD-10 Finland

Erythema intertrigo

2.1

63.7

704

1757

JBC01

NOMESCO Finland

Laparoscopic gastro-oesophageal antireflux operation

2.0

63.6

791

2065

WX725

NOMESCO Finland

Noninvasive ventilation

1.4

63.6

2722

9919

K29

ICPC

Cardiovascular sympt/complt other

1.5

63.6

1991

6800

W22

ICD-10 Finland

Striking against or struck by other object(s)

1.4

62.9

3323

12579

F10.09

ICD-10 Finland

Alcohol intoxication UNS

1.9

62.8

965

2713

M62.6

ICD-10 Finland

Muscle strain

1.6

62.8

1552

5009

XG405

NOMESCO Finland

Education on PEF monitoring

2.2

62.7

644

1560

R19.5

ICD-10 Finland

Other faecal abnormalities

2.0

62.6

797

2099

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

1.5

62.6

2189

7659

FN1AD

NOMESCO Finland

CT of coronary arteries

2.0

62.5

835

2238

SPAT1028

SPAT

Ultrasound examination of paranasal sinuses

1.4

62.3

2773

10178

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.5

62.3

2009

6906

M94.0

ICD-10 Finland

Chondrocostal junction syndrome [Tietze]

1.8

62.1

1158

3458

IAA01, ,

SPAT

2.5

62.1

483

1033

R00.1

ICD-10 Finland

Bradycardia, unspecified

1.6

61.8

1479

4734

D93

ICPC

Irritable bowel syndrome

2.1

61.7

668

1653

ZA1.0

ICD-10 Finland

Shoulder region

1.8

61.7

1111

3284

K57

ICD-10 Finland

Diverticular disease of intestine

1.9

61.6

906

2510

D06BX01

ATC

metronidazole; topical

1.3

61.6

5144

20891

NG1BA

NOMESCO Finland

Knee extensive X-ray examination

1.8

61.5

1048

3046

NB1BA

NOMESCO Finland

Shoulder extensive X-ray examination without contrast

1.6

61.4

1507

4854

J30.19

ICD-10 Finland

Pollen allergy UNS

1.5

61.4

2139

7478

N81.6

ICD-10 Finland

Rectocele

1.4

61.3

2806

10353

I25

ICD-10 Finland

Chronic ischaemic heart disease

1.5

61.3

1954

6700

SPAT1246

SPAT

Screening of depression or other psychiatric problem

1.5

61.2

2214

7800

N95.0

ICD-10 Finland

Postmenopausal bleeding

1.4

61.2

3692

14286

TAB00

NOMESCO Finland

Lumbar puncture

1.5

61.1

2034

7040

XA800

NOMESCO Finland

Neuropsychological investigation

1.5

61.0

1936

6631

G63.2*E11.4

ICD-10 Finland

Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy

2.3

60.9

521

1165

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

4.1

60.8

209

265

SPAT1284

SPAT

Extensive health certificate

1.7

60.8

1325

4137

SPAT1008

SPAT

Photography of fundus of the eye or interpretation of photograph

1.6

60.7

1548

5035

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

1.6

60.6

1728

5775

L50.9

ICD-10 Finland

Urticaria, unspecified

1.5

60.6

1922

6583

UJD10, ,

SPAT

1.7

60.5

1173

3544

F01

ICPC

Eye pain

1.6

60.5

1501

4849

M15.8

ICD-10 Finland

Other polyarthrosis

1.9

60.5

917

2567

M20.1

ICD-10 Finland

Hallux valgus (acquired)

1.4

60.4

3684

14280

S06

ICPC

Rash localized

1.4

60.3

2754

10157

J01MA01

ATC

ofloxacin; systemic

1.4

60.3

3551

13687

M13.9

ICD-10 Finland

Arthritis, unspecified

1.4

60.2

3614

13971

FM1DE

NOMESCO Finland

Doppler ultrasound examination of heart

1.3

60.2

4210

16665

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.5

60.2

2151

7560

Z08

ICPC

Social welfare problem

2.1

60.1

629

1536

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

1.8

60.1

1048

3068

C01BC04

ATC

flecainide; systemic

1.6

60.0

1477

4761

NH3AA, ,

SPAT

1.4

59.9

2835

10524

A27

ICPC

Fear of other disease NOS

1.5

59.9

2384

8565

K07.63

ICD-10 Finland

Pain in the jaw joint UNS

1.8

59.7

950

2701

SGB20

NOMESCO Finland

Root filling of tooth with onetwo root canals

1.4

59.7

3092

11662

Z63.4

ICD-10 Finland

Disappearance and death of family member

2.3

59.6

551

1276

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.4

59.6

3355

12834

I84

ICD-10 Finland

Hemorrhoids

1.7

59.5

1176

3573

R05DA01

ATC

ethylmorphine; oral

1.4

59.3

3528

13621

3007

Kela drug reimbursment

Erenumab and fremanezumab

2.1

59.2

627

1538

F43.28

ICD-10 Finland

Adaptive disorder with other predominant symptoms

3.1

59.2

305

519

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

2.5

59.1

458

978

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.4

59.1

3406

13082

R03DA04

ATC

theophylline; systemic, rectal

1.5

59.0

2082

7296

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3015235) Bicarbonate [Moles/volume] in Capillary blood

4205

8282

2.75

307.65

2.8

3.1

24.90

24.47

mmol/l

8.81

4148

8089

(3018418) pH of Serum or Plasma

23351

90867

1.50

307.65

4.2

4.4

7.40

1.51

16576

64712

(3017446) Testosterone [Moles/volume] in Serum or Plasma

7826

25012

1.71

307.65

2.7

2.1

12.31

12.99

nmol/l

9.81

7030

22817

(3013826) Glucose [Moles/volume] in Serum or Plasma

44443

181163

1.73

307.65

5.4

5.0

6.63

6.65

mmol/l

1.45

42223

170060

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

12847

45041

1.59

307.65

2.7

22.64

22.73

0.29

11866

41942

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

22319

80746

1.64

307.65

2.5

2.3

2.78

2.79

mg/l

0.40

19349

69845

(3015377) Calcium [Moles/volume] in Serum or Plasma

27646

102979

1.65

307.65

3.0

3.7

2.35

mmol/l

0.17

25156

94108

(3018010) Neutrophils/Leukocytes in Blood

37033

150186

1.59

307.65

6.3

6.5

57.02

57.27

3.55

35405

143953

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

4735

7659

3.38

307.65

3.4

4.9

24.91

24.65

mmol/l

6.48

4420

6983

(3002582) Erythrocytes [#/volume] in Urine

25237

101537

1.46

307.65

3.6

3.3

64.16

86.36

e6/l

1.83

19348

76995

(3021589) Normoblasts [#/volume] in Blood

33586

141415

1.45

307.65

12.2

11.1

0.00

e9/l

2.77

27498

115211

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

55636

228439

2.17

307.65

4.9

4.2

11.53

11.57

mm/h

0.25

52367

214300

(3013115) Eosinophils [#/volume] in Blood

41328

166499

1.69

307.65

6.4

6.8

0.20

0.19

e9/l

14.09

36343

145739

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

26278

97305

1.64

307.65

2.8

2.7

59.23

69.48

u/l

0.93

24239

90611

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

56161

236331

2.07

307.65

8.2

77.02

79.08

u/l

19.29

53498

224824

(3018095) Leukocytes [#/volume] in Urine

28823

117606

1.46

307.65

4.3

3.9

82.58

100.24

e6/l

2.96

20529

81332

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

65337

292971

2.67

307.65

5.8

4.5

5.95

5.84

mmol/l

75.41

60831

271381

(3022948) Iron [Moles/volume] in Serum or Plasma

14976

52592

1.61

307.65

2.7

2.6

13.52

13.48

umol/l

0.03

13890

49137

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

35419

131088

1.80

307.65

2.3

2.0

98.56

95.48

pmol/l

25.21

19243

70434

(3003129) Base excess in Capillary blood by calculation

1783

2050

4.63

307.65

2.0

2.6

0.49

0.44

mmol/l

0.20

1747

1885

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

65720

304653

2.36

307.65

5.5

4.5

1.40

1.47

mmol/l

307.65

61738

285588

(3009343) pH of Capillary blood

7970

14910

3.01

307.65

3.4

4.2

7.42

0.32

6573

12586

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

16211

56331

1.65

307.65

1.4

1.3

32.21

34.20

iu/ml

0.29

4587

17281

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

34623

135355

1.64

307.65

6.8

6.7

1.21

mmol/l

4.33

32099

125643

(3021960) Folate [Moles/volume] in Serum or Plasma

24044

82608

1.78

307.65

1.8

1.7

20.24

19.94

nmol/l

1.97

20677

71005

(3021601) Nitrite [Presence] in Urine by Test strip

40656

168170

1.60

307.65

4.2

3.7

0.00

estimate

0.43

9223

33878

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

36327

139503

1.72

307.65

2.7

2.4

2547.70

76.70

nmol/l

0.50

33175

127717

(3019198) Lymphocytes [#/volume] in Blood

40800

165417

1.66

307.65

6.3

6.5

1.97

1.90

e9/l

8.67

36141

145979

(3012095) Magnesium [Moles/volume] in Serum or Plasma

13743

50296

1.53

307.65

3.1

3.7

0.82

mmol/l

7.56

12839

47462

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

24673

91309

1.62

307.65

2.4

2.2

196.21

216.59

u/l

2.41

23317

86532

(3005322) IgE [Units/volume] in Serum or Plasma

6625

19924

1.81

307.65

1.4

1.3

226.78

254.29

u/ml

0.73

6183

18538

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

64671

286002

2.68

307.65

7.3

5.6

39.31

38.63

mmol/mol

67.97

61261

268600

(3036481) Cortisol [Moles/volume] in Serum or Plasma

9551

27258

1.96

307.65

2.2

2.4

364.33

389.54

nmol/l

24.32

8824

25482

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

66747

310577

2.55

307.65

6.3

5.2

2.67

2.74

mmol/l

68.49

62873

291431

(3026361) Erythrocytes [#/volume] in Blood

70817

347601

3.81

307.65

27.9

22.2

4.53

4.50

e12/l

59.84

69780

338972

(3006315) Basophils [#/volume] in Blood

40075

161712

1.66

307.65

6.2

6.5

0.04

e9/l

5.52

34704

139451

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

51675

216001

1.87

307.65

3.8

3.1

47.26

45.30

u/l

5.02

48868

204384

(3009508) Creatinine [Moles/volume] in Urine

28550

101214

1.78

307.65

3.6

3.4

7.95

7.59

mmol/l

25.55

23989

86981

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

27821

111242

1.50

307.65

3.7

3.4

1.42

2.15

e6/l

0.82

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

67806

314180

2.97

307.65

18.3

14.8

21.19

24.90

mg/l

158.37

58380

254196

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

69687

331937

3.51

307.65

13.3

11.2

27.80

25.89

u/l

64.19

68104

322792

(36304419) Bacteria [Presence] in Urine

20824

83639

1.42

307.65

3.4

3.2

40.17

256.79

estimate

0.87

380

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

66026

306585

2.40

307.65

5.6

4.6

4.55

4.66

mmol/l

127.26

62369

288885

(3000963) Hemoglobin [Mass/volume] in Blood

70821

347697

3.81

307.65

28.1

22.4

136.20

135.20

g/l

62.46

70395

344129

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

38578

151785

1.70

307.65

7.3

1.21

mmol/l

1.30

33140

131708

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

15617

58293

1.51

307.65

2.7

3.1

2.44

2.45

mmol/l

11.14

13933

52250

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

20888

74300

1.66

307.65

1.4

1.3

1.31

1.81

u/ml

7.71

5837

20179

(3019069) Monocytes/Leukocytes in Blood

36935

148754

1.60

307.65

6.5

6.8

8.70

8.81

10.84

34670

140153

(3001604) Monocytes [#/volume] in Blood

40006

161275

1.66

307.65

6.2

6.5

0.58

e9/l

3.17

34639

139117

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

65224

296196

2.50

307.65

17.3

14.3

83.84

83.55

ml/min/173m2

2.67

61056

270061

(3009542) Hematocrit [Volume Fraction] of Blood by calculation

70815

347578

3.81

307.65

28.4

22.6

41.06

40.87

0.61

70369

343784

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

30938

125800

1.50

307.65

2.0

1.8

1.45

1.31

mmol/l

114.60

25747

107729

(3007461) Platelets [#/volume] in Blood

70808

347389

3.82

307.65

27.9

22.2

254.07

252.57

e9/l

7.64

69951

339880

(3007164) IgA [Mass/volume] in Serum or Plasma

18088

64443

1.62

307.65

1.5

2.37

2.35

g/l

0.43

11341

40535

(3013650) Neutrophils [#/volume] in Blood by Automated count

43218

181884

1.60

307.65

8.5

10.1

4.18

4.11

e9/l

6.55

37578

157871

(3022145) Colonoscopy Study observation

10020

34158

1.62

307.65

1.4

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

19393

66213

1.72

307.65

1.8

0.98

1.32

mg/l

41.34

14829

51203

(3010813) Leukocytes [#/volume] in Blood

70823

347663

3.82

307.65

28.0

22.2

6.86

6.71

e9/l

48.43

69800

339043

(40768797) Stomach Pathology biopsy report

12329

39349

1.77

307.65

1.3

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

11992

37423

1.81

307.65

1.9

1.7

1.45

1.44

10582

33252

(3026493) Urate [Moles/volume] in Serum or Plasma

21757

77694

1.66

307.65

2.8

2.7

347.57

336.98

umol/l

39.35

19208

69246

(3024561) Albumin [Mass/volume] in Serum or Plasma

34826

136483

1.64

307.65

4.8

5.2

36.21

35.71

g/l

48.98

32552

128220

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

6888

13292

2.88

307.65

3.3

4.1

1.67

1.77

mmol/l

1.20

5204

9477

(3013512) EKG study

26031

97321

1.62

307.65

4.0

3.4

0.73

0.75

0.14

248

(3023103) Potassium [Moles/volume] in Serum or Plasma

68213

314213

3.28

307.65

21.4

17.2

3.96

mmol/l

0.09

67180

306960

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

63209

288465

2.13

307.65

4.7

3.9

1.37

1.24

mmol/l

311.08

58824

268409

(3022096) Basophils/Leukocytes in Blood

36801

148354

1.60

307.65

6.5

6.8

0.68

0.67

2.56

34491

139569

(3002030) Lymphocytes/Leukocytes in Blood

37669

153098

1.59

307.65

6.4

6.7

28.24

27.93

5.90

35752

145735

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

23792

82487

1.75

307.65

3.5

3.1

1155.58

1489.49

ng/l

26.87

19939

71307

(3019550) Sodium [Moles/volume] in Serum or Plasma

68102

313579

3.23

307.65

21.2

17.0

139.67

139.63

mmol/l

5.11

67118

306967

(3012516) Albumin [Mass/volume] in Urine

25403

91554

1.69

307.65

3.7

3.5

50.65

50.70

mg/l

0.01

16562

58148

(3001122) Ferritin [Mass/volume] in Serum or Plasma

40480

153197

1.86

307.65

3.5

3.1

111.62

118.88

ug/l

6.51

37894

143974

(3032080) INR in Blood by Coagulation assay

34472

138202

1.58

307.65

15.8

13.9

1.24

1.25

inr

0.23

29033

115287

(3029937) Albumin [Presence] in Urine by Test strip

23094

91647

1.46

307.65

4.4

3.9

0.00

estimate

0.37

8718

31128

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

30133

110701

1.72

307.65

4.2

3.5

74.87

64.64

ng/l

0.31

19782

73827

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

30846

127921

1.45

307.65

4.1

3.7

0.69

0.48

estimate

0.49

7717

27790

(3020564) Creatinine [Moles/volume] in Serum or Plasma

69950

333743

3.72

307.65

23.3

18.6

77.68

76.43

umol/l

16.92

69461

329642

(3028707) Methadone [Presence] in Urine by Screen method

2610

5598

2.49

307.65

3.1

3.0

—

(3048689) Calprotectin [Mass/mass] in Stool

12562

41362

1.71

307.65

2.4

2.6

117.45

136.82

ug/g

7.72

9899

33168

(3004789) Transferrin [Mass/volume] in Serum or Plasma

13929

48969

1.60

307.65

2.7

2.6

2.39

2.32

g/l

34.08

12801

45320

(3044889) 12 lead EKG panel

49683

209867

1.75

307.65

4.4

3.7

247.61

3204.64

1.30

409

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

40475

161178

1.70

307.65

5.7

6.8

11.00

11.66

umol/l

21.01

38360

153658

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

15098

51705

1.66

307.65

1.3

8.69

11.82

u/ml

5.55

5919

20361

(3037467) Urinalysis macro (dipstick) panel - Urine

50767

216428

1.75

307.65

5.1

4.4

8.63

43.62

0.40

322

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

8167

15391

3.00

307.65

3.5

4.2

5.19

5.09

kpa

18.39

7850

14577

(42870588) Differential panel, method unspecified - Blood

27485

106202

1.57

307.65

6.1

6.7

5.79

5.07

—

(3035350) Ketones [Presence] in Urine by Test strip

41024

170298

1.59

307.65

4.2

3.8

2.63

4.09

estimate

1.23

9334

34566

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

7331

21582

1.86

307.65

1.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

27229

104535

1.58

307.65

3.2

3.3

31.75

33.64

u/l

3.39

25596

99100

(3035941) MCH [Entitic mass]

70814

347553

3.81

307.65

27.8

22.1

30.26

30.25

1.08

70374

343932

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

59353

240339

2.60

307.65

5.1

4.2

14.68

14.74

pmol/l

6.33

55291

221192

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

17402

59580

1.69

307.65

1.8

1.7

28787163.48

35556303.81

pmol/l

0.77

14531

49913

(3037522) Nuclear Ab [Titer] in Serum

12569

43518

1.61

307.65

1.4

463.75

545.58

titre

5.22

2488

9184

(3009261) Glucose [Presence] in Urine by Test strip

41213

171591

1.59

307.65

4.2

3.8

0.20

0.26

estimate

0.17

8808

32983

(3020682) Albumin/Creatinine [Ratio] in Urine

25776

93390

1.68

307.65

4.4

4.2

8.61

9.05

mg/mmol

0.64

16263

58343

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

66226

286889

3.39

307.65

6.4

5.0

1.83

1.89

mu/l

14.75

62551

266948

(3006504) Eosinophils/Leukocytes in Blood

36848

148350

1.60

307.65

6.4

6.7

2.89

2.81

9.87

34556

139727

(3024731) MCV [Entitic mean volume] in Red Blood Cells

70816

347555

3.81

307.65

27.8

22.1

90.88

90.77

8.79

70374

343929

(3031040) Bacteria [#/volume] in Urine by Automated count

48629

207562

1.68

307.65

5.4

4.4

1707.33

1699.65

e6/l

0.01

727

2869

(3030467) Casts [#/volume] in Urine by Automated count

21930

87682

1.44

307.65

3.5

3.3

0.36

0.42

e6/l

3.19

16158

63795

(3000850) Epithelial cells [#/volume] in Urine

17903

69024

1.47

307.65

2.9

2.7

5.80

5.72

e6/l

0.24

16251

62831

(3041096) Erythrocytes [Presence] in Urine by Automated

23091

91700

1.46

307.65

3.5

3.2

0.33

0.22

estimate

0.52

7572

26987

(3019309) Folate [Moles/volume] in Red Blood Cells

13983

47930

1.65

307.65

1.8

1.7

1179.35

1150.66

nmol/l

2.74

10603

36654

(3015736) pH of Urine

33279

135888

1.52

307.65

3.7

3.4

6.18

6.25

18.88

18636

75771

(44816559) Phosphatidylethanol [Mass/volume] in Blood

4700

12073

2.10

307.65

1.8

1.7

0.28

0.31

mg/l

2.65

2227

5651

(3023368) Bacteria identified in Blood by Culture

20914

84860

1.40

305.55

4.5

4.3

—

(3011288) Drugs identified in Urine by Screen method Nominal

3887

10290

2.03

304.54

3.3

2.9

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

3565

9206

2.07

297.97

2.0

1.7

37.06

43.76

nmol/l

44.56

3484

9033

(3003458) Phosphate [Moles/volume] in Serum or Plasma

10959

39531

1.53

291.58

5.8

6.4

1.05

1.04

mmol/l

1.02

10184

36823

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

56199

268521

1.41

284.94

21.3

18.2

13.58

13.55

6.12

55590

264910

(3000494) Fungus identified in Specimen by Culture

10229

36554

1.54

283.11

1.5

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

2747

6530

2.24

280.72

2.1

1.7

195.82

203.59

pmol/l

2.72

2609

6230

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

13450

50980

1.46

280.29

2.0

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

9507

33640

1.55

274.17

5.4

4.5

31.63

32.89

22.21

6967

22353

(3026782) Osmolality of Urine

15078

58993

1.42

262.93

3.0

2.9

527.65

534.79

mosm/kgh2o

2.92

13165

51945

(3019225) pH of Specimen

7826

26727

1.59

261.78

4.2

7.36

7.35

2.59

5610

19180

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

11141

41256

1.48

258.27

2.5

2.1

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

33861

150903

1.32

256.89

2.8

—

estimate

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

11960

45012

1.46

255.31

2.6

2.2

—

(40761536) Microorganisms panel - Urine sediment

7195

24216

1.61

255.03

4.3

3.8

—

(3017732) Neutrophils [#/volume] in Blood

10549

38762

1.49

253.47

2.9

3.2

4.48

4.53

e9/l

0.21

9058

33765

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

6048

19495

1.68

253.35

3.3

3.6

4.50

4.54

pmol/l

1.98

5407

17668

(3016879) Cocaine [Presence] in Urine

4735

14521

1.75

236.15

2.5

2.0

—

(3014051) Protein [Presence] in Urine by Test strip

21999

92955

1.34

234.32

3.0

2.9

0.07

0.12

321

2104

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

14709

58304

1.40

233.82

4.3

3.7

377.69

504.87

ng/l

0.97

10791

44185

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

8129

28759

1.54

231.29

3.6

3.3

—

(3000764) Benzodiazepines [Presence] in Urine

4988

15658

1.71

229.05

2.4

2.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

6236

20786

1.62

228.30

1.2

—

(3027008) Opiates [Presence] in Urine

5005

15763

1.71

227.07

2.3

2.0

—

(3028300) Cannabinoids [Presence] in Urine

5012

15817

1.70

225.68

2.4

2.0

—

(3027944) Amphetamines [Presence] in Urine

4932

15598

1.70

220.14

2.4

1.9

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

6581

22699

1.56

207.94

3.8

4.0

1.23

mmol/l

1.45

5639

19666

(3033658) Prothrombin time (PT) actual/Normal

19033

79803

1.33

207.74

4.2

90.46

89.86

2.52

18558

78098

(36660697) Celiac disease serology panel - Serum

7359

26051

1.53

207.13

1.2

—

(1616796) Gas panel - Central venous blood

2390

6071

2.09

206.99

3.7

—

(3021901) Oxygen saturation in Capillary blood

2230

5562

2.13

202.16

3.0

90.60

89.96

4.25

2180

5389

(3028626) Oxygen [Partial pressure] in Capillary blood

2650

7142

1.97

195.87

3.6

3.7

8.36

8.34

kpa

0.21

2602

6941

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

20777

88864

1.31

194.16

5.6

5.3

2.59

3.42

ug/l

2.22

18794

80720

(3045414) Leukocytes [Presence] in Urine

8013

29262

1.48

193.69

2.1

2.0

0.02

estimate

0.78

1714

6011

(3009214) Lutropin [Units/volume] in Serum or Plasma

3338

9761

1.82

193.57

1.4

8.70

10.30

u/l

8.14

2687

7867

(3025159) Blasts/Leukocytes in Blood

7329

26444

1.50

187.39

4.4

4.9

0.19

0.31

0.87

1795

6875

(3021387) Prolactin [Units/volume] in Serum or Plasma

3978

12375

1.72

187.31

1.7

304.31

307.46

mu/l

0.17

3544

11287

(3042936) Bacteria identified in Isolate by Culture

11265

44097

1.40

186.88

2.1

2.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

4996

16533

1.62

186.44

1.4

22.68

26.39

iu/l

12.56

4254

14121

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

9505

36118

1.43

186.43

2.4

2.9

7.21

8.98

umol/l

14.41

8164

31704

(3002179) Metamyelocytes/Leukocytes in Blood

7226

26076

1.50

184.43

4.1

4.4

0.69

0.70

0.15

2064

7955

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

6380

22459

1.53

182.79

3.9

4.1

89.77

89.30

ng/l

0.14

5494

19603

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

5067

16951

1.60

180.74

1.1

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

9818

37798

1.41

178.35

1.9

1.8

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

6404

22741

1.52

175.86

1.2

126.71

146.06

u/ml

3.24

2357

8642

(3001019) Free T4 and TSH panel - Serum or Plasma

4629

15301

1.62

173.02

1.7

1.6

—

(3025941) Bacteria identified in Stool by Culture

5031

17082

1.58

168.21

1.3

1.2

—

(3021440) Promyelocytes/Leukocytes in Blood

7177

26338

1.47

167.53

4.3

4.7

0.11

0.12

0.76

1809

7284

(3005719) IgG [Mass/volume] in Serum or Plasma

6628

24007

1.49

164.96

2.6

3.0

10.52

10.63

g/l

1.03

6040

22341

(3045424) Erythrocytes [Presence] in Urine

4419

14610

1.62

164.74

2.1

0.03

0.14

estimate

0.89

1407

4703

(3017181) Myelocytes/Leukocytes in Blood

7439

27596

1.45

164.06

4.2

4.6

0.91

0.95

0.50

2067

8502

(3013290) Carbon dioxide [Partial pressure] in Blood

2126

5647

1.99

163.19

4.1

3.8

5.08

4.96

kpa

9.88

2082

5503

(3010421) pH of Blood

2956

8770

1.79

163.02

3.9

3.5

7.41

1.67

2914

8638

(3012501) Base excess in Blood by calculation

2125

5646

1.99

162.98

4.1

3.8

2.44

2.50

mmol/l

0.45

1485

3713

(3027315) Oxygen [Partial pressure] in Blood

2134

5686

1.99

162.40

4.1

3.8

8.74

8.65

kpa

1.18

2090

5541

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

6008

21396

1.51

162.04

2.4

19.70

21.23

au/ml

0.76

649

2487

(3011397) Hemoglobin [Presence] in Urine by Test strip

18171

77799

1.29

161.80

4.0

3.7

0.34

0.24

0.43

782

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

3634

11490

1.69

160.68

1.6

1.7

14.84

16.79

u/ml

0.74

776

2976

(46235355) HIV 1 and 2 tests - Meaningful Use set

16802

71256

1.30

160.51

2.2

2.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

5592

19702

1.52

158.37

1.3

45.53

53.49

au/ml

1.82

307

1249

(40758558) Short blood count panel - Blood

21749

95634

1.27

155.11

5.9

6.6

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

13439

55536

1.32

153.70

3.2

2.9

0.98

1.17

e6/l

2.42

6962

29353

(3019150) Specific gravity of Urine by Refractometry

17786

76366

1.29

153.24

4.2

3.9

1.02

1.18

kg/l

2.31

11781

50100

(3000570) Elastase.pancreatic [Mass/mass] in Stool

2879

8653

1.77

151.90

1.4

292.32

267.76

ug/g

5.54

1598

5068

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

6260

22780

1.48

151.49

2.3

2.0

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

7303

27467

1.43

148.69

2.5

2.1

—

(3027945) Reticulocytes/Erythrocytes in Blood

9018

35219

1.38

148.08

2.5

2.7

1.82

1.75

8.74

8010

31519

(3017143) Hepatitis C virus Ab [Presence] in Serum

10369

41436

1.36

147.66

1.7

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

18159

78474

1.28

147.49

2.4

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

5628

20166

1.50

146.66

8.2

8.4

25.03

24.64

mmol/l

12.74

5584

20017

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

12404

50969

1.33

146.60

3.3

3.0

3.07

2.96

e6/l

0.39

5878

24695

(3028026) IgM [Mass/volume] in Serum or Plasma

5250

18559

1.51

145.83

1.8

2.0

1.23

1.33

g/l

3.05

4808

17173

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

7826

29901

1.41

145.83

2.6

38.36

49.20

u/l

1.42

6609

25481

(40767503) Oxygen content in Capillary blood by calculation

2082

5770

1.91

141.51

2.7

2.6

16.93

16.34

12.77

2042

5632

(3015171) Extractable nuclear Ab [Units/volume] in Serum

3632

11908

1.62

139.28

1.3

0.63

0.96

u/ml

1.11

302

921

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

9075

35838

1.37

138.37

1.9

1.8

—

(3019977) pH of Arterial blood

8933

35255

1.37

136.57

7.8

7.42

1.06

4957

18970

(3027801) Oxygen [Partial pressure] in Arterial blood

8919

35211

1.37

136.04

7.8

11.80

12.83

kpa

63.42

8603

33824

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

1214

2765

2.31

135.88

1.2

34.52

28.25

nmol/l

0.60

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

8921

35228

1.37

135.83

7.8

5.16

5.05

kpa

20.86

8611

33841

(3020630) Protein [Mass/volume] in Serum or Plasma

6579

24665

1.43

135.47

2.3

2.8

66.80

66.23

g/l

7.71

6002

22691

(3003396) Base excess in Arterial blood by calculation

8860

34983

1.37

134.92

7.8

1.02

0.84

mmol/l

4.20

7425

28600

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

7530

29060

1.39

131.41

2.2

2.4

0.22

0.21

g/l

21.01

7028

27127

(3016502) Oxygen saturation in Arterial blood

7969

31330

1.37

123.75

8.1

8.2

95.29

95.78

8.55

7739

30196

(3020961) Endomysium IgA Ab [Titer] in Serum

4376

15409

1.51

122.96

1.1

242.11

179.06

titre

0.50

479

(3023520) Reticulocytes [#/volume] in Blood

6957

26815

1.39

121.66

2.6

2.7

72.05

68.36

e9/l

12.65

5137

19582

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6021

22708

1.42

119.10

1.6

1.7

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

873

1840

2.49

115.11

2.4

2.1

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

3713

12870

1.53

111.84

2.1

2.0

39.85

39.67

u/l

0.20

3292

11572

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

2723

8776

1.64

111.15

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

2398

7494

1.69

109.86

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

16239

71284

1.24

108.76

4.6

4.3

22.09

22.07

0.04

7403

34283

(3014111) Lactate [Moles/volume] in Serum or Plasma

7125

28053

1.36

108.59

7.9

7.7

1.34

1.35

mmol/l

0.08

6982

27508

(3020779) Urea [Moles/volume] in Serum or Plasma

7014

27582

1.36

107.67

7.5

7.8

9.89

9.76

mmol/l

0.71

6699

26341

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

4826

17852

1.44

105.47

9.5

10.0

24.47

24.15

mmol/l

9.27

4703

17441

(3006184) Hemoglobin [Mass/volume] in Capillary blood

2283

7125

1.69

105.06

2.3

2.2

132.98

128.80

g/l

11.55

1776

5531

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

12324

52598

1.27

104.54

3.4

3.1

0.70

0.80

ug/l

19.32

7865

33484

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

4203

15244

1.47

101.62

2.5

2.4

6329.15

6170.22

u/l

0.10

1503

6346

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

8292

33721

1.32

101.31

7.0

6.8

—

(3023420) DNA double strand Ab [Units/volume] in Serum

3727

13201

1.50

101.25

1.8

1.9

6.94

8.21

iu/ml

1.07

860

3146

(3012544) pH of Venous blood

7864

31782

1.33

100.26

4.3

4.0

7.38

1.43

4449

18450

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

4374

16071

1.45

98.83

1.1

9.85

7.14

u/ml

0.12

212

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

6124

23874

1.37

98.73

2.6

2.3

6.42

7.72

ug/l

4.32

5285

20915

(3018677) aPTT in Platelet poor plasma by Coagulation assay

11197

47522

1.27

98.71

2.1

2.2

29.74

29.58

1.77

10880

46260

(3021447) Carbon dioxide [Partial pressure] in Venous blood

7771

31423

1.33

98.58

4.3

4.0

5.90

5.80

kpa

15.00

7585

30636

(3002032) Base excess in Venous blood by calculation

7584

30565

1.33

98.43

4.3

4.0

1.88

1.70

mmol/l

4.17

6721

26704

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

1448

4029

1.89

97.07

1.3

0.24

nmol/l

0.03

272

(3030981) Hyaline casts [#/volume] in Urine by Automated count

6400

25200

1.36

96.79

2.6

2.5

0.36

0.42

e6/l

1.12

6122

24057

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

1427

3973

1.89

95.48

1.3

0.91

1.66

nmol/l

0.60

1378

3834

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

5835

22733

1.37

94.20

3.1

3.0

172.04

213.12

ng/l

10.10

5326

20796

(3008898) HLA-B27 [Presence]

3238

11304

1.52

94.00

1.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3622

12951

1.48

93.80

1.5

1.6

13.75

14.73

iu/ml

0.13

379

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

1359

3792

1.89

90.34

1.7

366.52

388.38

mu/l

0.69

1082

3092

(3028271) Lactate [Moles/volume] in Capillary blood

1496

4309

1.83

90.21

2.0

1.8

1.70

1.75

mmol/l

1.07

1462

4181

(3011985) Renin [Units/volume] in Plasma

1449

4132

1.85

90.16

1.5

1.6

70.10

60.13

mu/l

0.77

1308

3737

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

918

2217

2.18

89.81

2.1

2.4

19.36

19.43

nmol/l

0.06

866

2107

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3287

11646

1.50

88.89

2.1

2.0

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

2453

8147

1.59

88.51

1.2

4.25

4.00

0.58

340

1186

(4146454) Self-monitoring of blood glucose

1032

2631

2.06

88.20

2.7

2.8

—

(3023511) Choriogonadotropin [Units/volume] in Urine

2193

7099

1.63

87.75

1.5

1.3

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

2747

9410

1.54

86.78

1.3

31.11

40.52

u/ml

0.95

133

536

(3002256) Pathology report gross observation

9829

41645

1.27

86.60

1.3

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

3139

11079

1.50

86.41

1.3

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

3162

11189

1.50

85.97

1.7

1.6

4.44

4.09

mg/l

0.72

2563

7761

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

2851

9895

1.52

84.87

1.7

1.8

1.22

1.17

g/l

17.71

2733

9468

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

3026

10647

1.50

84.51

2.0

1.8

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

1342

3814

1.85

84.37

1.4

334.78

380.35

pmol/l

0.57

1163

3263

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

4768

18289

1.39

84.19

4.4

4.2

24.36

24.12

mmol/l

5.90

4707

18049

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

1195

3281

1.92

83.31

2.1

2.0

23.31

27.37

mg/l

1.94

470

1176

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

2774

9614

1.53

83.09

1.7

1.8

0.24

0.23

g/l

6.83

2648

9166

(40768443) Skin Pathology biopsy report

3747

13810

1.44

82.84

1.2

—

(3022621) pH of Urine by Test strip

6308

25339

1.33

82.80

2.6

2.5

6.07

6.10

2.00

4026

16864

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

1231

3444

1.88

81.19

1.3

0.20

0.27

nmol/l

0.49

929

2739

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

8707

36682

1.27

79.75

3.8

4.6

233.06

245.29

u/l

12.36

8225

34962

(3024666) Lithium [Moles/volume] in Serum or Plasma

699

1586

2.31

79.02

12.9

13.4

0.60

0.62

mmol/l

1.54

647

1462

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3105

11166

1.47

77.85

2.0

2.4

2.83

2.92

g/l

4.56

2819

10136

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

591

1259

2.46

76.42

2.2

2.0

144.09

119.44

umol/l

0.91

304

631

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3257

11876

1.45

76.04

2.0

2.4

7.36

7.37

g/l

0.08

2971

10840

(3024354) Oxygen [Partial pressure] in Venous blood

6430

26208

1.31

75.73

3.6

3.4

4.60

4.56

kpa

0.91

6260

25492

(3002173) Hemoglobin [Mass/volume] in Arterial blood

7171

29660

1.29

75.68

8.7

8.6

123.81

120.44

g/l

33.20

7037

28948

(3014765) Yersinia sp identified in Stool by Organism specific culture

2422

8315

1.54

75.63

1.2

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3251

11864

1.45

75.57

2.0

2.4

4.29

4.18

g/l

8.44

2970

10838

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

2211

7445

1.57

75.16

1.1

1.77

2.42

u/ml

2.54

1177

4017

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

3242

11846

1.45

74.85

2.0

2.4

3.74

3.71

g/l

0.56

2965

10817

(42529406) Shigella sp [Presence] in Stool by Culture

2422

8342

1.53

74.53

1.2

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

2403

8266

1.54

74.37

1.2

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

2538

8851

1.52

73.75

1.3

5.10

6.88

u/ml

0.50

242

846

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

13611

60679

1.21

73.51

1.7

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

2531

8835

1.51

73.22

1.3

6.94

9.36

u/ml

1.02

361

1287

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

1712

5447

1.66

73.16

1.2

116.67

145.81

titre

0.28

117

(3022806) Fractional oxyhemoglobin in Capillary blood

1159

3295

1.85

72.82

1.9

1.7

89.81

89.91

0.20

1146

3235

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

3016

10946

1.46

72.07

2.2

2.3

412.78

593.96

ug/l

2.94

2841

10328

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

2833

10195

1.47

70.67

2.2

2.5

0.75

0.84

g/l

0.67

2431

8789

(4198724) Urine methamphetamine measurement

623

1421

2.30

69.68

3.3

2.1

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1686

5414

1.64

69.54

1.2

322.52

289.51

titre

0.21

115

415

(3020891) Body temperature

3621

13701

1.40

68.86

4.6

36.93

36.90

°c

4.61

3584

13580

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

2328

8149

1.51

66.41

2.1

11.18

11.57

mg/l

1.32

2151

7670

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

5947

24429

1.30

65.57

2.7

2.8

68.37

67.27

ml/min/173m2

1.10

2681

9962

(3042517) Benzodiazepines panel - Urine

228

293

4.07

65.24

2.9

3.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

2243

7830

1.51

64.80

1.5

1.4

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

832

2208

1.98

63.97

1.2

1.4

1.72

2.25

u/ml

0.67

470

1363

(3034770) Mitochondria Ab [Titer] in Serum

2446

8726

1.48

63.65

1.2

1.3

972.84

941.31

titre

0.07

237

(3003888) Timothy IgE Ab [Units/volume] in Serum

1923

6515

1.56

63.61

1.1

5.23

5.65

u/ml

0.49

1002

3565

(44806420) Estimation of glomerular filtration rate

1085

3156

1.81

63.46

2.6

2.2

—

(3004616) Nuclear Ab [Presence] in Serum

1225

3703

1.74

63.03

1.3

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

1850

6225

1.57

63.03

1.1

0.99

1.15

u/ml

0.44

784

2866

(3024980) IgG subclass 4 [Mass/volume] in Serum

1604

5224

1.62

62.57

1.5

1.6

0.73

0.78

g/l

1.22

1221

4111

(3016244) Insulin [Units/volume] in Serum or Plasma

727

1850

2.06

62.56

3.2

3.0

28.66

22.90

mu/l

3.65

679

1734

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

2395

8551

1.48

62.06

1.1

4.67

5.79

eliau/ml

0.48

288

1117

(3028192) IgG subclass 2 [Mass/volume] in Serum

1075

3145

1.80

61.73

1.4

2.91

2.97

g/l

0.49

756

2293

(3026389) Candida sp identified in Specimen by Organism specific culture

1446

4606

1.65

61.53

1.4

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

3139

11820

1.40

61.23

1.3

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

1073

3146

1.79

61.18

1.4

0.36

0.42

g/l

5.09

756

2291

(3027135) IgG subclass 1 [Mass/volume] in Serum

1074

3151

1.79

61.11

1.4

6.63

6.83

g/l

0.94

753

2294

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

1501

4844

1.63

60.72

1.2

1.3

28.70

35.40

u/l

1.29

1292

4253

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

2238

7929

1.49

60.22

1.3

1.4

494.54

543.78

mg/l

2.87

2135

7613

(3014007) Fractional oxyhemoglobin in Arterial blood

4947

20051

1.31

60.00

10.0

93.62

94.08

5.04

4929

19992

(3010726) Horse dander IgE Ab [Units/volume] in Serum

1812

6142

1.55

59.80

1.1

1.81

1.94

u/ml

0.22

908

3176

(3004716) Salmonella sp identified in Stool by Organism specific culture

4152

16420

1.34

59.76

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

2468

8937

1.46

59.52

1.2

1.3

102.91

122.70

titre

0.68

247

841

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1213

3718

1.72

59.47

1.3

1.5

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1215

3728

1.71

59.35

1.3

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

1476

4786

1.62

58.60

1.4

1.3

22.34

26.37

u/l

4.70

1166

3977

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2182

7738

1.49

58.43

1.3

13.37

14.65

u/ml

0.06

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

1835

6272

1.54

58.36

2.3

2.4

145.78

97.00

ug/min

2.77

1120

3740

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2409

8722

1.46

58.13

1.2

1.1

—

(3037121) Protein [Mass/volume] in Urine

2772

10307

1.42

58.02

3.0

3.5

680.35

493.70

mg/l

0.58

1212

4989

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1232

3820

1.70

57.97

1.3

1.5

—

(4062490) Immunoglobulin typing, IgG

1049

3108

1.77

57.80

1.4

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1542

5073

1.60

57.75

1.1

4.63

5.12

u/ml

0.43

694

2364

(3014133) Dog dander IgE Ab [Units/volume] in Serum

1621

5402

1.58

57.54

1.1

3.95

4.17

u/ml

0.19

807

2799

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

4920

20046

1.30

57.33

9.9

1.36

1.31

2.76

4897

19920

(3010838) Calcium [Moles/time] in 24 hour Urine

1588

5275

1.58

57.14

2.0

1.9

5.10

5.08

mmol/24h

0.09

1411

4734

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

2392

8680

1.45

57.05

1.5

10.30

14.92

iu/ml

1.09

201

(4024509) Urine culture

3596

14011

1.36

56.98

2.0

1.9

—

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

416

866

2.52

56.51

2.3

2.7

1.06

1.17

ug/l

0.43

387

836

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

1629

5459

1.57

56.48

1.5

0.38

0.43

nmol/l

1.10

1252

4282

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

2001

7023

1.50

56.32

1.3

3.73

3.71

mmol/l

0.36

1889

6659

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

2760

10314

1.41

56.15

2.0

2.4

10.08

10.23

g/l

1.02

2440

9194

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

2395

8726

1.45

55.92

2.1

2.4

0.01

0.03

g/l

1.68

2132

7896

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

2097

7451

1.48

55.61

1.2

1.3

4.10

5.26

u/ml

0.29

137

497

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1623

5456

1.57

55.52

1.1

16.87

15.62

au/ml

0.26

397

1466

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2694

10066

1.41

54.84

2.7

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1151

3563

1.70

54.50

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1149

3560

1.70

54.23

1.3

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

2645

9873

1.41

54.14

2.8

3.5

39.60

44.53

mg/l

0.96

2160

8497

(3034860) Kappa light chains.free [Mass/volume] in Serum

2648

9888

1.41

54.08

2.8

3.5

51.24

70.89

mg/l

1.36

2162

8506

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

4764

19475

1.30

54.03

10.2

0.62

0.65

3.22

4742

19365

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

2705

10145

1.41

53.90

2.1

1.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

2065

7373

1.48

53.46

1.6

1.7

12920.36

13800.50

e6/l

0.31

1454

5261

(3020191) Ethanol [Moles/volume] in Serum or Plasma

883

2542

1.82

53.45

1.5

1.27

1.29

promille

0.10

670

2066

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1143

3554

1.69

53.26

1.3

1.5

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

1079

3311

1.71

52.73

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

2285

8361

1.44

52.14

2.1

2.4

0.00

g/l

0.29

1980

7366

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

1978

7037

1.48

52.12

1.4

1.5

1081.51

2249.27

e6/l

1.04

1565

5543

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

1955

6956

1.48

51.49

1.4

30.94

33.34

e6/l

0.10

1438

5181

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

1985

7100

1.47

50.93

1.2

1.3

40.59

46.34

u/ml

0.64

162

666

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

4012

16171

1.31

50.38

3.3

3.0

1.33

1.24

5.70

3999

16095

(3002079) Sodium [Moles/time] in 24 hour Urine

524

1278

2.15

50.30

1.3

163.13

156.08

mmol/24h

0.94

524

1278

(44813793) Dust mix specific IgE antibody measurement

759

2125

1.87

50.11

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

1304

4272

1.60

49.71

5.6

5.3

359.90

364.56

umol/l

0.51

1135

3754

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1371

4548

1.58

49.64

1.1

0.36

0.38

u/ml

0.06

431

1416

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

2553

9617

1.40

49.57

3.1

4.0

1.57

1.49

mg/l

4.44

2323

8889

(3023419) Bacteria identified in Sputum by Culture

1116

3518

1.67

49.46

2.6

—

(3040151) Glucose [Moles/volume] in Capillary blood

1079

3371

1.68

49.44

12.2

5.8

7.46

7.23

mmol/l

0.67

913

2756

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

54446

274082

1.15

49.40

22.5

18.8

332.60

g/l

0.00

54230

272404

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

2397

8939

1.41

49.28

2.0

12.98

16.96

iu/l

0.17

976

3676

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

3974

16053

1.31

49.09

3.3

3.0

0.61

0.63

5.12

3962

16003

(3035637) Corticotropin [Mass/volume] in Plasma

1210

3910

1.63

48.75

1.5

1.6

27.26

34.82

ng/l

2.67

1205

3905

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

1317

4356

1.59

48.29

1.1

2.64

2.82

0.28

234

724

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

529

1322

2.10

47.83

1.6

3.22

6.11

nmol/l

0.85

435

1104

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

2350

8797

1.41

47.28

2.7

3.4

2.52

6.16

ratio

1.90

1302

5160

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

613

1633

1.97

46.79

1.1

5.00

6.53

nmol/l

0.38

123

283

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

735

2085

1.85

46.66

1.2

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

1655

5813

1.50

46.42

1.4

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

726

2063

1.85

45.86

1.2

—

(3042631) Mycobacterium sp identified in Specimen

1119

3608

1.63

45.50

2.8

2.6

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

2119

7846

1.42

45.32

2.1

2.4

0.00

g/l

-0.00

1976

7350

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

730

2088

1.83

45.19

1.4

1.3

174.42

183.94

pmol/l

0.32

730

2088

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

857

2581

1.74

44.80

1.2

66.54

71.41

u/ml

0.14

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

3576

14426

1.31

44.51

1.8

1.53

1.51

g/l

0.84

3072

12423

(3008152) Bicarbonate [Moles/volume] in Arterial blood

4518

18817

1.27

43.95

6.9

6.8

24.72

24.41

mmol/l

6.44

4366

17957

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

989

3118

1.66

43.86

1.2

38.19

46.63

u/ml

0.45

159

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

2292

8660

1.39

43.69

1.8

1.7

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

2097

7803

1.41

43.64

1.5

1.6

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

235

413

2.98

43.49

1.6

1.7

0.76

1.18

nmol/l

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

4591

19195

1.27

43.24

3.6

3.4

131.80

128.60

g/l

17.00

4448

18686

(3023183) Ammonium ion [Moles/volume] in Plasma

1795

6524

1.45

42.43

2.6

2.7

32.57

33.93

umol/l

1.43

1628

5860

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

1400

4847

1.52

42.05

1.3

1.5

14.69

13.94

u/ml

0.05

101

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1896

6980

1.43

41.86

1.4

—

(3012565) Volume of 24 hour Urine

502

1296

2.03

41.80

2.0

2.2

1974.35

1973.27

0.01

448

1172

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1607

5736

1.47

41.68

1.4

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

405

964

2.20

41.34

1.4

153.28

217.57

nmol/24h

0.36

405

964

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

3014

11998

1.32

41.19

2.0

1.84

2.43

ug/l

1.72

2640

10654

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

470

1198

2.05

40.50

1.1

11.06

10.14

u/ml

0.15

209

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

2990

11956

1.32

39.58

1.3

232.03

224.78

miu/ml

0.47

1343

5620

(3006571) Granulocytes/Leukocytes in Synovial fluid

1057

3500

1.59

38.66

1.6

56.39

57.49

0.34

648

2271

(3024928) Oxygen saturation in Venous blood

2050

7776

1.39

38.19

3.6

3.3

61.87

62.02

0.11

1975

7494

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

2116

8069

1.38

38.19

1.6

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

1251

4323

1.52

37.94

1.1

1.48

1.51

g/l

1.96

1146

3970

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

1295

4513

1.51

37.76

1.4

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

1624

5928

1.44

37.55

1.9

2.2

0.98

0.82

nmol/l

14.05

1366

5055

(4015189) Microbial culture of sputum

273

569

2.51

37.23

2.0

2.4

—

(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum

1263

4394

1.51

37.13

1.2

12.79

18.68

u/ml

0.58

185

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

1658

6106

1.43

36.56

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

1658

6107

1.43

36.52

1.3

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2348

9182

1.35

36.16

1.3

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

1443

5193

1.46

35.95

1.7

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

1524

5547

1.44

35.80

1.1

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1516

5521

1.44

35.50

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

877

2838

1.62

35.27

1.3

1.58

1.37

nmol/l

5.83

801

2556

(3027923) C peptide [Moles/volume] in Serum or Plasma

555

1579

1.84

35.08

1.6

1.35

1.22

nmol/l

1.76

389

1244

(3038026) Centromere Ab [Units/volume] in Serum

724

2237

1.70

34.71

1.2

30.09

58.49

u/ml

2.27

145

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

1635

6066

1.42

34.62

1.6

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1457

5295

1.45

34.51

1.2

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1268

4494

1.48

34.13

1.6

1.5

—

(3003181) Sodium [Moles/volume] in Urine

1492

5478

1.43

33.47

1.4

61.22

61.91

mmol/l

0.25

1191

4359

(3018405) Lactate [Moles/volume] in Arterial blood

2390

9481

1.33

33.42

3.9

4.1

1.37

1.40

mmol/l

0.67

2354

9279

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

4232

18042

1.24

33.38

10.1

9.9

16.31

16.01

9.04

4111

17376

(3020717) Zinc [Moles/volume] in Serum or Plasma

580

1707

1.78

32.93

1.5

1.6

21.74

23.31

umol/l

0.62

541

1592

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

453

1232

1.93

32.81

3.9

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

634

1928

1.72

32.22

1.3

5.44

5.38

umol/l

0.10

554

1748

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

560

1653

1.77

31.51

1.5

5.94

5.97

u/l

0.02

491

1397

(3019832) Treponema pallidum Ab [Presence] in Serum

9167

42109

1.16

31.38

1.9

1.8

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1466

5431

1.42

31.33

3.5

3.3

0.79

0.81

nmol/l

1.08

1170

4371

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

525

1524

1.80

31.21

1.3

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

381

994

2.01

31.02

1.4

14.38

15.07

pmol/l

1.41

320

837

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

697

2200

1.66

30.95

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

2160

8542

1.33

30.87

3.0

3.3

1.90

2.26

index

1.22

1115

4367

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

3608

15245

1.25

30.80

4.3

4.0

49.52

47.14

6.60

3563

15037

(3019230) Fractional oxyhemoglobin in Venous blood

1721

6592

1.37

30.27

3.5

3.1

61.98

62.26

0.20

1713

6569

(3025018) Bordetella pertussis Ab [Titer] in Serum

677

2137

1.66

30.08

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

970

3345

1.52

29.81

1.1

23.13

24.81

au/ml

—

(3020876) Protein [Mass/time] in 24 hour Urine

1029

3595

1.50

29.76

2.4

2.5

1.31

1.22

g/24h

0.35

591

2156

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

711

2281

1.63

29.69

1.1

7.72

8.33

iu/ml

0.23

180

638

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

2263

9062

1.31

29.63

1.3

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

982

3401

1.51

29.59

1.1

—

(3044927) Protein electrophoresis panel - Urine

792

2614

1.59

29.50

1.2

—

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

999

3475

1.51

29.50

1.1

1.15

2.05

iu/ml

2.10

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

361

942

2.01

29.42

1.1

1.2

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

475

1369

1.82

28.94

1.6

2.1

1.94

1.93

umol/l

0.07

433

1250

(3027273) Bicarbonate [Moles/volume] in Venous blood

3278

13799

1.25

28.90

3.7

3.5

25.33

25.20

mmol/l

1.36

3172

13337

(3002523) Influenza virus A Ag [Presence] in Specimen

1671

6425

1.37

28.72

1.1

—

(3003694) ABO and Rh group [Type] in Blood

20409

98934

1.11

28.59

1.5

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

525

1567

1.75

28.53

1.4

1.5

—

(3003740) Influenza virus B Ag [Presence] in Specimen

1668

6421

1.36

28.46

1.1

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

543

1638

1.74

28.46

1.4

1.5

—

(3017569) Oxygen content in Arterial blood

496

1458

1.78

28.37

2.6

2.1

16.06

15.74

1.19

496

1458

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

813

2729

1.56

28.22

3.6

4.0

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

1086

3885

1.47

28.00

1.6

1.5

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

583

1803

1.69

27.98

1.5

1.6

6.96

8.62

ug/l

1.71

529

1656

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

2652

10930

1.28

27.92

1.6

1.5

11.00

5.54

iu/ml

0.35

451

2064

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1857

7290

1.34

27.91

1.2

1.3

54.44

43.66

u/ml

0.48

124

(3008295) Osmolality of Serum or Plasma

911

3149

1.52

27.74

1.5

1.4

279.61

278.43

mosm/kgh2o

0.72

676

2428

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

935

3264

1.50

27.19

1.1

24.24

67.42

au/ml

—

(3000012) Reticulocyte production index

1130

4104

1.44

26.96

2.1

2.2

0.95

0.89

2.46

749

2830

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

645

2074

1.63

26.75

1.6

25.05

25.14

u/ml

0.01

112

405

(3037756) Immunofixation for Serum or Plasma

1573

6062

1.36

26.68

1.5

1.7

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1231

4552

1.42

26.65

1.1

3.06

2.95

eliau/ml

0.09

577

2168

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1128

4111

1.44

26.43

1.3

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

1336

5024

1.40

26.29

1.1

178.88

3094.33

iu/ml

0.74

295

1030

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

2720

11344

1.26

25.97

1.5

1.4

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

731

2442

1.57

25.95

1.2

1.3

1.98

2.13

mmol/l

2.61

667

2269

(3004451) EKG impression Narrative

496

1500

1.73

25.83

1.3

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

423

1220

1.81

25.79

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1739

6855

1.33

25.45

1.2

1.3

261.20

253.37

u/ml

0.51

1081

4383

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

339

916

1.94

25.17

1.2

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

788

2701

1.53

25.00

1.4

151497.02

107627.35

e6/l

0.82

515

1794

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

563

1781

1.66

24.92

1.4

—

(4195642) Thrombophilia screening test

1252

4701

1.40

24.89

1.2

—

(3047181) Lactate [Moles/volume] in Blood

2273

9330

1.28

24.73

5.7

5.5

1.32

1.30

mmol/l

0.35

2036

8247

(3007463) Buprenorphine [Presence] in Urine

100

4.23

24.62

8.2

7.2

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

566

1801

1.65

24.51

1.4

1.3

473.78

525.00

titre

0.10

128

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

2853

12094

1.24

23.63

1.4

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

1083

4006

1.42

23.47

1.2

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

255

637

2.09

23.43

1.9

2.2

15.17

17.01

umol/l

1.67

255

637

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

1291

4924

1.38

23.40

1.3

19.60

25.00

u/l

—

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

549

1755

1.64

23.38

1.4

1.3

64.71

72.23

titre

0.19

130

(3020491) Glucose [Moles/volume] in Blood

647

2158

1.57

23.19

1.6

1.8

6.68

6.64

mmol/l

0.14

464

1631

(3003329) Lymphocytes/Leukocytes in Synovial fluid

769

2674

1.51

22.88

1.6

32.01

31.66

0.08

424

1733

(3014271) Vancomycin [Susceptibility]

426

1281

1.74

22.71

3.0

2.9

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

452

1383

1.71

22.67

1.1

1.2

7.85

13.74

u/ml

0.56

160

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

880

3156

1.46

22.51

1.2

1.4

18.50

53.57

u/ml

—

(3004809) Band form neutrophils/Leukocytes in Blood

1313

5064

1.36

22.23

3.3

3.5

1.42

1.56

0.72

1181

4525

(3043409) Potassium [Moles/volume] in Arterial blood

1961

8013

1.29

22.14

4.2

4.4

3.87

3.88

mmol/l

0.65

1951

7937

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

728

2522

1.51

22.07

1.2

111.69

110.88

pmol/l

0.12

728

2522

(3017354) Segmented neutrophils/Leukocytes in Blood

891

3216

1.45

22.07

3.1

3.6

57.17

57.28

0.05

769

2749

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

549

1784

1.61

21.96

2.0

1.9

110.26

98.45

ng/l

1.54

549

1778

(3020650) Glucose [Presence] in Urine

350

1010

1.81

21.42

1.6

1.5

0.06

0.02

estimate

1.04

350

1010

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

746

2620

1.49

21.21

1.2

1.1

36.76

45.11

mg/l

4.72

611

2251

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

1309

5088

1.35

21.11

1.2

1.34

1.05

0.46

234

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

1232

4744

1.36

21.10

1.1

118.75

116.33

1.76

1118

4339

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

418

1278

1.71

21.07

2.4

2.3

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

1027

3840

1.40

21.00

1.5

—

(3034891) Synovial lining cells/cells in Synovial fluid

443

1378

1.68

20.99

1.5

3.80

4.14

0.17

313

(3019897) Erythrocyte [DistWidth] in Red Blood Cells by Automated count

1152

4394

1.37

20.94

2.7

2.5

13.16

13.14

0.35

1141

4343

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

702

2449

1.50

20.63

1.1

290.72

406.33

mg/l

0.48

637

2248

(3045683) HLA typing for celiac disease panel - Blood or Tissue

570

1900

1.57

20.56

1.0

—

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

388

1171

1.73

20.49

1.5

1.4

73.46

73.02

0.25

368

1122

(3018851) Theophylline [Moles/volume] in Serum or Plasma

109

192

2.97

20.41

1.7

1.8

48.36

47.80

umol/l

0.05

109

192

(3036489) Thrombin time

2911

12566

1.22

20.29

1.9

2.2

20.63

21.09

3.66

2514

11152

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

382

1152

1.73

20.23

1.5

1.4

457.37

689.87

mu/l

1.55

362

1103

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

719

2532

1.49

20.21

1.1

246.07

269.28

mg/l

1.85

628

2268

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

652

2250

1.52

20.18

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

2345

9903

1.24

20.12

3.2

0.36

0.34

iu/ml

1.44

1313

5352

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

876

3211

1.43

20.04

1.2

60.76

64.84

u/l

0.84

758

2847

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1271

4962

1.34

19.95

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

686

2402

1.50

19.83

1.1

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

1097

4190

1.37

19.80

1.7

1.9

3219.46

3803.43

titre

0.15

175

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

842

3077

1.43

19.60

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

475

1538

1.62

19.35

1.3

1.2

344.73

320.60

u/l

0.12

429

1442

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

697

2499

1.46

17.98

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

697

2499

1.46

17.98

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

697

2499

1.46

17.98

1.5

1.7

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1088

4218

1.35

17.93

1.3

1.4

7.27

6.99

mmol/l

2.43

978

3734

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

1719

11234

0.79

17.89

1.4

1.5

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

868

3249

1.40

17.73

1.1

—

(3006270) Folate [Moles/volume] in Blood

633

2237

1.48

17.57

1.2

368.91

363.83

nmol/l

0.23

552

1870

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

1756

11417

0.80

17.46

1.4

1.5

1.16

1.17

ratio

0.14

1003

6895

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1869

12069

0.80

17.46

1.4

1.5

61.31

62.62

ug/l

0.56

1547

10135

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

1295

5172

1.31

17.45

1.3

1.2

4.68

3.78

u/ml

0.78

611

2487

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

227

609

1.95

17.41

1.1

1.2

17.40

29.34

u/ml

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

1331

5338

1.31

17.40

1.3

1.2

4.34

3.57

u/ml

0.52

525

2054

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

1763

11449

0.80

17.35

1.4

1.5

0.99

0.94

ratio

2.52

1009

6930

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

1763

11449

0.80

17.35

1.4

1.5

1.21

1.18

ratio

0.55

1010

6997

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1566

6419

1.28

17.34

1.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

399

1274

1.64

17.25

2.1

2.6

98.90

214.39

ug/l

0.49

380

1215

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

316

947

1.75

17.20

1.2

1.1

5.69

5.49

u/ml

0.03

(3029634) Reagin Ab [Titer] in Serum by VDRL

1258

5015

1.32

17.18

2.1

2.2

8.07

7.58

titre

0.04

144

(43055514) Macroprolactin [Presence] in Serum or Plasma

299

882

1.77

17.17

1.5

1.3

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

360

1122

1.68

17.06

1.2

0.30

g/l

0.15

284

909

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

643

2296

1.47

16.97

1.1

18.27

19.10

u/ml

0.21

278

915

(3023410) Appearance of Cerebral spinal fluid

852

3205

1.39

16.94

1.5

1.6

—

(3005570) Glucose [Moles/volume] in Urine

781

2895

1.41

16.90

2.0

1.9

0.14

21.03

mmol/l

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

3168

14028

1.19

16.85

5.2

4.8

1.70

1.63

2.75

3022

13294

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

499

1700

1.54

16.49

1.6

1.5

1853901.92

2105939.28

iu/ml

0.17

114

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

303

909

1.74

16.46

1.2

1.3

17.50

21.74

0.40

170

(3005033) Fetal Nuchal fold Thickness US

1392

9230

0.78

16.43

1.4

1.5

1.28

1.25

1.15

1009

6795

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

710

2601

1.43

16.41

1.1

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

337

1043

1.69

16.41

1.2

109.04

111.69

0.94

299

950

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

187

478

2.05

16.39

2.2

2.4

7.37

7.47

mmol/l

0.11

119

291

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

153

361

2.22

16.33

1.0

77.54

81.51

ug/l

0.52

129

273

(3047352) Trisomy 18 risk [Likelihood] in Fetus

1427

9425

0.79

16.30

1.4

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

358

1131

1.66

16.16

1.0

1.1

—

(3033306) Mononuclear cells/Leukocytes in Cerebral spinal fluid

444

1483

1.57

16.02

1.2

1.3

71.13

63.12

0.77

193

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1714

7174

1.25

15.99

1.4

1.5

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

472

1602

1.54

15.89

1.1

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

336

1050

1.67

15.81

1.9

2.1

40.45

40.31

g/l

0.16

336

1050

(3044242) Glucose [Moles/volume] in Arterial blood

456

1538

1.55

15.79

2.1

1.9

8.09

8.10

mmol/l

0.03

456

1538

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

451

1518

1.55

15.75

1.6

1.9

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

451

1518

1.55

15.75

1.6

1.9

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

451

1518

1.55

15.75

1.6

1.9

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

618

2227

1.45

15.62

1.5

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

282

844

1.75

15.49

1.3

119.73

136.44

nmol/l

0.68

220

607

(3043238) Trisomy 21 risk [Likelihood] in Fetus

1464

9582

0.79

15.49

1.5

1.6

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

554

1958

1.48

15.45

1.0

1.1

0.49

0.95

u/ml

0.73

137

511

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

929

6431

0.75

15.32

1.2

1.3

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

548

1937

1.48

15.28

1.2

1.1

1.06

1.07

ratio

1.04

461

1616

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

449

1521

1.54

15.27

1.6

1.9

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

495

1714

1.51

15.24

1.1

—

(4027681) Cerebrospinal fluid IgG ratio and IgG index

560

1991

1.47

15.18

1.3

1.2

0.70

0.65

ratio

0.16

321

1151

(3032057) Clostridioides difficile [Presence] in Stool

194

523

1.94

14.77

1.8

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

397

1322

1.57

14.57

1.6

2.1

28.89

28.26

umol/l

0.62

369

1242

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

2429

10647

1.20

14.51

1.5

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

508

1788

1.49

14.50

1.0

37.29

43.50

ng/l

2.39

371

1262

(3014599) Egg white IgE Ab [Units/volume] in Serum

596

2167

1.44

14.42

1.1

1.76

2.77

u/ml

0.64

149

575

(3000034) Microalbumin [Mass/volume] in Urine

650

2403

1.42

14.37

3.2

2.9

58.93

56.72

mg/l

0.05

474

1726

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1686

7132

1.24

14.36

1.4

1.5

22.66

20.86

u/ml

0.13

138

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

449

1545

1.52

14.27

1.1

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

506

1786

1.48

14.25

1.0

781.13

725.49

ng/l

1.78

362

1235

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

504

1780

1.48

14.16

1.0

353.82

344.21

ng/l

0.05

375

1276

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

828

3197

1.36

14.13

1.6

1.7

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

474

1654

1.50

14.12

1.1

20.44

24.29

u/l

0.92

420

1479

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

354

1158

1.60

14.02

2.3

2.6

136.29

154.09

nmol/l

2.54

319

1006

(3035320) C reactive protein [Mass/volume] in Body fluid

657

2445

1.41

14.01

3.1

2.5

27.45

29.18

mg/l

0.49

488

1747

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

393

1320

1.56

13.93

1.3

1.4

—

(3045716) Anion gap in Serum or Plasma by calculation

837

3246

1.35

13.90

3.0

10.40

10.82

mmol/l

2.47

825

3203

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

393

1321

1.56

13.89

1.3

1.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

1651

6996

1.24

13.86

1.5

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

475

1668

1.49

13.74

1.1

81.60

84.64

u/l

0.35

420

1492

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

498

1767

1.47

13.69

1.5

1.6

6.36

7.07

u/l

0.59

382

1425

(3020874) Milk IgE Ab [Units/volume] in Serum

609

2246

1.42

13.67

1.1

2.60

1.57

u/ml

0.41

196

761

(40761539) Cells [Type] in Urine sediment by Light microscopy

228

666

1.79

13.65

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

150

2.79

13.65

1.3

1.2

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

3646

21700

0.87

13.31

1.5

1.6

1006.58

1016.72

mu/l

0.22

3087

18506

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

2417

10674

1.19

13.31

2.1

2.5

95.17

92.71

6.29

2312

10291

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

2248

9874

1.19

13.16

2.4

2.7

184.32

189.90

2.08

2125

9416

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

920

3649

1.32

13.16

1.1

98.93

95.28

3.67

865

3437

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

707

2695

1.37

13.12

2.9

2.7

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

1015

4095

1.30

12.84

1.3

53.18

54.20

u/ml

0.04

242

(3007930) Methemoglobin/Hemoglobin.total in Blood

2856

12841

1.17

12.69

5.5

5.0

0.88

0.11

2716

12128

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

758

2939

1.35

12.66

1.7

1.8

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

158

420

1.97

12.60

1.6

108.63

112.65

ug/l

0.17

132

346

(21494755) Public health laboratory ask at order entry panel

7014

33422

1.11

12.48

1.3

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

680

2609

1.36

12.17

1.1

—

(3010015) Selenium [Moles/volume] in Serum or Plasma

120

291

2.15

12.15

2.0

1.9

1.35

1.31

umol/l

0.51

207

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

446

1589

1.47

12.09

2.4

2.3

200.78

202.10

u/l

0.12

441

1577

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

557

2069

1.41

12.09

2.7

3.7

110.72

160.38

nmol/l

1.82

547

2036

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

120

293

2.14

11.96

1.0

1.1

0.65

6.67

u/ml

0.56

155

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

631

2400

1.38

11.93

1.2

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

2343

14280

0.85

11.82

1.4

1.5

—

(3036180) Methadone [Presence] in Urine

4.16

11.81

2.3

4.4

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

585

2202

1.39

11.78

1.0

1.1

—

0.25

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

331

1114

1.55

11.73

1.1

1.0

8.76

11.82

u/ml

1.76

208

729

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

792

3132

1.32

11.64

1.2

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

375

1302

1.51

11.55

1.1

96.48

96.62

0.03

293

1037

(3033099) Centromere Ab [Titer] in Serum

236

733

1.68

11.53

1.1

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

175

498

1.84

11.48

1.9

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

415

1474

1.47

11.46

1.8

2.20

2.85

u/ml

0.48

106

436

(3033923) Metanephrine [Moles/time] in 24 hour Urine

184

534

1.80

11.35

1.1

1.05

3.26

umol/24h

0.40

274

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

8048

38781

1.09

11.29

2.0

1.8

3.61

3.45

ratio

19.67

6094

29184

(3000093) Morphology [Interpretation] in Blood Narrative

750

2958

1.33

11.24

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

222

683

1.70

11.24

1.2

1.1

—

(3016038) Potassium [Moles/volume] in Urine

540

2027

1.39

11.09

1.3

1.2

32.50

34.42

mmol/l

1.18

467

1786

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

160

449

1.86

10.98

2.0

2.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

436

1578

1.45

10.96

2.1

1.9

143.67

147.17

0.37

410

1501

(3036603) Volume of Urine

596

2282

1.37

10.87

1.6

2042.68

1970.13

0.87

582

2229

(3028717) Thiamine [Mass/volume] in Blood

137

366

1.96

10.85

1.2

62.15

62.90

ug/l

0.16

137

366

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

193

580

1.74

10.64

1.2

383.49

305.71

pmol/l

0.42

136

432

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

487

1813

1.41

10.52

1.1

1.05

1.10

u/l

0.86

185

757

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

1508

6522

1.21

10.50

1.8

1.6

—

(4268621) Lupus anticoagulant assay

914

3740

1.28

10.48

2.4

2.3

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

1529

6625

1.21

10.45

1.4

1.5

151.80

147.54

au/ml

0.63

388

1953

(3036670) Protein [Mass/volume] in Synovial fluid

251

817

1.61

10.31

1.2

1.3

40.07

40.28

g/l

0.07

114

453

(3046904) Somatotropin [Units/volume] in Serum or Plasma

4.20

10.16

2.8

1.9

3.65

2.32

mu/l

0.37

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

709

2822

1.31

10.04

4.5

5.5

94.24

108.83

u/ml

0.24

230

991

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

514

1948

1.38

10.03

1.3

1.4

—

(3001186) Copper [Moles/volume] in Serum or Plasma

253

834

1.59

9.89

1.4

1.3

16.49

16.52

umol/l

0.03

217

722

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

107

2.78

9.83

1.5

526.02

517.31

nmol/l

0.03

107

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

505

1917

1.38

9.77

1.3

1.4

—

(3015183) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells

407

1488

1.43

9.76

1.2

9.87

9.63

mm/h

0.15

407

1488

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

365

1309

1.46

9.69

2.3

2.6

51.61

52.04

umol/l

0.09

318

1144

(42529528) Centromere protein B Ab [Units/volume] in Serum by Line blot

190

585

1.70

9.68

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

188

578

1.70

9.63

1.2

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

147

420

1.83

9.62

1.0

8.49

9.45

u/ml

0.13

147

420

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

187

575

1.70

9.58

1.3

1.2

1.19

1.18

mmol/l

1.11

187

575

(3017509) Phencyclidine [Presence] in Urine

134

372

1.88

9.57

1.9

1.6

—

(4034850) Laboratory test

2087

9371

1.17

9.53

10.1

9.9

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

318

1114

1.49

9.50

1.8

2.1

—

(3026470) Cobalt [Mass/volume] in Blood

421

1557

1.41

9.50

2.2

3.85

3.80

ug/l

0.04

391

1441

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

240

2.11

9.47

1.7

1.6

4.02

3.65

mg/l

0.19

146

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

240

2.11

9.47

1.7

1.6

2.07

2.09

mg/l

0.01

157

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

240

2.11

9.47

1.7

1.6

2.68

2.75

mg/l

0.03

170

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

240

2.11

9.47

1.7

1.6

0.65

1.51

mg/l

1.86

141

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

240

2.11

9.47

1.7

1.6

0.71

0.94

mg/l

0.36

160

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

240

2.11

9.47

1.7

1.6

2.19

2.01

mg/l

0.10

174

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

240

2.11

9.47

1.7

1.6

2.15

2.61

mg/l

0.38

165

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

247

2.09

9.47

1.7

1.6

1.39

1.90

mg/l

0.53

157

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

241

2.10

9.38

1.7

1.6

1.58

1.97

mg/l

0.51

177

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

241

2.10

9.38

1.7

1.6

1.85

1.74

mg/l

0.07

147

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

1018

4282

1.24

9.32

6.6

6.2

11.53

11.73

mg/l

0.65

936

3970

(21494890) Protein electrophoresis panel - 24 hour Urine

739

2991

1.29

9.29

1.8

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

313

1106

1.48

9.00

1.8

2.1

—

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

588

2318

1.33

8.97

1.4

12.16

12.55

umol/l

0.62

553

2192

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

313

1107

1.48

8.96

1.8

2.1

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

311

1101

1.48

8.87

1.0

0.38

0.73

u/ml

1.53

302

1083

(3013637) Mi-2 Ab [Presence] in Serum

237

791

1.57

8.86

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

237

791

1.57

8.86

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

237

791

1.57

8.86

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

237

791

1.57

8.86

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

424

1593

1.39

8.79

1.5

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

387

1432

1.41

8.75

2.0

2.2

21.98

43.92

umol/l

2.30

138

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

230

766

1.57

8.68

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1722

7674

1.18

8.68

1.3

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

3597

16867

1.12

8.64

2.7

3.6

45.52

56.63

u/ml

1.29

3471

16323

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

351

1280

1.43

8.61

2.2

2.1

89.40

103.88

ug/min

0.16

310

(3018133) Calcium [Moles/volume] in Urine

191

610

1.64

8.55

2.1

1.9

2.58

2.72

mmol/l

0.43

174

563

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

380

1411

1.41

8.45

1.1

0.14

0.54

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

109

295

1.93

8.44

1.2

1.76

1.70

iu/ml

0.13

149

(3025577) Chromium [Mass/volume] in Blood

402

1513

1.39

8.28

2.1

2.2

2.23

2.40

ug/l

0.45

326

1279

(3051339) Copper [Moles/volume] in Blood

134

2.42

8.27

1.1

1.3

16.16

16.57

umol/l

0.27

115

(3024263) Appearance of Synovial fluid

382

1427

1.40

8.22

1.7

1.8

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

487

1893

1.35

8.21

2.3

2.6

769.11

1061.18

u/ml

2.90

479

1870

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

655

2657

1.29

8.17

1.2

188.46

196.27

titre

0.07

426

(3051387) C reactive protein [Mass/volume] in Capillary blood

1461

6460

1.18

8.11

4.1

3.2

25.78

27.58

mg/l

1.08

986

4483

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

305

1096

1.45

8.11

1.2

111.72

106.92

1.16

271

1012

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

298

1067

1.46

8.08

1.1

93.93

89.15

1.85

139

517

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

653

2652

1.29

8.08

1.2

160.00

212.21

titre

0.29

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

143

429

1.74

8.07

1.6

1.5

189922.70

198871.39

nmol/l

0.02

119

352

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

233

793

1.54

8.05

1.7

9.72

9.04

ug/l

1.31

233

793

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

293

1047

1.46

8.03

1.1

97.06

88.60

2.87

143

512

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

231

786

1.54

7.99

1.1

—

(3000330) Specific gravity of Urine by Test strip

3331

15627

1.12

7.96

3.5

3.3

1.02

ratio

0.04

2967

14004

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

822

3442

1.25

7.92

3.0

3.6

6.17

9.21

nmol/l

0.66

798

3334

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

975

1.47

7.85

3.8

2.9

4.95

4.91

kpa

0.24

275

975

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

275

975

1.47

7.85

3.8

2.9

10.40

10.56

kpa

0.31

275

975

(3011412) CD3 cells [#/volume] in Blood

747

3097

1.26

7.84

2.1

2.5

1294.64

1189.11

e6/l

1.51

655

2710

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

105

289

1.90

7.79

1.0

1.1

0.20

0.98

u/ml

1.25

210

(40762814) Titanium [Mass/volume] in Blood

134

399

1.75

7.77

2.5

4.86

3.28

ug/l

1.00

150

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

692

2846

1.27

7.77

1.2

—

(3010503) CD19 cells [#/volume] in Blood

476

1861

1.34

7.76

2.2

2.7

297.02

299.80

e6/l

0.01

458

1816

(3017817) Protein [Mass] in Urine collected for unspecified duration

662

2709

1.28

7.74

2.3

2.6

1123.02

1063.37

0.31

657

2683

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

349

1301

1.40

7.64

1.1

225.72

329.01

ng/l

0.43

358

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

306

1114

1.44

7.64

1.1

—

(4211845) Urine protein measurement

399

1522

1.37

7.63

3.1

2.9

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

218

744

1.53

7.48

1.6

0.39

0.40

ug/l

0.05

149

543

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2283

10510

1.14

7.46

2.5

2.7

3.66

3.56

g/l

2.22

2179

10089

(37021550) Renin [Units/volume] in Plasma --upright

163

521

1.63

7.36

1.2

1.3

65.56

87.02

mu/l

0.56

118

394

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

484

1913

1.32

7.35

1.2

1.3

84.27

96.36

u/l

1.76

402

1659

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

220

756

1.52

7.33

1.1

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.82

7.32

1.0

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

782

3290

1.24

7.27

1.3

1.4

8.79

8.11

mmol/l

4.24

746

3154

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

124

369

1.76

7.24

1.1

1.2

—

(40762365) Oxygen content in Arterial blood by calculation

133

404

1.72

7.24

2.8

3.1

15.11

14.71

ml/dl

0.75

121

375

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.28

7.24

1.3

1.1

2.22

2.00

g/l

0.41

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

234

1.96

7.23

1.2

0.58

0.57

iu/ml

0.03

111

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

181

2.11

7.20

1.0

21.74

17.37

u/ml

0.27

144

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

116

339

1.79

7.20

1.0

0.22

0.30

u/ml

0.20

215

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

251

893

1.47

7.10

2.4

3.3

1.96

1.80

ratio

0.78

234

817

(3012494) Peanut IgE Ab [Units/volume] in Serum

260

932

1.46

7.08

1.1

13.91

7.74

u/ml

0.25

140

553

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

171

560

1.60

7.03

6.6

7.1

68.08

70.97

0.69

133

429

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

545

2205

1.29

7.02

2.0

2.6

548.69

525.45

e6/l

0.33

442

1762

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

471

1868

1.32

7.01

1.2

1.3

25.26

26.04

u/l

0.10

383

1597

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

116

342

1.77

7.01

1.1

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

207

711

1.52

6.94

1.1

4.09

1.29

u/ml

0.42

168

627

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1573

7096

1.16

6.89

5.2

6.0

4200.62

1003.90

iu/ml

0.49

196

1046

(40759836) Histone Ab [Presence] in Serum by Immunoblot

670

2793

1.25

6.79

1.2

—

(3001556) Androgen free Index in Serum or Plasma

109

320

1.78

6.70

1.4

1.2

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

401

1567

1.34

6.64

1.7

1.8

2.99

2.79

u/field

0.15

297

1104

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

128

395

1.69

6.64

1.2

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

1582

7163

1.16

6.62

1.4

108.91

143.76

pmol/l

2.61

1535

6990

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

585

2408

1.27

6.61

1.7

1.8

3.76

3.86

mg/l

0.20

555

2315

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

660

2756

1.25

6.61

1.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

454

3070

0.77

6.60

1.4

1.6

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

553

2264

1.28

6.53

1.7

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

425

1680

1.32

6.52

1.1

1.2

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

658

2753

1.25

6.49

1.2

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

185

630

1.53

6.48

1.1

10.41

6.20

u/ml

0.27

106

430

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

165

549

1.57

6.40

1.2

1.1

21.20

35.75

iu/ml

—

(3006462) Nitrate [Presence] in Urine

359

1389

1.35

6.37

3.2

3.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

195

675

1.51

6.35

1.1

31.87

29.03

iu/ml

0.30

195

675

(21491868) Cryoglobulin [Mass/volume] in Serum

296

1112

1.39

6.30

1.2

0.28

0.48

g/l

0.58

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

306

1157

1.38

6.27

2.3

1.9

157.53

169.44

1.25

287

1105

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1229

5483

1.17

6.25

2.7

3.0

11369.83

4730.48

u/ml

0.34

314

(3021367) Citalopram [Moles/volume] in Serum or Plasma

2.93

6.16

1.2

1.3

135.83

109.31

nmol/l

0.50

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

154

2.10

6.15

1.2

1.1

1.05

1.21

u/field

0.85

102

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

553

2283

1.27

6.14

2.2

2.7

242.70

225.95

e6/l

0.97

470

1920

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

636

2672

1.24

6.08

1.2

—

(3039000) Anion gap in Blood by calculation

1422

6433

1.16

6.06

7.1

6.5

11.40

11.26

mmol/l

0.77

1300

5785

(3018572) Chloride [Moles/volume] in Blood

1422

6434

1.16

6.05

7.1

6.5

104.88

105.11

mmol/l

1.06

1300

5788

(3025130) Human papilloma virus identified in Specimen

1244

5572

1.17

6.04

1.8

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

112

344

1.70

5.96

1.0

0.24

0.55

u/ml

0.72

174

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

214

1.90

5.95

1.1

1.2

43.76

50.96

mg/l

0.91

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

118

368

1.68

5.94

1.0

0.22

0.62

u/ml

0.69

182

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

120

376

1.67

5.94

1.0

9.49

1.07

u/ml

0.67

183

(3016750) Collection duration of Urine

403

1606

1.31

5.89

2.1

2.3

499.43

501.56

min

0.17

286

1233

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

192

676

1.48

5.81

2.0

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

162

550

1.54

5.81

1.2

1.6

4.81

5.90

nmol/l

3.73

151

534

(3013466) aPTT in Blood by Coagulation assay

173

1.99

5.73

1.2

1.1

36.38

37.74

0.59

152

(3008116) Ketones [Moles/volume] in Urine by Test strip

194

687

1.48

5.72

1.5

1.4

0.20

0.27

mmol/l

0.57

112

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

631

2669

1.24

5.71

1.2

—

(3010370) Gastrin [Moles/volume] in Serum or Plasma

143

474

1.58

5.69

1.8

1.9

53.47

53.75

pmol/l

0.01

114

411

(3042301) Urate [Moles/volume] in Synovial fluid

3.06

5.60

1.0

400.09

336.75

umol/l

0.65

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

269

1.77

5.55

1.0

0.08

0.03

u/ml

0.69

269

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

106

328

1.69

5.52

1.0

1.1

1.15

2.44

u/ml

0.56

252

(3005011) Chlamydia sp Ab [Titer] in Serum

121

388

1.63

5.52

1.7

1.5

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

112

352

1.66

5.52

1.1

1.0

—

(44790049) Parainfluenza type 3 nucleic acid detection

943

4163

1.18

5.50

1.5

—

(3024869) Neuronal Ab [Presence] in Serum

149

503

1.55

5.50

1.1

—

(3004982) Buprenorphine [Mass/volume] in Serum or Plasma

3.18

5.49

3.9

2.7

2.31

2.90

ug/l

0.71

(44790048) Parainfluenza type 2 nucleic acid detection

943

4166

1.18

5.46

1.5

—

(3007700) Barley IgE Ab [Units/volume] in Serum

162

2.00

5.45

1.0

0.42

8.90

u/ml

0.50

(44790047) Parainfluenza type 1 nucleic acid detection

943

4167

1.18

5.45

1.5

—

(44806118) Parainfluenza type 4 nucleic acid detection

942

4164

1.18

5.42

1.5

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

150

509

1.54

5.42

1.2

1.3

572.50

201.57

titre

0.32

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

199

1.89

5.42

1.5

1.4

19.20

14.94

pmol/l

0.45

174

(3028433) Virus identified in Specimen by Culture

251

943

1.39

5.42

1.1

1.2

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.32

5.38

1.0

1.1

0.04

0.12

u/ml

0.48

(40762887) Creatinine [Moles/volume] in Blood

196

1.89

5.37

1.5

1.4

—

(3004775) Volume in Urine collected for unspecified duration

523

2184

1.25

5.34

2.1

2.4

654.74

674.43

0.47

349

1532

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

308

1199

1.34

5.34

2.7

112.74

157.50

au/ml

1.02

174

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

197

1.88

5.29

1.1

8.18

10.16

u/l

0.49

197

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

124

405

1.60

5.28

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

190

1.90

5.26

1.0

1.1

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

105

329

1.67

5.25

1.0

1.1

0.48

2.50

u/ml

2.38

256

(3018333) Ribosomal P Ab [Presence] in Serum

611

2603

1.23

5.21

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

548

2309

1.24

5.18

1.1

1.2

1.21

3.11

0.72

(3002619) Bacteria identified in Specimen by Culture

218

810

1.41

5.05

1.2

—

(3019174) dRVVT (LA screen)

254

1.75

5.04

1.1

1.2

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

243

1.76

5.00

1.0

11.66

7.29

u/ml

0.67

145

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

5960

29291

1.07

5.00

1.7

1.6

3.45

3.48

mmol/l

0.90

4068

19560

(3034274) Bile acid [Moles/volume] in Serum --fasting

1196

5428

1.15

4.97

1.9

2.3

5.85

7.04

umol/l

2.05

866

4008

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

134

453

1.55

4.97

1.1

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

295

1156

1.33

4.93

2.3

2.1

67.25

59.73

ug/l

0.65

286

1136

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

118

388

1.59

4.92

2.5

2.4

0.86

1.27

mmol/l

1.56

272

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

124

413

1.57

4.91

1.2

1.3

34.97

44.25

mg/l

1.60

101

354

(37208534) Antinuclear antibody arbitrary concentration in serum

280

1095

1.34

4.76

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

114

376

1.58

4.72

1.4

1.3

—

(3039744) RNA polymerase III Ab [Units/volume] in Serum

244

1.73

4.71

1.0

7.89

3.24

u/ml

—

(3051611) Lipemic interference index of Serum or Plasma

697

3043

1.20

4.69

3.1

3.5

14.69

13.88

index

0.51

396

1753

(4035726) Immunohistochemistry procedure

5538

27219

1.07

4.65

1.4

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

245

1.73

4.65

1.1

93.23

97.04

titre

0.14

245

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

136

469

1.51

4.64

1.2

1.4

85.58

278.39

ng/l

0.56

306

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

145

508

1.49

4.60

1.5

0.26

0.24

nmol/l

0.26

104

372

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

132

455

1.52

4.53

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

266

1045

1.33

4.43

1.1

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

480

2032

1.23

4.43

1.2

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

111

370

1.57

4.42

1.1

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

266

1046

1.33

4.40

2.8

3.1

28.02

28.81

umol/l

0.54

187

806

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

177

652

1.42

4.37

1.1

1.2

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

184

1.82

4.36

1.5

1.7

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

177

653

1.42

4.34

1.1

1.2

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

110

368

1.56

4.33

1.1

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

372

1539

1.26

4.22

1.2

1.1

4.58

4.06

iu/ml

0.29

126

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

176

653

1.41

4.19

1.1

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

114

388

1.53

4.18

1.2

—

(3018001) Oat IgE Ab [Units/volume] in Serum

238

1.69

4.14

1.0

0.27

0.77

u/ml

0.55

135

(3009015) Lactate [Moles/volume] in Synovial fluid

282

1.63

4.14

1.2

1.3

5.55

6.60

mmol/l

0.60

142

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

106

2.07

4.13

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

145

521

1.45

4.11

2.4

2.8

43.99

43.11

mg/l

0.02

131

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

121

419

1.51

4.11

1.1

—

(40762482) Peach recombinant (rPru p) 3 IgE Ab [Units/volume] in Serum

223

1.71

4.10

1.0

0.62

0.65

u/ml

0.01

207

(3007542) Rye IgE Ab [Units/volume] in Serum

188

1.78

4.10

1.0

0.44

10.20

u/ml

0.50

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

136

483

1.47

4.09

1.1

1.2

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

516

2223

1.21

4.06

1.4

12.73

12.93

u/l

0.28

497

2147

(44806071) Cardiolipin IgM antibody measurement

124

433

1.50

4.05

1.1

—

(40760866) Procollagen type III.N-terminal propeptide [Units/volume] in Serum

4.85

3.99

1.0

1.02

0.78

u/ml

1.55

(3011325) HIV 1+2 Ab [Presence] in Serum

133

1.92

3.99

1.0

0.09

0.08

0.35

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

281

1.62

3.98

1.8

1.6

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

408

1719

1.24

3.98

1.3

1.4

5.73

5.54

mmol/l

2.59

383

1633

(3019920) Amitriptyline [Moles/volume] in Serum or Plasma

2.47

3.95

1.7

1.4

272.52

284.74

nmol/l

0.04

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

2.61

3.89

5.8

5.1

0.28

0.21

mmol/l

0.54

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

219

1.69

3.87

1.0

0.36

2.02

u/ml

1.47

178

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

125

442

1.48

3.87

4.9

5.6

46.09

44.32

ug/min

0.09

354

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

477

2054

1.21

3.80

1.7

2.3

99.52

97.41

0.61

432

1950

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

301

1232

1.28

3.78

1.9

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

253

1.63

3.76

1.6

1.3

7.87

14.96

pmol/l

1.93

217

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

253

1.63

3.76

1.4

1.3

13.55

17.48

nmol/l

0.78

(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay

125

1.92

3.75

1.1

1.2

2160.67

4490.77

ng/l

1.24

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

516

3218

0.84

3.75

1.5

1.6

8.00

7.59

mmol/l

3.23

500

3088

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

328

1360

1.26

3.71

1.1

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

337

1.53

3.68

1.1

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

130

469

1.45

3.66

1.4

1.6

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

330

1372

1.26

3.66

3.7

3.5

7.86

8.79

mg/l

1.80

262

1125

(3026926) Nortriptyline [Moles/volume] in Serum or Plasma

2.22

3.63

1.6

1.5

160.41

271.38

nmol/l

1.02

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

283

1157

1.28

3.61

2.0

1.7

61792.29

13576.90

u/ml

0.68

164

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

1135

5258

1.13

3.60

1.1

5.43

3.18

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

150

1.81

3.57

2.2

1.9

186.47

216.37

ng/l

1.60

132

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

158

594

1.39

3.56

1.2

69.17

62.34

mg/l

0.05

108

427

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

128

464

1.44

3.53

1.0

0.45

0.21

u/ml

0.43

294

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

1833

10474

0.91

3.51

1.5

1.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

268

1094

1.28

3.48

1.1

1.2

—

(3025296) Carrot IgE Ab [Units/volume] in Serum

2.31

3.47

1.0

2.20

0.85

u/ml

0.29

(1175426) CD3 cells/Lymphocytes in Blood

573

2534

1.18

3.46

1.9

2.1

72.87

0.00

551

2443

(3045142) Bone marrow Pathology biopsy report

748

3379

1.16

3.46

1.3

1.4

—

(3006576) Bicarbonate [Moles/volume] in Blood

238

959

1.30

3.42

6.0

6.4

24.96

24.99

mmol/l

0.04

223

860

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

2.04

3.30

1.0

1.1

0.20

0.21

g/l

0.41

(3022493) Free Hemoglobin [Mass/volume] in Plasma

341

1443

1.23

3.28

4.1

4.4

3932.27

1355.01

mg/l

0.95

225

1058

(3008037) Lactate [Moles/volume] in Venous blood

1575

7473

1.10

3.28

3.5

3.1

1.54

1.57

mmol/l

0.67

1524

7313

(3041806) Other cells [#/volume] in Blood by Manual count

353

1503

1.23

3.22

1.6

1.4

0.50

0.52

e9/l

0.67

353

1503

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

114

1.88

3.18

1.1

1.5

—

(3027035) Albumin [Mass/time] in 24 hour Urine

265

1.56

3.18

1.4

1.2

179.55

295.46

mg/24h

0.31

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

145

549

1.38

3.18

3.2

2.3

1.19

mmol/l

0.10

138

519

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

541

2401

1.18

3.17

1.9

2.0

1.93

2.95

u/field

0.53

308

1350

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

307

1.51

3.17

1.1

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/cells in Blood

548

2436

1.18

3.16

1.9

2.1

14.46

14.91

0.47

538

2371

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.13

3.14

1.1

—

mmol/l

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

229

1.60

3.13

1.0

1.1

0.03

0.21

u/ml

1.77

229

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

250

1.57

3.11

1.3

1.2

88.69

107.57

ug/l

0.56

145

(3034988) Calcium [Moles/volume] in Capillary blood

141

534

1.38

3.10

3.2

2.3

1.19

1.18

mmol/l

0.20

134

505

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

226

1.59

3.08

1.2

—

(3044009) aPTT.lupus sensitive (LA screen)

272

1.54

3.06

1.1

1.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

323

1.49

3.04

1.1

—

(3012898) Urea [Moles/volume] in Urine

311

1.49

3.01

1.4

1.5

180.04

155.40

mmol/l

0.91

273

(3017704) Immunofixation for Urine

364

1569

1.21

2.97

1.6

1.7

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

196

1.63

2.95

1.2

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

221

1.58

2.93

2.9

3.3

8.82

421.44

pmol/l

0.69

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

539

2410

1.17

2.92

2.0

2.2

—

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

2.24

2.92

1.1

1.2

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

138

1.74

2.86

1.1

1.5

—

(3016228) CD19 cells/cells in Blood

288

1218

1.24

2.85

2.0

2.1

9.25

8.05

0.81

277

1193

(3013166) Neutrophils/Leukocytes in Synovial fluid

205

833

1.29

2.84

1.4

50.85

55.62

0.97

168

722

(3043410) Blood group antigens tested for on Red Blood Cells

213

870

1.28

2.83

1.9

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

1056

4954

1.11

2.80

1.5

1.7

—

(3046861) Legionella sp Ag [Presence] in Urine

179

1.63

2.78

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.94

2.77

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

2.22

2.77

1.1

3.43

2.48

0.58

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

275

1.50

2.75

1.2

1.1

1.90

2.98

umol/24h

0.38

275

(3026906) Gabapentin [Moles/volume] in Serum or Plasma

3.59

2.71

1.1

1.0

61.83

63.30

umol/l

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

117

1.79

2.71

1.2

1.1

261.94

447.36

u/l

0.71

(3030313) Adrenal Ab [Titer] in Serum

328

1.45

2.68

1.2

1.1

55.00

28.13

titre

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

296

1266

1.22

2.66

2.0

2.2

7.94

9.41

mg/l

4.30

240

1053

(3048879) Bone marrow aspiration report

192

782

1.28

2.64

1.5

2.0

2.00

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

182

1.61

2.63

1.1

—

(3017166) Chili Pepper IgE Ab [Units/volume] in Serum

2.21

2.63

1.0

0.03

0.12

u/ml

0.56

(3020951) Lymphocytes/Leukocytes in Cerebral spinal fluid

103

382

1.41

2.62

1.5

1.3

56.16

51.30

0.45

188

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.93

2.59

1.0

1.1

0.05

0.06

u/ml

0.11

(40761995) Spermatozoa Progressive [#/volume] in Semen

152

1033

0.77

2.58

3.2

3.3

44.82

44.91

0.02

152

1033

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

152

1033

0.77

2.58

6.4

6.5

8.78

0.00

152

1033

(3047189) Immunofixation for 24 hour Urine

308

1329

1.21

2.55

1.6

1.8

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

196

1.57

2.55

2.5

2.3

0.62

0.70

ug/l

1.03

196

(3029396) Erythrocyte agglutination [Presence] in Blood

194

1277

0.79

2.55

2.8

3.1

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

180

1.60

2.53

1.1

44.93

91.49

u/l

0.72

149

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

6358

31929

1.04

2.49

3.5

4.4

16.91

27.74

ug/l

2.09

4978

25922

(3014148) Varicella zoster virus Ab [Titer] in Serum

1067

5045

1.11

2.49

1.2

—

(3035153) Lemon IgE Ab [Units/volume] in Serum

3.92

2.48

1.1

1.0

—

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

348

1.41

2.44

1.9

1.8

1.64

1.76

mg/l

0.34

294

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

203

1.54

2.42

1.2

1.4

2.43

4.48

u/ml

0.49

170

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

142

0.40

2.40

2.8

3.4

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

224

942

1.24

2.40

1.7

134.47

132.05

au/ml

0.03

134

(4133840) Spirometry

205

854

1.25

2.39

1.1

1.2

—

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

2.15

2.38

1.2

1.4

68.79

55.86

e6/l

0.10

(3034426) Prothrombin time (PT)

242

1028

1.23

2.37

1.3

1.2

28.05

28.17

0.12

242

1028

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

173

707

1.28

2.36

1.1

1.2

89.50

84.97

0.60

199

(3020123) Porphyrins [Interpretation] in Serum or Plasma

167

1.59

2.36

1.1

1.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

1.86

2.36

1.2

33.35

31.53

mg/24h

0.16

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

107

1.76

2.36

2.2

2.0

225.77

242.60

ug/l

0.21

107

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

127

1.69

2.34

1.7

1.5

0.25

0.18

u/l

—

(3051651) Icteric interference index of Serum or Plasma

402

1793

1.17

2.34

3.2

4.0

0.82

0.90

index

1.02

396

1750

(37019676) Renin [Units/volume] in Plasma --supine

2.09

2.33

1.0

1.1

74.31

62.23

mu/l

0.11

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

184

760

1.26

2.31

1.2

1.3

106.93

106.70

0.03

176

725

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

108

1.74

2.29

1.2

1.1

1.77

1.00

u/field

0.44

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

386

1721

1.17

2.27

1.2

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

175

721

1.27

2.26

1.0

1.1

—

(3033086) Enterovirus Ab [Titer] in Serum

1.78

2.25

1.1

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

190

1.54

2.25

1.1

—

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

183

759

1.26

2.24

1.2

12.45

11.62

pmol/l

0.11

285

(3036782) Glucose [Moles/volume] in Pleural fluid

650

3011

1.13

2.23

1.3

6.40

6.23

mmol/l

0.78

602

2811

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

410

1842

1.16

2.20

6.7

7.4

123.11

62.46

ug/l

0.38

271

1224

(3036071) Salmonella sp Ab [Titer] in Serum

239

1024

1.22

2.19

1.1

—

(3027874) Urate [Moles/volume] in Urine

102

1.74

2.18

1.1

1.91

7.31

mmol/l

0.48

(3016031) Almond IgE Ab [Units/volume] in Serum

273

1.43

2.17

1.0

1.1

0.37

0.73

u/ml

1.22

159

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

171

707

1.26

2.16

1.1

74.15

75.93

0.15

192

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

1434

8082

0.92

2.14

1.4

1.5

58.92

60.34

ug/l

0.59

1434

8082

(3042847) Granulocytes/Leukocytes in Cerebral spinal fluid

198

1.50

2.09

1.1

26.89

22.59

0.19

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

1.83

2.05

1.0

4.54

2.24

u/ml

0.37

(3044590) Delta aminolevulinate [Moles/volume] in Urine

3.48

2.04

1.0

1.1

13.50

21.33

umol/l

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

195

1.50

2.04

1.5

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

133

1.61

2.01

1.4

1.2

0.06

0.08

g/l

1.54

(3003675) Hemoglobin [Mass/volume] in Cerebral spinal fluid

2.73

2.00

1.1

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

309

1.39

1.99

1.1

21.64

20.15

u/l

0.25

203

(3003577) Lead [Moles/volume] in Blood

261

1.42

1.98

1.4

0.16

0.38

umol/l

1.29

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

2.36

1.96

1.0

1.1

—

(3004280) Aldosterone [Moles/volume] in Serum or Plasma --supine

1.74

1.95

1.0

1.1

160.25

245.36

pmol/l

0.86

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

118

1.64

1.95

4.9

5.9

15.63

17.53

mmol/l

1.47

110

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

267

1174

1.19

1.91

2.5

2.9

0.62

0.61

mmol/l

2.91

267

1174

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

455

2086

1.14

1.90

1.7

2.0

177.48

927.49

pmol/l

1.37

313

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

1319

6390

1.08

1.88

3.0

3.6

485.07

1048.96

u/ml

1.75

1195

5786

(40768441) Liver Pathology biopsy report

517

2393

1.13

1.86

1.3

1.4

—

(3009871) Measles virus Ab [Titer] in Serum

288

1278

1.18

1.86

1.6

3157.82

3390.34

titre

0.20

202

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

149

1.54

1.84

1.1

—

(40760849) Centromere Ab [Presence] in Serum by Immunoblot

104

1.66

1.83

1.2

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

227

1.43

1.80

1.1

12.29

19.07

iu/ml

0.48

(3050794) Legionella sp Ab [Presence] in Serum

280

1.38

1.79

1.1

—

(3013336) Amino acids [Identifier] in Serum or Plasma

1.72

1.77

3.9

2.7

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

235

1030

1.19

1.77

1.5

1.4

—

(21494434) Karyotype in Bone marrow

566

2645

1.12

1.76

1.2

—

(3033463) Neutrophils [#/volume] in Cerebral spinal fluid

2.50

1.73

1.0

1.1

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

110

1.61

1.72

1.2

1.3

1.00

1.18

u/field

0.52

(3027570) Oxalate [Moles/time] in 24 hour Urine

203

1.44

1.72

1.5

286.95

314.81

umol/24h

0.63

203

(3016273) Islet cell 512 Ab [Units/volume] in Serum

212

1.43

1.71

1.0

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

883

5014

0.92

1.67

3.2

3.9

35.70

40.24

u/ml

0.29

853

4841

(3041918) Cholesterol [Moles/volume] in Pleural fluid

139

582

1.25

1.66

1.2

1.62

1.60

mmol/l

0.05

378

(42528596) U1 small nuclear ribonucleoprotein A Ab [Presence] in Serum by Line blot

1.72

1.66

1.0

—

(3007456) Orange IgE Ab [Units/volume] in Serum

1.72

1.66

1.0

0.04

0.21

u/ml

0.65

(3012215) Mononuclear cells/Leukocytes in Synovial fluid

182

787

1.21

1.61

1.3

39.44

38.86

0.07

132

525

(3000936) Kiwifruit IgE Ab [Units/volume] in Serum

1.70

1.60

1.0

0.33

0.79

u/ml

0.64

(3027696) Helicobacter pylori Ab [Titer] in Serum

2.06

1.60

1.1

1798.67

2137.63

titre

0.27

(40765096) Chromosome analysis panel by Banding

205

898

1.19

1.59

1.1

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

2.19

1.59

1.0

0.11

0.05

u/ml

0.44

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.46

1.55

5.3

5.6

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

219

968

1.18

1.54

2.0

1.99

1.77

ratio

1.05

206

940

(3027974) Hepatitis B virus e Ag [Presence] in Serum

208

1.41

1.54

1.6

1.5

—

(42528595) U1 small nuclear ribonucleoprotein 70kD Ab [Presence] in Serum by Line blot

1.74

1.54

1.0

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

415

1925

1.13

1.51

1.9

1.8

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

699

3334

1.10

1.51

1.5

1.4

91744.44

45633.17

e6/l

1.82

367

1903

(3000690) Aldosterone [Moles/time] in 24 hour Urine

2.81

1.51

1.3

1.1

26.96

28.00

nmol/24h

—

(3000219) Insulin receptor Ab [Presence] in Serum

3.73

1.50

1.0

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

424

0.74

1.49

8.9

9.3

0.36

0.41

umol/l

0.32

378

(3043722) Hyaline casts [#/area] in Urine sediment by Automated count

1.74

1.48

1.2

1.0

1.18

1.38

u/field

0.28

(3006598) pH of Arterial cord blood

246

0.66

1.48

1.0

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

1.72

1.48

1.5

1.6

461.75

2025.50

umol/l

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

337

1995

0.88

1.46

2.5

2.8

42.20

38.79

2.45

197

1066

(3004959) Base excess in Arterial cord blood by calculation

245

0.66

1.46

1.0

-1.16

-2.63

mmol/l

0.70

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

2795

13976

1.05

1.46

1.2

0.89

g/l

0.09

2786

13942

(21494567) Legionella sp IgM Ab [Presence] in Serum

233

1.37

1.45

1.1

—

0.23

—

(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma

0.38

1.44

1.2

2.0

9.80

16.11

ng/l

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

176

1.42

1.44

1.0

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

225

0.65

1.43

1.0

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

478

2245

1.11

1.43

2.2

2.7

0.80

0.66

e9/l

3.61

453

2160

(3022229) Phosphate [Moles/volume] in Urine

216

1.38

1.42

2.4

1.9

14.61

19.76

mmol/l

2.22

185

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.65

1.42

1.1

1.2

28.34

49.51

umol/24h

0.59

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

1.96

1.42

1.0

1.1

—

(3022764) Mononuclear cells/Leukocytes in Peritoneal fluid

1.69

1.42

9.5

9.7

49.67

44.34

—

(3051101) Glucose [Moles/volume] in Cord blood

515

0.77

1.42

5.4

5.7

8.52

8.56

mmol/l

0.03

515

(3022640) Eosinophils/Leukocytes in Cerebral spinal fluid

155

1.45

1.41

1.7

1.3

0.96

1.48

0.45

105

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

394

1.27

1.40

3.0

2.8

54.62

78.40

pmol/l

1.54

341

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

121

512

1.23

1.37

1.0

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1193

5840

1.07

1.37

1.3

1.4

3.31

3.65

ug/l

0.80

1085

5287

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

178

1.41

1.37

1.0

1.1

2.40

2.92

u/l

—

(3004541) Aldosterone [Moles/volume] in Urine

2.85

1.36

1.2

1.1

41.00

38.36

nmol/l

—

(3008896) Cortisol [Moles/volume] in Urine

2.61

1.36

1.1

1.2

228.75

72.19

nmol/l

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

319

0.72

1.32

2.8

2.4

3.32

3.26

mg/l

0.06

310

(40768446) Kidney Pathology biopsy report

297

1364

1.14

1.31

1.7

—

(40763791) Oxygen content in Venous blood by calculation

1.65

1.31

4.7

7.4

12.41

12.16

ml/dl

0.09

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

103

0.51

1.30

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

158

1.42

1.30

1.1

—

(42868555) Amyloid beta 40 peptide [Mass/volume] in Cerebral spinal fluid

1.55

1.29

1.0

8560.71

9761.52

ng/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

216

1.35

1.29

2.6

2.5

—

(3021661) Pineapple IgE Ab [Units/volume] in Serum

1.82

1.25

1.0

0.10

0.22

u/ml

—

(3003434) Protein [Mass/volume] in Pleural fluid

872

4239

1.07

1.25

1.5

1.4

33.37

39.93

g/l

0.44

794

3839

(3022577) Toxoplasma gondii IgM Ab [Presence] in Cerebral spinal fluid

2.61

1.25

1.2

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

1.94

1.22

2.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

1.94

1.22

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

1.94

1.22

1.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

1.94

1.22

1.0

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

1.94

1.22

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

1.94

1.22

1.0

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

212

959

1.15

1.19

1.7

108.43

23571643.79

iu/ml

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

399

1.24

1.19

1.7

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

2.05

1.19

1.1

1.0

—

(3009883) Potato IgE Ab [Units/volume] in Serum

1.78

1.18

1.0

0.34

0.35

u/ml

0.01

(3013247) Albumin in CSF/Albumin in Serum or Plasma

169

752

1.17

1.18

1.1

6.61

7.04

mg/g

0.32

163

718

(3038515) Glucose [Moles/volume] in Venous blood

1269

6261

1.06

1.18

3.7

3.3

7.43

7.58

mmol/l

0.81

1225

6138

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.54

1.17

9.9

8.4

—

(3023199) Leukocytes [#/volume] in Pleural fluid

777

3773

1.08

1.17

1.5

1.4

2476.11

3352.95

e6/l

0.82

524

2663

(3037577) Monocytes/Leukocytes in Cerebral spinal fluid

184

1.36

1.17

1.9

1.4

15.15

12.59

0.28

135

(21494815) CD4 cells/Lymphocytes in Specimen

607

2920

1.09

1.16

2.1

2.3

41.11

38.22

4.73

593

2872

(3032868) Hemoglobin electrophoresis panel in Blood

312

1.27

1.16

1.5

—

(3041672) Baker's yeast Ab [Presence] in Serum

185

1.35

1.14

1.0

1.1

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

181

1.36

1.12

1.0

1.1

—

(46236302) HLA-C [Type] by High resolution typing

143

0.62

1.11

1.0

—

(3013862) HLA-DP [Type]

143

0.62

1.11

1.0

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

124

1.43

1.10

1.4

1.2

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

1.56

1.10

1.0

—

(3018562) Neutrophils/Leukocytes in Cerebral spinal fluid

209

1.32

1.09

1.7

1.4

32.80

38.49

0.46

144

(40760409) HLA-A [Type] by High resolution

142

0.62

1.09

1.0

—

(40760410) HLA-B [Type] by High resolution

142

0.62

1.09

1.0

—

(3006969) Lambda light chains [Mass/volume] in Urine

1.52

1.07

1.2

1.1

0.11

0.06

g/l

0.22

(3031659) Enterovirus Ab [Titer] in Cerebral spinal fluid

1.52

1.07

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

1.78

1.06

1.1

1.0

—

(3033942) Copper [Moles/time] in 24 hour Urine

143

1.39

1.05

1.2

1.03

0.79

umol/24h

0.15

(3035082) Kappa light chains [Mass/volume] in Urine

1.49

1.04

1.1

0.02

0.15

g/l

0.68

(40763590) HLA-DQ beta [Type]

140

0.63

1.03

1.0

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

545

3077

0.92

1.02

3.6

4.4

32.97

61.51

u/ml

3.87

539

3041

(3007449) CD3+CD8+ (T8 suppressor) cells/cells in Blood

281

1312

1.12

1.02

1.9

2.2

28.17

30.06

1.52

272

1249

(40768806) Pleura Pathology biopsy report

652

3167

1.08

1.02

1.5

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

122

1.41

1.01

1.2

1.1

0.05

0.42

mg/l

0.50

104

(3007919) Fasciola sp Ab [Titer] in Serum

1.60

1.01

1.1

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

2121

11511

0.96

1.01

2.9

3.7

789.50

2228.22

u/ml

1.39

1783

9988

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.54

0.98

1.0

1.1

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

320

1.24

0.98

1.1

—

(40768800) Prostate Pathology biopsy report

1133

5611

1.06

0.97

1.2

—

(43055459) Dabigatran [Mass/volume] in Serum or Plasma

1.49

0.97

1.5

1.7

156.00

113.31

ug/l

0.41

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

150

1.36

0.97

1.1

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

1.45

0.97

1.1

—

(3024316) Viscosity of Plasma

146

1.36

0.95

1.7

1.9

1.76

1.63

mpas

0.31

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

1.93

0.95

1.1

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

599

2913

1.07

0.93

1.4

—

(3001218) Citrate [Mass/time] in 24 hour Urine

1.55

0.91

1.5

429.68

389.05

mg/24h

0.21

(3006245) CD3-CD19+ cells/cells in Blood

293

1383

1.11

0.91

2.1

2.3

9.94

10.14

0.12

279

1290

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

152

1.34

0.90

1.4

1.3

1.81

1.66

mg/l

0.41

131

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

176

806

1.14

0.90

1.2

—

(3036048) Francisella tularensis Ab [Titer] in Serum

169

773

1.14

0.89

1.2

352.00

576.67

titre

—

(3008640) Bordetella pertussis IgG Ab [Titer] in Serum

1.74

0.86

1.1

3492.17

3559.83

titre

0.03

(4038314) Semen analysis, post vasectomy

302

1.23

0.86

1.3

1.2

—

(3026051) Granulocytes/Leukocytes in Pleural fluid

144

653

1.15

0.86

1.4

22.76

23.14

0.05

119

539

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

538

3011

0.93

0.85

1.6

1.9

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

594

2901

1.07

0.84

1.3

460.92

486.04

u/l

0.08

560

2747

(3038702) Sodium [Moles/volume] in Capillary blood

0.00

0.83

0.0

3.6

—

139.29

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

2532

12813

1.03

0.83

1.1

0.66

0.61

ratio

2.60

274

1468

(40758292) HTLV I+II Ab panel - Serum

115

697

0.86

0.82

1.3

—

(3041354) Potassium [Moles/volume] in Venous blood

695

3416

1.06

0.82

2.5

2.3

4.03

4.06

mmol/l

1.42

689

3389

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

414

1.19

0.82

1.1

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

371

1.20

0.81

1.1

1.3

—

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

137

1.33

0.81

1.0

0.10

0.15

u/ml

0.21

(3022475) Manganese [Moles/volume] in Blood

183

1.28

0.80

1.3

0.16

umol/l

0.20

183

(3021691) Plasmodium malariae Ab [Titer] in Serum

1.74

0.80

2.4

—

(3041184) Isoniazid [Presence] in Urine

1.74

0.80

1.6

2.7

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

536

2616

1.07

0.79

1.2

1.3

78.79

79.81

0.10

192

(3035285) Chloride [Moles/volume] in Venous blood

694

3416

1.06

0.79

2.5

2.3

105.93

105.61

mmol/l

1.13

688

3388

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

207

1.26

0.78

1.7

2.1

209.30

175.51

ug/g

0.55

182

(40771922) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by based on 1.73 sq M

250

1.23

0.77

1.3

1.4

1.05

1.54

ml/s/173m2

0.76

161

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

180

1.28

0.76

1.0

1.3

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

162

1.29

0.75

1.3

1.9

0.67

0.74

umol/l

0.31

127

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

254

0.78

0.75

1.0

1.1

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

156

721

1.13

0.74

1.5

1.3

26.24

61.37

g/l

0.75

117

551

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

195

1.26

0.74

1.0

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

544

0.85

0.73

2.3

2.6

—

(3039114) Acanthocytes/1000 erythrocytes in Blood by Light microscopy

1.69

0.73

1.5

1.0

1.91

1.21

0.41

(3008536) Aspergillus sp Ab [Presence] in Serum

141

649

1.13

0.72

1.7

2.3

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

916

4560

1.05

0.72

2.8

2.9

184.23

814.55

u/ml

1.63

907

4508

(3004593) Baker's yeast IgA Ab [Units/volume] in Serum

229

1.23

0.71

1.1

18.43

30.43

u/ml

0.92

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

229

1.23

0.71

1.1

16.66

24.24

u/ml

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

406

2274

0.93

0.70

18.2

21.5

1328.54

2818.79

nmol/l

1.10

393

2192

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

133

0.71

0.70

1.0

1.1

—

(3045788) Cell count panel - Pleural fluid

620

3059

1.06

0.69

1.5

1.4

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

467

2284

1.07

0.68

1.3

13.45

14.60

u/l

0.46

429

2103

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

179

1.25

0.67

1.0

1.2

—

470.00

—

(3029612) Listeria sp Ab [Titer] in Serum

1.45

0.67

1.4

1.3

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

399

1.16

0.67

1.3

5.84

5.74

mmol/l

0.46

399

(3052592) Norovirus Ag [Presence] in Stool

100

600

0.87

0.67

1.2

1.4

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

170

1.26

0.66

4.7

5.2

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

138

1.29

0.65

1.0

1.1

1.71

1.06

u/ml

0.15

138

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

845

4212

1.05

0.65

2.4

2.5

26.94

26.91

iu/ml

0.00

374

(3017501) Neutrophils [#/volume] in Blood by Manual count

0.00

0.64

0.0

1.7

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

678

3365

1.05

0.63

2.5

2.3

1.20

mmol/l

0.54

672

3338

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

344

0.83

0.62

1.0

1.1

1.13

1.18

mom

0.25

344

(3046914) Granular casts [#/area] in Urine by Computer assisted method

1.48

0.62

1.5

1.3

0.50

0.67

u/field

—

(3011544) Albumin [Mass/volume] in Pleural fluid

296

1.18

0.61

1.1

1.2

17.37

17.20

g/l

0.07

271

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

254

1438

0.92

0.61

1.1

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

171

807

1.11

0.61

1.3

1.4

14.71

13.29

g/l

1.06

127

602

(3049233) Organic acids panel - Urine

1.49

0.61

1.1

1.2

—

(40757373) Influenza virus identified in Isolate

589

0.88

0.60

1.9

1.5

—

(3000285) Sodium [Moles/volume] in Blood

123

570

1.13

0.60

1.2

138.76

138.18

mmol/l

1.00

102

480

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

348

0.84

0.60

2.7

3.2

1.52

1.24

mg/l

0.44

236

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

146

684

1.11

0.60

2.6

2.7

7.85

505.59

ug/l

1.75

146

684

(40759632) Porphyrins [Mass/mass] in Stool

1.55

0.59

1.0

1.1

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

326

1.17

0.59

1.1

373.69

278.10

u/ml

0.46

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

124

577

1.12

0.58

1.4

1896.43

167018.73

u/ml

0.53

(3020356) Listeria sp identified in Specimen by Organism specific culture

267

0.82

0.57

1.1

—

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

101

464

1.14

0.57

1.5

1.7

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.46

0.56

1.2

1.0

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

1.48

0.54

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

387

2146

0.94

0.54

14.1

16.0

768.53

2146.45

nmol/l

1.07

373

2077

(4212803) Bone marrow aspirate examination

242

1.19

0.54

1.1

—

(3035611) Eosinophils/Leukocytes in Synovial fluid

185

1.21

0.54

1.8

1.03

0.53

0.69

145

(1617658) Protocol used for examination of sentinel lymph nodes

445

2197

1.06

0.53

1.0

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

1.49

0.53

1.0

—

(3045462) Protein/Creatinine [Ratio] in Urine

471

0.88

0.52

4.1

4.3

55.55

49.43

mg/mmol

0.11

429

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

246

0.83

0.51

1.7

2.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

268

1304

1.07

0.51

1.1

1.2

—

(3013762) Body weight Measured

107

0.73

0.51

1.1

—

(3001729) Color of Synovial fluid

220

1.19

0.51

1.7

—

(3026480) Teichoate Ab [Titer] in Serum

269

1.16

0.49

1.1

—

2.62

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

426

1.13

0.49

1.3

394.22

70.95

u/l

0.50

307

(3017958) Strawberry IgE Ab [Units/volume] in Serum

107

1.27

0.48

1.0

0.07

0.15

u/ml

0.41

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

105

491

1.12

0.48

1.2

1.4

—

(3044316) Mercury [Moles/volume] in Urine

0.58

0.48

1.6

2.7

4.52

12.35

nmol/l

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

212

1.18

0.47

6.6

4.8

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

123

582

1.10

0.46

1.1

1.2

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

379

1.13

0.46

2.9

3.3

39.71

41.66

umol/l

0.35

318

(3013727) Leukocytes other/Leukocytes in Blood

198

958

1.08

0.46

3.9

3.5

52.60

52.21

0.09

192

925

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

1.74

0.45

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

1.74

0.45

1.0

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

218

1060

1.07

0.45

1.9

2.2

0.26

0.71

e9/l

0.93

105

489

(42528783) Honey bee recombinant (rApi m) 10 IgE Ab [Units/volume] in Serum

1.38

0.44

1.0

1.1

1.02

0.43

u/ml

0.25

(3018738) Hemoglobin F/Hemoglobin.total in Blood

241

0.84

0.43

2.0

3.4

19.64

11.95

—

(3025311) HLA-B [Type]

0.00

0.43

0.0

1.0

—

(3005067) clonazePAM [Moles/volume] in Serum or Plasma

1.39

0.42

7.4

1.4

62.60

61.28

nmol/l

—

(3020399) Glucose [Mass/volume] in Urine

0.00

0.42

0.0

1.6

—

1.77

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

119

1.23

0.41

1.2

1.1

231.09

314.86

nmol/l

1.11

119

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

216

1.16

0.40

4.9

5.7

—

(3010937) Rubella virus Ab [Presence] in Serum

261

0.86

0.40

1.0

1.1

—

(3009677) Dengue virus Ab [Presence] in Serum

144

1.20

0.39

1.2

1.1

—

(3034614) HLA Ag [Interpretation]

1.29

0.38

1.0

1.2

—

(3020618) Glucose [Moles/volume] in Synovial fluid

106

1.23

0.38

1.0

1.1

5.41

4.84

mmol/l

0.41

(3006567) Chloride [Moles/time] in 24 hour Urine

1.36

0.38

1.1

1.2

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.76

0.36

1.0

1.1

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

1.42

0.36

1.7

1.1

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.27

0.35

5.7

5.5

5.29

7.10

mg/l

—

(3026250) Tacrolimus [Mass/volume] in Blood

312

1551

1.05

0.35

40.5

42.9

7.41

7.23

ug/l

0.91

281

1419

(3042733) HLA Ab [Presence] in Serum

232

1144

1.06

0.35

5.1

4.9

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

368

1.11

0.34

2.7

2.4

0.67

0.58

u/field

0.27

368

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

176

1.16

0.33

3.7

3.8

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

149

833

0.93

0.33

1.2

64.42

68.56

ug/l

0.48

149

833

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

152

1.17

0.33

7.8

11.1

106.71

104.58

g/l

0.41

152

(3038071) Oxygen [Partial pressure] in Mixed venous blood

144

701

1.07

0.33

7.1

7.8

5.79

5.67

kpa

0.18

144

701

(3015665) Acarus siro IgE Ab [Units/volume] in Serum

123

1.19

0.32

1.0

0.14

0.39

u/ml

0.88

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.33

0.32

1.0

1.1

—

(3036955) Alkaline phosphatase.liver/Alkaline phosphatase.total in Serum or Plasma

1.28

0.32

2.3

2.0

30.43

26.88

0.42

(3006840) Garlic IgE Ab [Units/volume] in Serum

1.37

0.32

1.0

1.1

0.07

0.81

u/ml

—

(40758358) Immune stain study

124

1.18

0.30

1.0

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

124

1.18

0.30

1.0

0.01

0.08

u/ml

1.27

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

139

1.16

0.29

7.5

10.3

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

1.21

0.29

1.1

1.0

20.51

10.42

mg/l

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

358

1.09

0.28

1.3

1.2

21.61

20.62

mmol/l

1.06

305

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

0.77

0.28

9.7

3.6

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

384

1.09

0.27

2.3

2.6

—

(4281824) Cell count and differential, peritoneal fluid

638

3423

0.97

0.27

1.2

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

284

1545

0.96

0.26

1.3

1031.25

1041.57

titre

0.04

344

(40768795) Lymph node Pathology biopsy report

624

3170

1.03

0.26

1.2

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

136

1.15

0.26

1.0

1.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

460

2327

1.03

0.26

1.4

1.5

33.90

34.34

nmol/l

0.10

411

2171

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

327

0.91

0.25

1.3

1.2

0.08

0.31

u/ml

—

(3003157) Bacteria [#/volume] in Mother's milk

0.81

0.25

6.4

6.8

—

(3018291) Platelet Ab [Presence] in Serum

1.26

0.25

1.0

1.1

—

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

759

3871

1.02

0.25

2.0

23.93

26.64

ug/l

0.34

739

3795

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

1.37

0.24

1.0

—

(3018910) Alkaline phosphatase.bone [Mass/volume] in Serum or Plasma

1.37

0.24

1.0

1.2

20.50

37.34

ug/l

—

(3045759) Histamine [Moles/volume] in Serum or Plasma

1.31

0.23

1.0

1.6

—

(3012989) Citrate [Moles/time] in 24 hour Urine

1.21

0.23

1.9

1.4

1.71

2.00

mmol/24h

0.48

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

160

794

1.05

0.23

7.3

7.9

5.98

5.96

kpa

0.07

145

702

(3022912) Hexacarboxylporphyrin [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.0

—

(3020132) Chylomicrons [Presence] in Serum or Plasma

0.00

0.22

0.0

2.2

—

(1176058) AMPAR2 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.22

0.0

1.0

—

(1175312) AMPAR1 Ab [Titer] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.22

0.0

1.0

—

(42529039) t(15;17)(q24.1;q21.1)(PML,RARA) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.22

0.0

6.0

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

466

1.06

0.21

2.2

1.9

—

(3000510) Lepidoglyphus destructor IgE Ab [Units/volume] in Serum

119

1.14

0.21

1.0

0.11

0.57

u/ml

1.29

(3001893) Eosinophils/Leukocytes in Pleural fluid

162

885

0.96

0.20

1.4

2.94

2.72

0.13

140

744

(3023383) Lactate [Moles/volume] in Pleural fluid

183

916

1.04

0.20

1.3

3.84

3.40

mmol/l

1.01

167

843

(3000919) Neutrophils/Leukocytes in Pleural fluid

148

809

0.95

0.20

1.4

21.08

21.21

0.02

138

727

(3029856) Leukocytes [#/volume] in Peritoneal dialysis fluid

170

1.11

0.19

15.6

11.2

207.26

223.81

e6/l

0.05

120

(3036005) Urine sediment comments by Light microscopy Narrative

1.18

0.18

1.0

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

122

668

0.95

0.18

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.85

0.18

1.1

294.57

269.44

u/ml

0.27

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

297

1.07

0.17

1.6

1.4

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

168

0.90

0.17

1.4

1.1

—

(3024471) HLA-A [Type]

200

1080

0.97

0.16

1.0

—

(3040794) Aluminum [Moles/volume] in Urine

1.12

0.15

1.3

1.1

0.40

0.30

umol/l

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

264

1.07

0.14

1.4

1.1

9.36

9.77

mg/l

0.09

244

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

173

1.09

0.14

1.0

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

153

771

1.04

0.14

2.2

2.8

130.90

101.66

ng/l

0.47

427

(3020393) Adenovirus Ag [Presence] in Stool

382

1.05

0.14

1.3

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

187

1006

0.97

0.13

2.0

1.8

12621.93

11829.53

e6/l

0.05

505

(3028029) Mesothelial cells/Leukocytes in Pleural fluid

438

0.95

0.13

1.4

10.10

11.52

0.28

211

(3036312) Salmon IgE Ab [Units/volume] in Serum

220

1.07

0.12

1.0

4.20

1.19

u/ml

0.46

151

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

346

1771

1.02

0.12

1.2

—

(3022670) pH of Venous cord blood

1.11

0.12

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

372

0.95

0.11

1.4

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

135

1.08

0.11

1.4

1.6

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

153

821

0.97

0.10

1.6

1.9

37.34

40.01

u/l

0.07

142

746

(3018834) Bilirubin.total [Presence] in Urine by Test strip

179

0.93

0.10

3.4

4.0

0.00

estimate

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

1.09

0.10

1.2

1.0

—

(3008838) Granulocytes/Leukocytes in Peritoneal fluid

1.04

0.09

1.0

1.4

—

24.67

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

364

0.96

0.09

1.7

2.5

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

385

0.96

0.09

2.4

3.0

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

166

848

1.02

0.08

1.3

260.81

233.55

ug/l

0.06

451

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

326

1678

1.01

0.08

5.5

6.7

727.20

3044.50

u/ml

0.59

320

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

132

1.07

0.08

3.3

3.9

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

447

2359

0.99

0.07

1.2

—

(3032641) Amino acids panel - Urine

1.04

0.07

1.4

1.3

—

(3004437) Lymphocytes/Leukocytes in Peritoneal fluid

261

0.96

0.07

2.1

64.88

58.49

0.54

166

(3010375) cycloSPORINE [Mass/volume] in Blood

272

1440

0.99

0.07

29.3

29.6

114.58

116.94

ug/l

0.22

217

1199

(3034459) Mononuclear cells/Leukocytes in Pleural fluid

354

1.03

0.07

1.4

73.89

70.62

0.38

292

(3024932) HLA-DR beta [Type]

198

1051

0.98

0.07

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

434

0.97

0.06

1.2

1.9

6.41

7.55

mmol/l

2.11

142

(3021162) Amylase [Enzymatic activity/volume] in Specimen

100

534

0.98

0.06

3.0

2.7

877.46

1645.98

u/l

0.65

480

(40765089) Chromosome analysis panel - Blood by G-banded

266

1372

1.01

0.05

1.0

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

154

791

1.02

0.05

1.1

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

270

1395

1.01

0.04

3.4

3.3

1.29

1.32

0.07

270

1395

(3044007) Cell count panel - Peritoneal fluid

187

988

0.99

0.04

2.2

1.8

—

(3014891) Appearance of Pleural fluid

405

0.98

0.04

1.7

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

181

934

1.01

0.04

1.6

1.5

—

(46234826) Other cells/Leukocytes in Peritoneal fluid by Manual count

210

0.97

0.03

2.3

2.1

14.89

17.32

0.23

106

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

286

1.02

0.03

1.0

1.1

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

220

1158

0.99

0.03

2.1

1.9

5133.92

1817.44

e6/l

0.42

146

754

(3005532) Lymphocytes/Leukocytes in Pleural fluid

195

1026

0.99

0.02

1.4

61.80

63.48

0.27

160

845

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

309

1622

0.99

0.02

1.4

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood by calculation

523

0.99

0.02

7.0

6.7

10.39

10.67

0.60

523

(3035880) pH of Pleural fluid

313

1626

1.00

0.02

1.3

7.41

0.02

214

1156

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

309

1621

1.00

0.02

1.4

1.5

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

506

1.01

0.02

1.2

1.3

0.78

1.31

mmol/l

0.85

334

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

293

1.02

0.01

1.1

—

(1761482) Bacteria [#/volume] in Urine by Culture

1400

7299

1.00

0.01

4.4

4.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

218

0.98

0.01

1.0

—

(3017414) Tyrophagus putrescentiae IgE Ab [Units/volume] in Serum

111

0.99

0.00

1.0

0.09

0.96

u/ml

0.75

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

186

1.01

0.00

1.2

1.3

173.19

1072.97

u/l

1.17

165

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

116

607

1.00

0.00

1.9

1.8

2.20

3.56

ug/l

0.77

386

(44786800) Granulocytes/Leukocytes in Body fluid

332

1.01

0.00

1.4

1.3

27.84

23.72

0.41

257

(3027653) Mycophenolate [Mass/volume] in Serum or Plasma

269

0.99

0.00

3.0

4.4

2.36

2.25

mg/l

0.16

227

(40771459) Voltage-gated potassium channel Ab [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: SLEEP – Sleep disorders (combined)

GWS hits: 35

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Sleep disorders (combined)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints